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Abstract 
 
Malaria is a vector-borne disease causing at least 200 million cases and 580,000 
deaths annually. Frequent exposure to the Plasmodium parasites that cause malaria 
induces immunity that prevents symptoms, but not infection. In endemic areas, 
asymptomatic, or ‘silent,’ human infections are common, potentially representing 
persistent sources of transmission. To characterize such infectious reservoirs, cross-
sectional surveys were undertaken seasonally across three diverse Districts in southern 
Malawi. Humans can infect mosquitoes that feed on their blood when it contains the 
Plasmodium gametocyte stage, but gametocytes occur at low densities, and are difficult 
to detect using traditional microscopy. Blood samples from a subset of the study 
population were tested using polymerase chain reaction (PCR) for P. falciparum genomic 
DNA and a novel quantitative reverse transcription-PCR (qRT-PCR) assay for stage-
specific messenger RNA (mRNA) transcripts. The qRT-PCR assay was found to be valid 
for use in this community-based study population, and vastly improved sensitivity for 
detecting gametocytes over microscopy. These results were then used to analyze the 
population-level predictors of gametocytemia. Asymptomatically infected people were as 
likely to be gametocytemic as those reporting symptoms. School-aged children (6-15 
years) were the most likely to be gametocytemic, though under-5-year-olds suffer the 
greatest malaria disease burden. Since untreated infections can persist for months, 
treatment-seeking behaviors were assessed for their potential to shorten duration of 
infectiousness. Treatment-seeking was common (>85%) among participants reporting 
recent fever, but few afebrile subjects sought treatment. Only 25% of P. falciparum-
infected people had sought treatment in the previous two weeks. Appropriate testing and 
antimalarial treatment was most likely to occur at government/private facilities, but 
school-aged children and adults were more likely to use shops or other sources. These 
studies demonstrated that gametocyte carriage is common among asymptomatic 
xv 
 
infections, and that these infections are unlikely to receive antimalarial treatment. School-
aged children were key reservoirs of the infectious stage of the Plasmodium parasite. 
Malaria elimination interventions will need to address these human reservoirs in order to 
interrupt transmission, but control efforts will benefit from expanding coverage to school-
aged populations. 
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CHAPTER 1 Introduction 
 
1.1 Malaria epidemiology and parasite life cycle 
Human malaria is a mosquito-borne disease caused by any of five species of 
Plasmodium protozoan parasites: P. falciparum, P. vivax, P. malariae, P. ovale, and P. 
knowlesi.1 The early symptoms of malaria are non-specific, and may include periodic 
fever, rigors, myalgia, arthralgia, headache, cough, diarrhea, vomiting, and anemia. 
Those infections caused by P. falciparum can lead to more severe complications, 
including cerebral malaria with coma, convulsions, respiratory distress, severe anemia, 
and renal failure.1,2 Infections caused by other Plasmodium species are not typically life-
threatening, though P. vivax can rarely lead to splenic rupture, and may contribute more 
to mortality than previously thought.1 In the latest World Malaria Report, the World 
Health Organization (WHO) estimated that there were 198 million cases and 584,000 
deaths globally in 2013, with the majority of cases and 90% of deaths concentrated in 
sub-Saharan Africa (SSA) (Figure 1.1).3 Although this represents significant progress 
toward malaria control in the past decade, there are still an estimated 3.2 billion people 
living at risk of infection, and 1.2 billion at high risk of disease (>1 in 1000 chance of 
getting malaria in the next year).3 
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Figure 1.1. Global incidence of malaria, 20133 
 
 
 Nearly all transmission of Plasmodium is vector-borne, with an obligate phase of 
sexual reproduction taking place in mosquitoes of the genus Anopheles (Figure 1.2).4 
Plasmodium infections in mosquitoes are transmitted to humans by the bite of infected 
Anopheles mosquitoes, which primarily bite at night.2 When an infected mosquito takes a 
blood meal, sporozoite forms of the parasite are injected with saliva from the mosquito 
salivary glands into the human bloodstream. In the initial, exo-erythrocytic stage of 
human infection, these sporozoites then invade hepatocytes in the human liver and 
develop into liver schizonts through asexual reproduction.1,2,4 After 6 to 14 days, these 
liver schizonts rupture, releasing thousands of merozoites into the bloodstream to initiate 
the second asexual phase of reproduction, the erythrocytic stage of the life cycle.1,2 In this 
erythrocytic cycle, merozoites invade red blood cells (RBCs), develop into trophozoites, 
and undergo asexual reproduction to produce blood schizonts, which also rupture and 
release merozoites into the bloodstream, continuing the cycle.4 The periodic release of 
asexual merozoites into the bloodstream is responsible for the clinical manifestations of 
malaria disease;1 however, these asexual stages of the parasite are not involved in 
transmission to other blood-feeding mosquitoes.  
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Figure 1.2. Life cycle of the Plasmodium parasite4 
 
 
A small proportion of merozoites invade RBCs and, instead of continuing asexual 
reproduction, develop into the sexual stage gametocytes that are infectious to mosquitoes 
(Figure 1.3).5 Usually gametocytes make up <5% of detectable circulating parasites, and 
the triggers that lead certain merozoites to commit to gametocytogenesis are poorly 
understood.5 After invasion of a RBC, these sexually-committed merozoites go through 
five stages to develop into mature gametocytes over the course of one to two weeks.5,6 
Early gametocyte stages (I-III) are morphologically indistinguishable from asexual 
parasite stages by microscopy, and tend to sequester in the spleen and bone marrow.5–7 
By stage V, the mature gametocytes circulate in the bloodstream, and male 
(microgametocyte) and female (macrogametocyte) P. falciparum gametocytes are 
morphologically distinguishable.5 Circulating gametocytes do not play a role in clinical 
manifestations of malaria disease,2,5 but, because they infect mosquitoes, are critical for 
ongoing transmission.  
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Figure 1.3. Stages of P. falciparum gametocyte maturation5 
 
 
For a human to transmit a Plasmodium infection to an anopheline mosquito, the 
mosquito must ingest at least one male and one female stage V gametocyte during 
feeding (Figure 1.2).4,5 Once inside the mosquito midgut, the sexual, sporogonic phase of 
the lifecycle takes place. The male microgametocyte exflagellates and merges with the 
female macrogametocyte to form an ookinete, which then penetrates the wall of the 
mosquito’s midgut and becomes an oocyst in the hemocele.1,2,4 Asexual division occurs 
within the oocyst over a period of days to weeks (the extrinsic incubation period) until 
the oocyst bursts, and the released sporozoites travel to the salivary glands, where they 
can infect a human during subsequent blood meals.1,2,4 
 
1.2 Reservoirs of infection 
Frequent human exposure to Plasmodium parasites confers some immune 
protection from symptomatic malaria disease, but does not lead to full protection against 
future infection.8,9 Instead, there is thought to be a gradual development of a non-
sterilizing immune response over time, and ‘silent,’ asymptomatic infections are common 
in endemic areas.9–12 Given that asymptomatic infections are unlikely to be treated, this 
may lead to chronic carriage of the parasite that can last for months or even years,13,14 
rarely, if ever, prompting acute symptoms of malaria disease.8,15 
Traditionally, light microscopy of stained blood smears on glass slides has been 
used to determine Plasmodium presence and diagnose malaria in clinical cases. The 
lower limit of detection (LOD) of microscopy is estimated to be between 10 and 40 
parasites/µL, or more, depending on field conditions.8,9,16,17 This is sufficiently sensitive 
for clinical diagnostic purposes, as the "pyrogenic threshold" for an infection to induce 
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fever varies with age and season, but has been estimated to be more than 200 
parasites/µL.15,18,19 This LOD, however, does not permit the detection of all human 
infections, some of which can be <<10 parasites/µL. Although some asymptomatic 
infections have sufficient parasite densities to be microscopically detectable, more 
sensitive molecular detection methods like polymerase chain reaction (PCR) reveal that 
infections with submicroscopic parasite densities are also highly prevalent in endemic 
populations.9,20 Indeed, PCR-based methods typically detect twice as many cases as 
microscopy in endemic populations.9,20 
As the Gates Foundation and the WHO have resurrected the goal of malaria 
eradication, the importance of asymptomatic human reservoirs of infection has recently 
drawn considerable attention as a potential impediment to such efforts.8 As ‘silent’ 
carriers of the parasite, these people are difficult to identify and treat using existing 
methods in most contemporary health system infrastructures. The difficulty is only 
amplified by the large number of submicroscopic infections in some populations. 
Molecular techniques are needed to detect such human infections, but most facilities only 
have the capacity to perform more traditional diagnostics like microscopy, or even less 
sensitive rapid diagnostic tests (RDTs). Many facilities lack even these diagnostic 
methods, and distribute treatment presumptively.21 Because such asymptomatically 
infected people pose a significant challenge to current intervention strategies, it is 
important to understand their contribution to ongoing transmission in different 
epidemiologic contexts. Characterizing the human infectious reservoir demands an 
understanding of the epidemiology of gametocytemia in both symptomatic and 
asymptomatic infections. 
 
1.3 Detection and clearance of gametocytemia 
Given their importance to transmission, surprisingly little is known about the 
population prevalence and individual-level dynamics of gametocytemia. This is due in 
part to their relative unimportance for clinical disease compared to asexual Plasmodium 
stages, and also due to the limited sensitivity of microscopy.5,22 As gametocytes typically 
comprise a small proportion (<5%) of the total parasite burden, they frequently occur 
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beneath the LOD of microscopy, even in high-density clinical infections.5,23 Higher blood 
density of gametocytes is associated with a higher probability of transmission to a 
mosquito in a blood meal, but even densities as low as one gametocyte/µL are capable of 
causing infection.5,24–26 Molecular detection techniques that identify gametocyte-specific 
messenger RNA (mRNA) transcripts, such as quantitative nucleic acid sequence-based 
amplification (QT-NASBA) and quantitative reverse transcription – polymerase chain 
reaction (qRT-PCR), have emerged that enable detection of a greater proportion of 
transmissibly relevant gametocyte infections than microscopy. These molecular 
techniques can detect gametocytes at densities of less than one gametocyte/µL, and 
identify four- to seven-fold more gametocytemic infections than microscopy.13,14,27–32 
Although such molecular detection techniques have existed for the past 15 years, 
they have rarely been used in community-based studies to characterize population 
prevalences of gametocytemia that include both asymptomatic and symptomatic 
infections.13,14,27,28 QT-NASBA and qRT-PCR require sophisticated and reliable 
laboratory facilities and can be expensive, making it cost-prohibitive to apply them to 
study populations in which a large proportion of study participants are expected to be 
uninfected. Nonetheless, population-level gametocyte prevalence data are critical to 
understanding the role of the asymptomatic reservoir to ongoing parasite transmission. 
For an intervention to effectively interrupt transmission from the human 
infectious reservoir, gametocytes should be completely cleared from the bloodstream. By 
eliminating the asexual stages that are the precursors for gametocytogenesis, successful 
antimalarial treatments, which eliminate the asexual stages that cause disease, can 
prevent the development of new gametocytes. Unfortunately, most antimalarials, 
including artemisinin combination therapies (ACTs), have limited effects on existing 
mature and immature gametocytes, typically allowing them to persist for up to a month 
after treatment.5,33 Primaquine is a gametocytocidal drug that can potentially clear 
gametocytes in a week, but it is contraindicated for use in people with glucose-6-
phosphate dehydrogenase (G6PD) deficiency, in whom it can cause hemolytic anemia.5,34 
The WHO has recommended incorporating a single low dose of primaquine with ACT to 
reduce duration of infectiousness in addition to treating clinical symptoms, but this has 
rarely been attempted in practice.34 Antimalarial treatment with ACTs alone is common, 
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and has at least some potential for limiting the duration of infectiousness in 
gametocytemic people compared to natural clearance of infection. Population treatment 
patterns affect the duration of infectiousness, and are important to understanding the 
relative roles of symptomatic and asymptomatic cases in propagating Plasmodium 
transmission. 
 
1.4 Research setting: Malawi 
The research for this dissertation took place in Malawi, a small, land-locked 
nation in SSA (Figure 1.4). It is one of the poorest nations in the world, with a per capita 
gross domestic product (GDP) of US$667, and a human development index ranking of 
164 out of 177 countries.35 The most recent census in 2008 indicated a population 
estimate of about 13 million people, growing at about 2.8% annually since 1998.36 The 
average life expectancy is 47 years for males and 46 years for females, with 46% of the 
population being <15 years of age.35 The health sector of the country, like others in SSA, 
faces numerous challenges. The prevalence of human immunodeficiency virus (HIV) is 
estimated to be 12% among adults 15-49 years, with 28,000 incident cases of tuberculosis 
each year.35 Although many Malawi Ministry of Health (MoH) services are provided for 
free, only 46% of the population lives within 5 km of a health facility, and nationally 
there are only two physicians and 59 nurses per 100,000 population.35 Malaria 
persistently occurs throughout the country, with a seasonal pattern accompanying the 
annual rains that begin in November-December and continue through March-April.21 An 
estimated 5 million cases occur each year, and about half of all inpatient hospitalizations 
are attributed to malaria.21,37 Plasmodium falciparum is responsible for the vast majority 
of infections, but P. ovale and P. malariae infections have also been reported.38 Data on 
the national morbidity and mortality of malaria are limited by poor public health 
infrastructure and inconsistent surveillance.21  
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Figure 1.4. Location of Malawi on the African continent 
 
 
With support from the Global Fund and the President’s Malaria Initiative (PMI), 
Malawi’s National Malaria Control Programme (NMCP) has attempted to control malaria 
by achieving 85% coverage in high-risk groups with four key interventions: long lasting 
insecticide-treated nets (LLINs), intermittent preventive treatment during pregnancy 
(IPTp), indoor residual spraying (IRS) with insecticides, and prompt treatment with 
artemisinin-combination therapies (ACTs).21,37 Distribution of LLINs targeted at 
pregnant women and children <5 yrs and the use of IPTp have had reasonably high 
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coverage, reaching >50% of the population in recent years.21 IRS had been limited to 
certain pilot districts as of 2010, with nationwide coverage at <2%, though the MoH 
intended to scale up coverage in more recent years.21 Since 2007, the government has 
recommended lumefantrine-artemether (LA) as the first-line ACT treatment for malaria.21 
Although diagnostic testing for fever is recommended, the MoH supports presumptive 
treatment for febrile children <5 yrs when diagnostic capacity is limited.21,39 Treatment 
with LA has been provided for free at government health facilities since 2007, but the 
proportion of febrile people who rapidly receive antimalarials is estimated to remain 
low.21 While there is evidence that all-cause, under-five mortality has decreased in the 
past decade, suggesting some success in aggressive implementation of interventions by 
the NMCP, malaria transmission remains a persistent threat. Passive surveillance systems 
have even reported an increase in diagnosed cases between 2005 and 2009, though this 
may be attributable in part to increased population size and improved case detection.21,37 
International funding and national commitment offer hope, but research is needed to 
guide more effective application of interventions to reduce the burden of malaria in 
Malawi. 
To this end, one of the ten National Institutes of Health (NIH)-funded 
International Centers of Excellence for Malaria Research (ICEMR) was established in 
Malawi, and based in Blantyre, the second largest city in the country.21,37 The Malawi 
ICEMR has built an epidemiologic research infrastructure in Blantyre and two of its more 
rural neighboring Districts: Thyolo and Chikhwawa.21 Both Blantyre and Thyolo 
Districts are at relatively high elevations, but Chikhwawa District lies in the Shire Valley, 
a lowland area with more intense transmission of P. falciparum.21 These three eco-
geographically diverse zones have been the sites of cross-sectional surveillance studies at 
the end of each rainy and dry season since 2012. This infrastructure and active sampling 
serves as the basis for data that were analyzed in my dissertation 
 
1.5 Dissertation aims 
The purpose of the analysis reported herein was to characterize the community of 
potentially infectious human reservoirs of Plasmodium in southern Malawi. Data from a 
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repeated sample cross-sectional survey carried out at the end of each rainy and dry season 
in 2012 and 2013 by the Malawi ICEMR were used to address three specific aims. The 
first aim (reported in Chapter 2) was to validate the use of a novel qRT-PCR assay in 
conjunction with PCR testing to identify the prevalence of specific stages of P. 
falciparum, especially gametocytes, in a community-based study population. This 
recently developed assay distinguishes asexual ring stages, asexual trophozoites, 
immature gametocytes, and mature gametocytes based on expression of specific mRNA 
transcripts, but had not been applied to community samples to assess stage composition 
of infections in the general population. The results of this assay were then used to address 
aim two, that of characterizing the prevalence and predictors of gametocytemia across 
different seasons and eco-geographic settings (presented in Chapter 3). Reliable 
gametocyte prevalence data using sensitive molecular detection techniques had not been 
previously reported for this population, and contribute to the relatively small body of 
literature on the gametocyte status of asymptomatic human reservoirs of infection. These 
results help to evaluate the potential role of asymptomatic and submicroscopic infections 
in propagating P. falciparum transmission, and in maintaining a persistent malaria burden 
in endemic populations. Finally, for aim three, predictors of treatment-seeking and the 
use of antimalarial treatments were analyzed to identify gaps in treatment patterns 
(presented in Chapter 4). These results have implications for the duration of infection and 
potential infectiousness in different subsets of the population, and suggest the new tools 
and intervention changes that are necessary to interrupt transmission in the region. 
Overall, the goal of this dissertation is to contribute to the ongoing debate about the role 
of asymptomatic human reservoirs of Plasmodium infection, and to help identify research 
and development goals that will support further progress toward malaria control and 
elimination. 
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CHAPTER 2 Assessment of a combined PCR and qRT-PCR testing strategy for the 
detection of Plasmodium falciparum gametocytes in a community-based study in 
southern Malawi 
2.1 Abstract 
Plasmodium falciparum gametocytes, the stages that are transmitted from infected 
humans to Anopheles mosquitoes, occur at low densities in people compared to asexual 
parasite stages, and are frequently beneath the threshold of detection of traditional light 
microscopy. More sensitive tools are needed to adequately characterize gametocyte 
carriage. This study evaluates the potential of using polymerase chain reaction (PCR) and 
a stage-specific quantitative reverse transcription-PCR (qRT-PCR) assay in series to 
detect parasite stage composition, especially gametocytemia, in a community-based study 
population.  
Methods: Blood smears on slides for microscopy, dried blood spots on filter paper 
for PCR, and whole blood preserved in RNAprotect® (Qiagen, Valencia, CA) for qRT-
PCR were collected from 1,511 people of all ages in cross-sectional surveys during the 
dry season 2012 and subsequent rainy season 2013 in southern Malawi. Blood spots were 
tested by PCR for P. falciparum genomic DNA (gDNA); messenger RNA (mRNA) from 
parasitemic individuals was then tested by qRT-PCR to detect five stage-specific 
transcripts. These results were compared to those from microscopy for Plasmodium 
parasitemia and gametocyte presence. 
Results: Stage-specific mRNA transcripts were tested by qRT-PCR from 50 PCR-
positive and 5 PCR-negative samples from the dry season 2012 and 162 PCR-positive 
and 9 PCR-negative samples from the rainy season 2013. The qRT-PCR testing 
corresponded well with PCR results: no parasite mRNA was detected in the PCR-
negative samples, and mRNA for at least one stage of P. falciparum was detected in 98% 
of PCR-positive samples from the dry season and 86% from the rainy season. 
Quantification of the ring stage by qRT-PCR was strongly correlated with parasite 
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density estimates from microscopy. qRT-PCR detected more than three- to five-times as 
many gametocyte-positive infections as traditional microscopy. If qRT-PCR results are 
assumed to be the gold standard, the sensitivity of microscopy for detecting gametocytes 
was only 21%. This assay also enabled detection and stage determination of immature 
gametocytes from morphologically similar asexual ring stages. Immature gametocytes 
were frequently detected in the peripheral blood samples, often concurrent with mature 
gametocytes.  
Conclusion: PCR for parasite gDNA followed by qRT-PCR for stage composition 
is a sensitive strategy for molecular detection of P. falciparum gametocytes in large, 
community-based study populations. The stage-specific qRT-PCR assay vastly improves 
the sensitivity of gametocyte detection over microscopy, and enables simultaneous 
distinction of both mature and immature gametocytes from asexual stage P. falciparum 
parasites. The implications for epidemiological studies of population-level Plasmodium 
transmission are considerable. 
2.2 Introduction 
Despite recent efforts to prevent and treat malaria, the disease continues to be a 
major source of global morbidity and mortality.1,2 The recent Malaria Eradication 
Research Agenda evaluation argued that, although malaria incidence has decreased in 
some locations following scaling up of control efforts, eradication is not feasible with 
current knowledge and interventions.3  Continued progress toward local elimination, 
particularly in holoendemic settings, requires effective control of transmission, including 
transmission to mosquito vectors. While asexual Plasmodium stages are responsible for 
the clinical presentation of malaria (i.e. fever),4,5 transmission of Plasmodium to a 
susceptible mosquito vector only occurs when the sexual stage of the parasite, 
gametocytes, are taken up in a blood meal.6 In part due to the limited clinical relevance, 
and in part due to the difficulties of gametocyte detection by traditional techniques, little 
is known about the human population-level prevalence of gametocytemia, or the 
dynamics of gametocytemia during the course of symptomatic and asymptomatic 
infections.6,7  
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Although traditional microscopy of Giemsa or Fields stained peripheral blood 
smears is generally considered adequately sensitive for detection of the asexual ring 
stages for clinical diagnosis of malaria disease, gametocytes frequently occur at "sub-
microscopic" blood concentrations.6,8–10 The lowest limit of detection (LOD) by 
microscopy is approximately 10 parasites per microliter (µL), but may require as many as 
40 or more parasites per µL depending on the film preparation, the skill of the reader, and 
the number of fields viewed.11  In typical P. falciparum infections, the percentage of 
gametocytes in the total parasite burden is low compared to asexual stages, thought to 
average ≤5% in endemic areas;12 however, submicroscopic gametocyte densities have 
been shown to be infectious to mosquitoes.6,13,14 Therefore, microscopy is too insensitive 
to fully characterize the gametocytemic reservoir and assess its contributions to 
population-level transmission dynamics. Recently developed molecular techniques are 
required to provide more sensitive, accurate data for meaningful insights about 
population-level gametocytemia and potential human reservoirs for transmission to 
mosquitoes. 
Gametocytes are not highly active metabolically, but researchers have identified a 
few genes, such as Pfs2515 and Pfg377,16 that are expressed exclusively in gametocytes. 
These gametocyte-specific molecular markers have been used to distinguish gametocytes 
from asexual stages in molecular testing. Such molecular methods, including quantitative 
nucleic acid sequence-based amplification (QT-NASBA) and quantitative reverse 
transcription polymerase chain reactions (qRT-PCR), can indicate the presence of 
gametocytes at densities of <1 gametocyte/µL, as demonstrated in recent studies.4,8,15–20 
These mRNA transcripts, however, are primarily expressed in mature (stage V) 
gametocytes,11,16,18 thus failing to detect infections that had recently initiated 
gametocytogenesis and carried immature, developing gametocytes. Joice et al. recently 
developed a novel, stage-specific qRT-PCR assay that uses five key transcriptional 
primers that can detect and distinguish immature (stages I-III) and mature (stages IV-V) 
P. falciparum gametocytes from asexual ring and trophozoite stages, and infer overall 
stage composition in parasitemic blood samples.21 The assay was previously evaluated 
for gametocyte detection compared to microscopy in samples from children with 
clinically severe malaria.21 Building on this work, the present study sought to provide 
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additional evidence about the parasite stage composition in a community-based study 
population, with both uncomplicated malaria cases  and asymptomatic infections.  
As the qRT-PCR assay has high per sample costs (>US$50) and requires several 
days of processing, it may be infeasible for use in populations with low prevalence of P. 
falciparum. Therefore we applied a two-step molecular testing strategy in our 
community-based study population, screening first for individuals with P. falciparum 
gDNA using PCR and subsequently testing these for parasite stage distribution using the 
qRT-PCR assay. We evaluated the validity of using this two-step molecular testing 
strategy for the detection of population-based gametocyte prevalence by comparing the 
results of PCR vs. qRT-PCR for any parasite genomic material, and the combined 
molecular strategy vs. microscopy for the detection of gametocytemia. We hypothesized 
that the PCR and qRT-PCR results would correspond well, and that the strategy would 
provide an improvement in sensitivity for gametocyte detection compared to traditional 
microscopy. This testing strategy represents a new method for the detection of 
submicroscopic levels of both immature and mature P. falciparum gametocytes in other 
endemic communities. 
2.3 Methods 
The study was carried out under the auspices of the Malawi International Center 
of Excellence for Malaria Research (ICEMR), and all methods were approved by the 
independent Institutional Review Boards (IRB) of the University of Malawi College of 
Medicine, the University of Maryland, Baltimore, and Michigan State University (MSU). 
The University of Michigan IRB determined the expansion of gametocyte testing to be 
non-regulated based on existing approvals. 
 Study design 
Data and samples were collected in three Districts of southern Malawi during 
biannual cross-sectional surveys at the conclusion of each rainy season (April-May) and 
dry season (September-October) from 2012 to 2014. This report analyzed samples 
collected during the dry season 2012 and subsequent rainy season 2013. The three 
Districts were expected to represent different transmission patterns. Blantyre is an urban 
District in the highlands with low transmission, Thyolo is a semi-rural District with 
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moderate transmission, and Chikhwawa is a rural District at low elevation with high 
transmission. A preliminary census was performed in each District to delineate 
enumeration areas (EAs) containing approximately 30 households each. Ten EAs were 
randomly selected from each District (excluding EAs on the Thyolo-Chikhwawa 
boundary) to be visited during each of the surveys. Thus, approximately 900 households 
were visited during each survey. As the average household size in Southern Malawi is 4.2 
persons,22 more than 3,500 individuals were expected to participate each round. The local 
survey team communicated closely with local health representatives and local chiefs to 
encourage high levels of participation. 
At each visit, the field team interviewed household members in the local language 
(Chichewa) to obtain information about household-level variables and individual-level 
variables for all members of the household. The questionnaires sought data on 
demographics (i.e. age, sex, household size), house construction, use of malaria 
interventions (including details on insecticide treated net (ITN) quality and use, indoor 
residual spraying (IRS), intermittent preventive therapy in pregnancy (IPTp) and other 
treatment-seeking behaviors), and self-reported recent malaria symptoms (fever in the 
previous two weeks and a more extensive list of symptoms from the past 48 hours).  
 Sample collection and preservation 
Malawian nurses on each field team measured the current axillary temperature 
and took peripheral blood samples from all subjects ≥6 months of age who were present 
and consented (or were assented) to participate in the study. During all surveys, the 
nurses collected ~0.5 mL of blood onto slides as thick smears for microscopy, onto filter 
paper for polymerase chain reaction (PCR), and into a Hemocue® device (Hb 201+ 
System, Hemocue, Inc) for immediate testing of hemoglobin levels for children 6 mos – 5 
years old (yo). During the dry season 2012 survey, whole blood samples of 
approximately 50 μL were collected into 250 μL of RNAprotect® (Qiagen, Valencia, 
CA) for a subset of subjects in eight of the 30 EAs. RNA collection was expanded to 
include all subjects for the subsequent surveys. For the present study, we included all 
subjects in the same eight EAs from whom RNA samples were collected during the dry 
season 2012 and the subsequent rainy season 2013.  
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 Microscopy procedure 
Thick smears were air dried, methanol fixed, and Giemsa stained upon delivery to 
the laboratory at the end of each day of sample collection.  Thick smears were read at 
100X objective magnification by two trained microscopists, who recorded the number of 
parasites seen per 200 white blood cells (WBCs). The two reads were considered 
discrepant if one reader recorded presence of any Plasmodium parasites and the other did 
not, if one reader counted more than 10 times as many as the other when the lowest 
reader was less than 20 parasites seen, or if one reader counted more than twice as many 
as the other when both reads were 20 parasites or greater. Discrepant slides were sent to a 
third reader. All readers were blinded to the smear results recorded by the other readers. 
The final smear value was calculated as 0 if two readers reported no parasites. If at least 
two readers reported parasite counts, the final smear value per microliter was estimated 
using an assumed WBC count of 8000/µL, and calculating the geometric mean of the two 
positive reads multiplied by 40, using the two closest reads if all three were positive for 
parasites. 
No additional efforts were integrated into the microscopy protocol in order to 
increase sensitivity for detection and quantification of gametocytes; however, all readers 
were asked to record dichotomously whether or not they observed at least one 
gametocyte while counting parasites per 200 white blood cells. Since the sensitivity of 
gametocyte detection by microscopy is known to be low6,23,24, samples were considered 
to be microscopy positive for gametocytes when any one of the readers positively 
reported gametocytes. It was therefore possible for a sample to positive for gametocytes 
but have a final smear parasitemia estimate of 0 parasites per µL. 
 Molecular testing 
PCR for P. falciparum gDNA:  Dried blood spots on filter paper were stored 
individually in plastic bags with silica packets and kept in dry storage cabinets at the 
ICEMR-Malawi laboratory in the University of Malawi College of Medicine for up to 8 
months before genomic DNA (gDNA) extraction and testing. Blood spots were cut from 
the filter paper into a 1.5 mL Eppendorf tube using scissors that were sterilized in 
methanol and DNA OUT™ (G-Biosciences, St. Louis, MO) between each sample. gDNA 
was fixed to the filter paper by submersion in 50 µL of molecular grade methanol for 15 
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minutes, after which the majority of the methanol was discarded and the filter paper was 
left out to dry completely for at least two hours. Once completely dry, 50 µL of DNase-
free sterile water were added to extract the parasite gDNA from the papers by heating the 
tubes for 30 minutes at 99°C, vortexing at 15 minutes. The resulting gDNA samples were 
stored overnight at -20°C or used immediately for PCR.  
Following extraction, these gDNA samples were used in PCR reactions targeting 
the P. falciparum lactate dehydrogenase (LDH) gene, as described by Rantala et al.25 
Each 25 µL reaction consisted of 12.5 µL Taqman® (Life Technologies™, Carlsbad, 
CA), 0.25 µL each of forward and reverse primers at 250 nM, 0.30 µL of probe at 300 
nM, 10.7 µL nuclease-free water, and 1 µL of gDNA sample. Each plate was run with 
positive control wells of lab-cultured P. falciparum clone 3D7 samples at a known 
density of 2.7 parasite/µL and negative control wells of nuclease-free water. The plate 
was then placed in a 7300 Real Time PCR System (Applied Biosystems) machine for the 
following program: 1) 1 repetition of 2 minutes at 50.0°C, 2) 1 repetition of 10 minutes at 
95.0°C, and 3) 50 repetitions of 15 seconds at 95.0°C followed by 1 minute at 60.0°C. 
All samples were run in duplicate and considered positive for P. falciparum if LDH had a 
clear amplification curve in at least one of the two wells. 
qRT-PCR assay for stage-specific RNA expression: qRT-PCR was used to detect 
parasite stage-specific mRNA expression based on a novel assay that distinguishes ring 
stage parasites, trophozoites, immature (stage I-III) gametocytes, and mature (stage IV-
V) gametocytes, as described by Joice et al.21 The qRT-PCR assay was only performed to 
identify P. falciparum stage composition for subjects that had tested positive for any P. 
falciparum gDNA during PCR testing of filter papers. A few samples were initially 
recorded as PCR-positive through human errors in data entry; as these had been tested 
using the qRT-PCR assay but later proved to be PCR-negative during quality control 
review, they were evaluated as negative controls of the qRT-PCR assay. 
The preserved RNA samples (approximately 50 µL whole blood in 250 µL 
RNAprotect®) were transferred to cold storage in a -80°C freezer within at most 48 
hours, but typically less than 24 hours, of sample collection, and maintained there until 
thawed for RNA extraction and testing. After thawing, the samples were spun at full 
speed in a microfuge for 15 minutes at room temperature to obtain a visible pellet; the 
 21 
 
spin was repeated under the same conditions if no pellet was initially visible. The 
supernatant was then extracted with a pipette and stored until the extraction proved 
successful. RNA was extracted from the selected samples using RNeasy Plus Mini-Kits® 
(Qiagen, Valencia, CA) and treated with RNase-free DNase Sets® (Qiagen, Valencia, 
CA) to eliminate all traces of parasite gDNA.  
Reverse transcription was performed using Invitrogen Superscript complementary 
DNA (cDNA) Synthesis Kits® (Life Technologies™, Carlsbad, CA) in a double reaction 
compared to the Invitrogen protocol. First, 2 µL of 50 ng/µL random hexamers as the 
primer, 2 µL of 10 mM dNTP mix, and 16 µL of extracted RNA samples were combined 
to create 20 µL reactions. After briefly centrifuging the PCR strip, a Techne 
Thermocycler was used to incubate the samples for 5 minutes at 65°C, reducing to 4°C 
for 1 minute. Each RNA/primer sample was then combined with 20 µL of a cDNA 
synthesis mix that consisted of 4 µL of 10X RT buffer, 8 µL of 25 mM MgCl2, 4 µL of 
0.1 M DTT, 2 µL of RNaseOut and 2 µL of Super Script III RT (200 U/µL). The samples 
were then returned to the Techne Thermocycler for 10 minutes at 25°C, 50 minutes at 
50°C, and 5 minutes at 85°C. After centrifuging again to collect the sample, 2 µL of 
RNase H were added to each sample before returning it to the Thermocycler for 20 
minutes at 37°C to complete the reverse transcription reaction. If qRT-PCR could not be 
performed immediately, then the resulting cDNA samples were temporarily stored 
overnight at -20°C. 
The qRT-PCR assay involved the following stage-specific markers: 1) PFE0065w 
for the early asexual stage (ring stage), 2) PF10_0020 for the late asexual stage 
(trophozoite), 3) PF14_0748 for young gametocytes, 4) PF14_0367 for mature 
gametocytes, and 5) PF11_0209 as a constitutive protein. The assay was performed in 
triplicate for each stage-specific marker using 4 μL of sample per well, which required a 
dilution of the cDNA samples with 24 µL of nuclease-free water to obtain a volume of 66 
µL for each cDNA sample. Primer/probe mixes were created by combining 18 µL of 
forward primers and 18 µL of reverse primers at a concentration of 900 nM, 5 µL of 
probe at a concentration of 250 nM, and 59 µL of nuclease-free water. These mixes were 
stored at -20°C in a dark box with minimal light exposure. Each well of the qRT-PCR 
reaction consisted of 10 µL of ABI TaqMan Gene Expression Master Mix® (Life 
 22 
 
Technologies™, Carlsbad, CA), 1 µL of the primer/probe mix, 5 µL of nuclease-free 
water, and 4 µL of cDNA sample. Each plate included two types of negative controls: a 
set for each stage-specific marker using nuclease-free water instead of a cDNA sample, 
and a set of controls using reserved RNA from each sample that did not undergo reverse-
transcription (RT-negative controls) that were tested only using the constitutive protein 
marker. The qRT-PCR program for each plate consisted of one repetition of 2 minutes at 
50.0°C, one repetition of 10 minutes at 95.0°C, and 50 repetitions of 15 seconds at 
95.0°C followed by 1 minute at 60.0°C.   
The results of the qRT-PCR were recorded both dichotomously and 
quantitatively. Each sample was considered to be positive for a particular marker only if 
at least two of the three wells had a clear amplification curve. Quantification of the 
presence of each stage was estimated relative to the expression of the constitutive protein 
marker, PF11_0209. If at least two of the three wells for any stage-specific marker had 
an amplification curve, a delogged threshold cycle (dCt) value was calculated as 2^(- 
mean Cycle threshold [Ct]). The dCt value for each of the four stage markers (ring stage, 
trophozoite, immature gametocyte, and mature gametocyte) was then normalized against 
the dCt value of the constitutive protein marker. These four normalized dCt values could 
then be plotted for each sample as a rough estimate of the relative density of each stage of 
the P. falciparum parasite in the peripheral blood.  
 Data management and analysis 
All study data were stored in the Research Electronic Data Capture (REDCap, 
Vanderbilt University) system hosted at the University of Malawi College of Medicine.26 
These data were downloaded and all statistical analyses were performed in Statistical 
Analysis System (SAS) versions 9.3 and 9.4 (SAS Institute, Cary, NC).  
2.4 Results 
 Samples tested 
Of 1,077 individuals from 249 study households during the dry season 2012 
survey, there were 836 (77.6%) older than 6 months of age who were present and 
consented to give blood samples. Blood samples to test for P. falciparum RNA were 
collected from a subset of 628 (75.1%) of these subjects from 215 households during this 
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initial phase of RNA sampling. Of 1,017 individuals in 248 households from the same 
eight EAs that participated in the rainy season 2013 survey, RNA samples were obtained 
from all 905 (89.0%) individuals older than 6 months of age from 247 households who 
were present and consented to give samples. Consent documentation was lost for 22 
individuals (11 from each of the two surveys); these 22 subjects were excluded from all 
analyses. Thus, there were 617 samples available to test for parasite RNA from the dry 
season 2012 and 894 from the rainy season 2013. 
As discussed above, filter paper samples were tested by PCR for LDH to identify 
subjects with any P. falciparum parasitemia to be tested with qRT-PCR. There were three 
subjects for whom filter papers were unavailable, one from the dry season 2012 and two 
from the rainy season 2013. There were 50 subjects from the dry season 2012 and 162 
from the rainy season 2013 that were positive for P. falciparum gDNA and subsequently 
had their RNA-preserved samples tested using the qRT-PCR assay for stage-specific P. 
falciparum mRNA expression. We tested five additional samples from the dry season 
2012 and nine from the rainy season 2013 that were negative by PCR and were used to 
evaluate the specificity of the RNA assay. Figure 2.1 displays the sample testing scheme. 
Figure 2.1. Sample sizes for qRT-PCR testing, ICEMR-Malawi cross-sectional 
survey 
 
 24 
 
 
 Sensitivity and specificity of stage-specific RNA assay 
Only two (2) and 14 samples during the dry and rainy seasons, respectively, were 
recorded as positive by microscopy and negative for P. falciparum gDNA by PCR; none 
of these were tested by the qRT-PCR assay for P. falciparum mRNA expression. Among 
the samples that were PCR-positive for P. falciparum gDNA, 35 of 50 from the dry 
season 2012 (70.0%) and 66 of 162 from the rainy season 2013 (40.7%) were recorded as 
negative for any parasite stage by microscopy, suggesting that P. falciparum infections 
with submicroscopic peripheral parasitemia were common in this study population. The 
results of the qRT-PCR assay corresponded well with the results from PCR for P. 
falciparum gDNA. As expected, no parasite RNA was detected in any of the 14 samples 
that were negative for parasite gDNA by PCR. Conversely, P. falciparum RNA from at 
least one stage of the parasite (or the constitutive marker) was detected in 49 of 50 
samples (98%) from dry season 2012 and 140 of 162 samples (86.4%) from rainy season 
2013.  
Precise quantification of the density of each stage of the marker was not 
attempted; however, the dCt for the ring stage marker and the microscopy-based parasite 
density estimates were highly correlated. Both variables were normalized by log-
transformation after adding one to eliminate zero values, and entered into a simple linear 
regression model to assess the predictive value of the qRT-PCR ring marker results for 
overall parasite density per microliter (Figure 2.2). The qRT-PCR output and parasite 
density by microscopy were highly correlated (F=196.7, p<0.0001). Despite a strong 
correlation overall, the samples that were PCR-positive but submicroscopic did not show 
consistently lower dCt values by the qRT-PCR assay than the microscopy positive 
samples. 
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 Stage-specific marker detection 
The results of the qRT-PCR assay for each marker in the PCR-positive samples 
from the dry season and the estimated prevalence of the stage among the PCR-positive 
samples and in the entire study population are reported in Table 2.1. The ring stage 
marker was found in all but two samples: one was negative for all mRNA markers, and 
the other tested positive only for the constitutive protein marker, PF11_0209. The 
constitutive protein marker was not detected in 11 samples in which at least one other 
stage of the parasite tested positive. Immature gametocytes were detected in 22 samples: 
3.6% of the total population, and 44.0% of the samples in which P. falciparum gDNA 
was detected by PCR. Mature gametocytes were detected in 21 samples: 3.4% of the total 
population, and 42.0% of the samples in which P. falciparum was detected by PCR. 
Trophozoites were the least likely stage to be detected in these peripheral blood samples, 
and found in only 12 samples. 
Figure 2.2. Log-transformed parasite density from light microscopy vs. log-
transformed dCt of the ring stage from the qRT-PCR assay for all PCR positive 
samples in which the ring stage was detected, n=183 
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Table 2.1. Summary of qRT-PCR results from dry season 2012 
Stage RNA positive (n) 
Prevalence in PCR+ 
samples  
(n = 50) 
Prevalence in total 
population  
(n = 617) 
Ring stage 48 96.0% 7.8% 
Trophozoites 12 24.0% 1.9% 
Immature gametocytes 22 44.0% 3.6% 
Mature gametocytes 21 42.0% 3.4% 
 
There were 16 samples that tested positive for both the immature and mature 
gametocyte markers, with six (6) that tested positive for only the immature gametocyte 
marker and five (5) that tested positive only for the mature gametocyte marker (Figure 
2.3). Thus, there were a total of 27 samples in which either immature gametocytes, 
mature gametocytes, or both were detected, representing 4.3% of the total population, and 
54.0% of the samples in which P. falciparum was detected by PCR. 
Figure 2.3. Co-occurrence of trophozoites, immature gametocytes, and mature 
gametocytes in samples from the dry season 2012* 
 
 
The corresponding results for the rainy season are presented in Table 2.2. None of 
the five mRNA markers were detected in 22 of 162 (13.6%) samples tested. The ring 
stage marker was detected in all but two of the remaining 140 samples: one of these 
tested positive for both immature and mature gametocytes (as well as the constitutive 
*Ring stages were present in all 28 of these samples, and expressed in 20 additional samples where no 
other stages were present 
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protein marker), and the other tested positive only for mature gametocytes. The 
constitutive protein marker was not detected in 19 samples in which at least one other 
stage of the parasite tested positive. 
Table 2.2. Summary of qRT-PCR results from rainy season 2013 
Stage RNA positive (n) 
Prevalence in PCR+ 
samples  
(n = 158) 
Prevalence in total 
population  
(n = 894) 
Ring stage 138 87.3% 15.4% 
Trophozoites 46 29.1% 5.1% 
Immature gametocytes 70 44.3% 7.8% 
Mature gametocytes 78 49.4% 8.7% 
 
During the rainy season, there were 65 samples (41.1%) that tested positive for 
both the immature and mature gametocyte markers, with five (5) and 13 samples positive 
for only the immature or mature marker, respectively (Figure 2.4). Thus, there were a 
total of 83 samples in which either immature gametocytes, mature gametocytes, or both 
were detected, representing 9.3% of the total population, and 52.5% of the samples in 
which P. falciparum was detected by PCR. 
Figure 2.4. Co-occurrence of trophozoites, immature gametocytes, and mature 
gametocytes in samples from the rainy season 2013* 
 
 
*Ring stages were present in all but two (2) of these 95 samples, one that had both mature and immature 
gametocytes, and one that had only mature gametocytes. The ring stage marker was expressed in 43 
additional samples where none of these other stages were detected. 
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The sensitivity and specificity of microscopy for the detection of gametocytes in 
thick smears were calculated compared to the PCR/qRT-PCR testing strategy (Tables 
2.3-2.4). There were six samples for which a microscopist recorded gametocytemia that 
were negative for P. falciparum gDNA by PCR, and therefore were not tested by the 
qRT-PCR assay or included in Figures 2.5-2.7 above. The qRT-PCR assay results for the 
early and/or late stage gametocyte marker corresponded well with the microscopy results 
for gametocyte presence in all other PCR positive samples that were tested. qRT-PCR 
detected either the early or late stage gametocyte marker in 23 of 29 samples that were 
recorded as positive for gametocytes by at least one microscopist and tested by the qRT-
PCR assay: all four (4) samples from the dry season 2012 and 19 of 25 samples from 
rainy season 2013. Alternatively, the qRT-PCR assay demonstrated a marked increase in 
sensitivity compared to microscopy, identifying an additional 23 and 64 early or late 
stage gametocyte-positive samples from the dry and rainy seasons, respectively. If the 
molecular testing results are assumed to be the gold standard, microscopy had a high 
specificity, but very low sensitivity for the detection of gametocytes. During the dry 
seasons, the sensitivity was 14.8% and specificity was 99.8%; during the rainy seasons, 
the sensitivity was 22.9% and specificity was 98.6%. Overall, this represented a 
sensitivity of 20.9% and a specificity of 99.1%. The molecular testing strategy detected 
more than five times as many gametocytemic infections in the population during the dry 
season and more than three times as many gametocytemic infections in the population 
during the rainy season. 
Table 2.3. Microscopy vs. molecular testing strategy (PCR/qRT-PCR) for detection 
of any stage of gametocytes, dry season 2012 
  Microscopy results  
  Gametocyte + Gametocyte - Total 
Molecular 
results 
Gametocyte + 4 23 27 
Gametocyte - 1 589 590 
 Total 5 612 617 
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Table 2.4. Microscopy vs. molecular testing strategy (PCR/qRT-PCR) for detection 
of any stage of gametocytes, rainy season 2013 
  Microscopy results  
  Gametocyte + Gametocyte - Total 
Molecular 
results 
Gametocyte + 19 64 83 
Gametocyte - 11 800 811 
 Total 30 864 894 
 
 
Quantitative estimates of the relative presence of each stage of the parasite are 
shown in comparison to the parasite densities estimated by microscopy for dry season 
samples in Figure 2.5 and rainy season samples in Figures 2.6-2.7. The results are only 
presented for the 38 dry season samples and 121 rainy season samples in which the 
constitutive protein was detected by qRT-PCR (enabling the calculation of normalized 
dCt values for each other stage). The presence of gametocytes was indicated 
dichotomously by microscopists while counting parasites per 200 WBCs, and is also 
presented in panel A of Figures 2.5-2.7.
  
 
3
0 
Figure 2.5. Comparison of microscopy and stage-specific qRT-PCR assay results for 38 subjects* from dry season 2012 
 
  
 
3
1 
Figure 2.6. Comparison of microscopy and stage-specific qRT-PCR assay results for 60 subjects with lowest delogged mean Ct 
values for the ring stage marker normalized to PF11_0209* from rainy season 2013 
 
 
 
  
 
3
2 
Figure 2.7. Comparison of microscopy and stage-specific qRT-PCR assay results for 61 subjects with highest delogged mean 
Ct values for the ring stage marker normalized to PF11_0209* from rainy season 2013 
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Previously published results from the use of this qRT-PCR assay (with a slightly 
expanded mRNA marker panel) showed the stage-specific parasite composition in 58 
children with severe malaria from the research ward at the Queen Elizabeth Central 
Hospital in 2011.21 These results are reproduced in Figure 2.8. In that severe malaria 
cohort, the parasite stage composition differed from those presented in the community-
based infections shown in Figures 2.5-2.7, which included both symptomatic and 
asymptomatic infections. The ring stage predominated in both study populations, being 
detected in all severe cases and most community-based infections, as described above. 
However, trophozoites were far more common in the severe malaria cohort (47 of 58 
samples, 81%) than the community-based infections from this study (48 of 208 samples 
23%), and gametocytes of any stage were much more common in the community-based 
infections (110 of 208 samples, 52.9%) than the severe malaria cohort (6 of 58 samples, 
10.3%). 
Figure 2.8. Parasite stage composition in pediatric severe malaria patients from 
Blantyre in 2009 (reproduced from Joice et al.Figure 4A)21 
 
 
U Undefined stage 
R Ring stages 
T Trophozoites 
YG Young gametocytes (stage I) 
DG Developing gametocytes (stages II-IV) 
MG Mature gametocytes (stage V) 
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2.5 Discussion 
Malaria’s resistance to the recent expansion of intervention efforts suggests a 
need for new approaches to understand and interrupt transmission. Past research on 
transmission has been limited by traditional microscopy’s lack of sensitivity for the 
detection of the P. falciparum parasite, particularly the transmissible gametocyte stage. 
Molecular techniques have emerged that begin to address these limitations, but a broader 
spectrum of options is needed to supplement our ability to answer different questions 
about the drivers of transmission. The new qRT-PCR assay developed by Joice et al. 
provides another tool in the arsenal of transmission research, with sensitive and specific 
detection of a broad spectrum of the P. falciparum life cycle stages in human infections, 
including both immature and mature gametocytes. Previous research established that the 
assay had a high degree of sensitivity and specificity in clinical samples. The results of 
the current study indicate that, when combined with screening for parasitemic samples 
using PCR testing for P. falciparum gDNA, the assay can also be used effectively to 
detect gametocytemia in community-based study populations. The two-step PCR and 
qRT-PCR testing strategy enabled the detection of three- to five-times as many 
gametocytemic infections in the population as traditional microscopy, and, compared to 
previous molecular gametocyte detection efforts, further provided the ability to 
distinguish between immature and mature gametocyte presence and potentially quantify 
their relative expression. 
 Comparison of PCR and qRT-PCR results 
Applications of the qRT-PCR assay in other study populations has indicated that 
its mRNA detection may be more sensitive than the PCR assay for detection of parasite 
gDNA (unpublished data from communications with Dr. Matthias Marti)); however, in 
this study, the sensitivity for stage-specific parasite detection was limited by the two-step 
testing design using PCR for initial sample screening. In this nonclinical study 
population, the majority of samples were expected to be aparasitemic, making it 
inefficient and cost-prohibitive to test every sample with the stage-specific qRT-PCR 
assay, for which the per sample cost is >US$50. Testing in series with the qRT-PCR 
assay only after a positive result for parasite gDNA by PCR limited the sensitivity for 
stage-specific parasite detection to that of the PCR for LDH, which has a LOD of 
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approximately 2.7 parasites per µL in the ICEMR-Malawi laboratory. For instance, as 
they were PCR-negative, none of the 16 samples discussed above that were PCR-
negative and microscopy-positive were tested with the qRT-PCR assay, which may have 
enabled identification of samples that were false negative by PCR. Though the use of the 
qRT-PCR assay in all samples could theoretically have higher sensitivity for gametocyte 
detection, the two-step testing strategy lowered the study costs enough to be feasible. 
Moreover, the LOD of 2.7 parasites per µL by the molecular testing strategy still 
constitutes a vast improvement over that of microscopy of thick smears, which has an 
LOD of about 10-40 parasites per µL under ideal conditions.11  
Regardless of this limitation, the results of the qRT-PCR assay appeared to 
correspond well to the PCR results. While specificity could not be fully evaluated for all 
PCR-negative samples, the qRT-PCR assay was negative for all stage-specific markers in 
the 14 PCR-negative samples that were tested. Regarding sensitivity, the qRT-PCR assay 
positively identified mRNA expression for at least one stage of P. falciparum in 189 of 
208 (90.7%) of the samples that tested positive for P. falciparum gDNA by PCR. The 23 
samples which were identified as positive for P. falciparum gDNA but negative for all 
stage-specific mRNA were investigated further.  
Using the microscopy results on parasite density for comparison, all 23 PCR-
positive and qRT-PCR-negative individuals appeared to have very low densities of 
parasitemia, with 22 being submicroscopic and only one recorded as parasite positive by 
microscopy. Thus, the levels of parasite genetic material may have been near the LOD of 
the molecular assays, where there is a degree of stochastic error in detection. 
Furthermore, some mRNA expression was, in fact, detected in four of these samples, but 
since only one of three wells in the plate tested positive, the sample was considered 
negative for analysis purposes. This supports the hypothesis that these samples may have 
had low densities of parasitemia that approached the LOD. These results may also reflect 
a true difference in the persistence of parasite gDNA vs. mRNA in recently cleared 
infections, though the cross-sectional sampling method limited our ability to assess such 
a difference through the course of individual infectsions. We investigated whether any of 
these subjects had recently received an antimalarial that might have contributed to 
clearance of the infection, but none reported use of any antimalarial (including 
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lumefantrine artemether, chloroquine, quinine, or sulfadoxine pyrimethamine) in the two 
weeks prior to sample collection. Though we were unable to conclusively identify the 
reason(s) for the discrepancies among the 23 PCR-positive and qRT-PCR negative 
individuals, they comprised a small number of the tested subjects, and overall the 
sensitivity for P. falciparum mRNA detection by qRT-PCR compared to gDNA detection 
by PCR was high. 
 The PCR/qRT-PCR testing strategy for stage-specific parasite detection 
True validation of the two-step, PCR and qRT-PCR testing strategy for the 
detection of each specific stage of the parasite was limited by the lack of an adequate 
‘gold standard’ value for each sample in the population, since microscopy is known to be 
less sensitive than molecular testing strategies. For instance, when the PCR assay is 
treated as the gold standard for any stage P. falciparum detection, the sensitivity of 
microscopy was only 30.0% during the dry season and 59.3% during the rainy season in 
this subset of eight EAs. Submicroscopic infection is explored in greater detail in another 
publication that considers all 30 EAs from the corresponding surveys.27 Furthermore, the 
microscopists recorded the presence of gametocytes if they were observed, but did not 
quantify the gametocytemia, and no microscopy data were collected regarding the 
presence of the trophozoite stage or the distinction between immature and mature stages 
of gametocytes.  While further improvements in sensitivity may be possible, the 
comparison of the PCR/qRT-PCR results with microscopy do confirm the expected 
increase in sensitivity for gametocyte detection, with microscopy detecting only 20.9% of 
the molecularly-identified gametocytemic samples. 
Assessment of the validity of the two molecular tests compared to microscopy 
results was somewhat complicated by the presence of multiple species of Plasmodium in 
the area. Though P. falciparum is predominant, P. ovale and P. malariae infections have 
also been recorded in the region.28 Microscopists counted parasites seen without 
identifying the species of Plasmodium, but could conceivably detect any species. On the 
other hand, both PCR and qRT-PCR were specific to the detection of P. falciparum. 
There were 16 samples in the total study population of 1,511 individuals that were 
counted as positive by microscopy but negative by PCR; these may be samples that were 
false negatives for P. falciparum by molecular testing, samples that were infected with 
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other species of the Plasmodium parasite, or samples that were false positive by 
microscopy. Based on the available information, we were unable to delineate the ultimate 
source of these discrepancies, but even if all were truly parasitemic, the number of false 
negatives by PCR was still very small (≤1% in the study population). 
Surprisingly, there were 12 samples in which gametocytes were reported by 
microscopy that were not identified as gametocytemic by the PCR/qRT-PCR testing 
strategy: six that were PCR-negative and did not get tested for P. falciparum mRNA by 
the assay, and six that were tested by the qRT-PCR and determined to be negative for 
both the immature and mature gametocyte markers. Of the six untested PCR-negative 
samples, four were ultimately determined to be aparasitemic in the final smear 
calculation after resolving discrepancies among the readers. The other two subjects had 
three or fewer total parasites counted by each reader, and may represent either false 
positives or non-falciparum infections; however, it is possible that the sample testing 
strategy led us to falsely identify these samples as negative for the presence of 
gametocytes. Of the six PCR-positive samples, there were four in which the marker for 
either immature or mature gametocytes was detected in only one of three wells by qRT-
PCR, suggesting that they may have been true gametocyte positive infections at very low 
densities. Defining as positive any samples with an amplification curve in at least one 
well by the qRT-PCR assay may indeed increase the sensitivity for identifying very low 
density gametocyte infections, but could also reduce specificity. Given the small number 
of apparent false negatives and large number of gametocyte positives that were not 
identified by microscopy, using two of three wells to identify positive samples by the 
qRT-PCR assay appears to be sufficient to improve upon the sensitivity of microscopy in 
this study population without a loss in specificity. 
 Quantification of P. falciparum stage-specific densities 
There were several limitations for using the stage-specific qRT-PCR assay to 
estimate the quantitative blood density of each stage. Ideally, each plate would have been 
run with a positive control in which each stage was present at a known concentration in 
order to estimate the relative concentration of the test samples by comparing the test 
sample dCt values to those of the positive control. No such positive controls were 
available. Furthermore, while we attempted to consistently preserve 50 µL of blood from 
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each individual participant, it was not possible to guarantee the precision of this quantity 
in the field collection procedures, so there may have been some variation in the amount 
of starting material for each sample tested. Such variation would lead to a difference in 
the amount of parasite genetic material tested for each sample (and the resulting dCt 
values) that is not reflective of true differences in parasitemia. Nevertheless, the dCt 
values still offer a rough estimate of the relative densities of parasitemia for each sample, 
as demonstrated by the high correlation between the dCt value for the ring stage and the 
estimated parasite density by microscopy (p<0.0001).  
One surprising feature of the relationship between the dCt value of the ring stage 
marker by qRT-PCR and the parasite density recorded by the microscopists was that 
submicroscopic infections (those that were negative by microscopy) did not have 
consistently lower dCt values than microscopically-detected infections. This may reflect 
a limitation of microscopic slide readings from a non-clinical population with a large 
proportion of infections having low peripheral densities, and the lack of granularity 
inherent in estimating smear density per microliter as 40 times the number of parasites 
observed. Despite the limitations of the microscopy data, the statistical model did confirm 
that the qRT-PCR results for the ring stage marker were strongly correlated with the 
observed parasite density in peripheral blood, which suggests that the dCt values of other 
stage-specific mRNA markers are also correlated with the quantitative blood density of 
their respective stages. While our collaborators continue to refine a linear model to 
predict the relative stage composition of a given individual’s infection based on the 
output from the qRT-PCR assay, the ring stage marker results support the possibility of 
comparing the dCt values of the other stage-specific markers to estimate the relative 
density of a particular parasite stage across different individual subjects based on the 
currently available data alone. 
Comparison of the results of the assay in this community-based study population 
differ considerably from those that were previously reported for a cohort of severe 
malaria cases in a pediatric population in Blantyre from 2009.21 Gametocytes were far 
more common in our community infections than the severe malaria cases, while 
trophozoites expression was much more common in the severe cases than the 
community-based infections. The severe malaria cases may represent the stage 
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distribution of relatively new infections, whereas the community-based samples 
considered here were collected cross-sectionally, and will represent prevalent infections 
of any duration, up to multiple months. While a P. falciparum infection could potentially 
develop gametocytes at any point in time, if gametocytemia persists once it develops, 
then older infections would be more likely to be gametocytemic. This would have 
profound implications for the relative importance of asymptomatic infections to the 
human infectious reservoir, since they tend to be untreated and of long duration. Further 
research is needed to understand the reasons for these distinct presentations of parasite 
stages, especially research involving longitudinal sampling over the course of individual 
infections. In particular, such data would be useful to understand the relationship between 
the age of an infection and the development of gametocytemia/potential contribution to 
the population-level infectious reservoir, or any association between parasite stage 
composition and symptom severity.  
 Conclusions 
Ultimately, despite a number of limitations for validation, the results presented here 
indicates that this molecular testing strategy involving PCR for gDNA and a novel, stage-
specific qRT-PCR assay is effective for the detection of four stages of P. falciparum 
infections in community-based study populations. Like other molecular testing strategies, 
such as the detection of Pfs25 mRNA transcripts from mature gametocytes using QT-
NASBA or RT-PCR, this assay shows a marked improvement in sensitivity compared to 
traditional light microscopy. The use of markers that span exon-exon junctions ensures 
stage specificity, and use of a panel of such markers makes this test uniquely suited to 
answering questions about complex parasite stage dynamics within human hosts, 
including the ability to distinguish sexual from asexual stage presence, and mature from 
immature gametocyte presence. Future publications could use this assay for research into 
parasite life cycle presence in the course of both symptomatic and asymptomatic 
infections to investigate their relationship to disease severity and duration. In Chapter 3, 
the results of this assay will be analyzed in regression models to determine the predictors 
of gametocytemia across the different study settings and seasons, in an effort to better 
understand population-level transmission dynamics and potential reservoirs for P. 
falciparum infection in southern Malawi. 
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CHAPTER 3 Moving beyond microscopy: Epidemiology and predictors of the 
human gametocyte reservoir based on molecular detection methods in 
communities of southern Malawi 
3.1 Abstract 
Asymptomatic Plasmodium falciparum infections in humans are common in areas 
where malaria is endemic. The extent to which asymptomatic infections contribute to 
ongoing transmission remains unclear. The presence of mature P. falciparum 
gametocytes is a prerequisite for transmission, but population-level prevalence of human 
gametocytemia is poorly characterized due to the difficulty in measuring gametocyte 
carriage, which frequently occurs at submicroscopic densities. This study applied more 
sensitive molecular detection techniques to characterize the epidemiologic patterns of the 
human gametocytemic reservoir in communities of southern Malawi.  
Methods: Blood samples were collected from ~30 households in each of eight 
geographically diverse enumeration areas (EAs) during two cross-sectional surveys: one 
at the end of the dry season 2012 and one at the end of the following rainy season 2013. 
About 616 people in 2012 and 892 in 2013 were bled for molecular parasite testing. 
Presence of mature gametocytes was determined by quantitative reverse transcription 
polymerase chain reaction (qRT-PCR) for all people who were polymerase chain reaction 
(PCR)-positive for P. falciparum genomic DNA (gDNA). Multilevel logistic regression 
models were used to identify the predictors of gametocytemia in the total population, and 
among people with prevalent P. falciparum infections, based on data from household- 
and individual-level surveys. 
Results: The overall prevalence of mature gametocyte carriage in the study 
population was 3.4% during the dry season and 8.7% during the rainy season, with 
substantial EA-level heterogeneity. Nearly half of PCR-positive P. falciparum infections 
carried detectable mature gametocytes by qRT-PCR, regardless of recent symptom status. 
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People who lived in unfinished houses, owned bednets, or were of lower socioeconomic 
status tended to have higher prevalence of gametocytemia in the total population, and 
among P. falciparum-infected people, though only a few associations were statistically 
significant after adjustment. School-aged children, 6-15 years old (yo), had significantly 
higher odds than adults (≥16 yo) of being gametocytemic when infected, and were 
significantly more likely to be gametocytemic than either younger children (<5 yo) or 
adults in the total population. 
Conclusions: School-aged children are an important gametocyte reservoir, and 
may contribute significantly to transmission, despite suffering less of the burden of 
malaria disease than younger children. Factors that increase the risk of being infected also 
tended to increase the odds of being gametocytemic given infection, though the 
individual associations were not statistically significant in the study population. 
Asymptomatic cases are frequently gametocytemic and therefore a potential source for 
perpetuating transmission to mosquitoes. Malaria elimination strategies will need to 
consider these human reservoirs, but there may be opportunities for targeting 
interventions through schools to treat this school-aged group with the highest gametocyte 
prevalence. 
3.2 Introduction 
As the global malaria burden has proven somewhat intractable to our best efforts 
to prevent infection and treat the disease, attention has been increasingly drawn to the 
existence of asymptomatic and submicroscopic Plasmodium infections.1–6 Such 
infections are widespread in areas where malaria is endemic, but the extent of their 
infectiousness and contribution to transmission dynamics is not fully understood.7 
Transmission from an infected human to a mosquito requires only that at least one male 
and one female gametocyte, the sexual stages of the parasite, are ingested in a blood 
meal.8 As the average size of a blood meal for Anopheline mosquitoes is approximately 
two to three microliters (µL),9 human blood density of one gametocyte per µL would be a 
theoretical lower limit for parasite transmission. Though the probability that a given 
mosquito will develop infectious oocysts after taking a blood meal decreases with 
diminishing gametocyte density in human hosts, even gametocyte densities <1/µL have 
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been found to be potentially infectious to mosquitoes.8,10 Humans with asymptomatic or 
submicroscopic infections may have low-density gametocytemia and contribute 
significantly to ongoing transmission, particularly if they are disproportionately likely to 
be bitten by mosquitoes, or maintain gametocytemia for long durations compared to 
symptomatic cases. Indeed, previous research found that individuals could remain 
gametocytemic through months of a dry season with negligible transmission.11,12 New 
data on the population-level dynamics of gametocytemia will improve our understanding 
of the potential infectiousness of human reservoirs for Plasmodium infection in endemic 
communities, including those people with submicroscopic and asymptomatic infections. 
Few studies have reported on the prevalence of gametocytemia in communities 
where people are apparently healthy, and most of these studies have relied on microscopy 
to detect gametocytes. The lower limit of detection of microscopy ranges between 10 and 
40 parasites/µL, depending on slide preparation, the skill of the reader, and the number of 
fields viewed.13 Conclusions from previous research regarding the gametocytemic human 
reservoir are limited by the low sensitivity of microscopy, which cannot detect all 
gametocyte infections of potentially infectious densities. Modern molecular testing 
techniques that detect gametocyte-specific mRNA transcripts, such as quantitative 
reverse transcription polymerase chain reaction (qRT-PCR) and quantitative nucleic acid 
sequence based amplification (QT-NASBA), offer a vastly improved sensitivity over that 
of microscopy.8,14,15 Some studies attempted to improve sensitivity by increasing the 
number of fields viewed or white blood cells (WBCs) counted by a microscopist, but 
none has approached the sensitivity achieved by molecular methods, which can 
potentially detect <1 parasite/µL.15 Studies based in clinical populations alone are also 
insufficient for characterizing the human infectious reservoir, because asexual stage 
parasites, and not gametocytes, are associated with the occurrence of symptoms. There is 
a need for improved estimates of the gametocyte carriers using molecular detection in 
community-based samples that include asymptomatic cases across a variety of 
transmission settings. These data will aid public health workers in identifying who are the 
important infectious human reservoirs and intervening effectively to interrupt 
transmission. 
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Of the relatively small number of prior studies that reported gametocyte 
epidemiology for community-based samples, most reported a monotonic decrease in 
gametocyte prevalence by age.16–27 The majority of these used microscopy alone for 
gametocyte detection, and all involved samples collected before 2006. The current study 
is the first to report the epidemiology of gametocytemia among people living in southern 
Malawi using a sensitive, stage-specific qRT-PCR assay.  
While direct measures of infectiousness from mosquito blood-feeding were not 
available, the current studysought to identify the potentially infectious (a.k.a. 
gametocytemic) human reservoirs, and assess the predictors of gametocytemia in a 
community-based population across two seasons and a variety of geographic zones with 
varying transmission intensities. We hypothesized that people with asymptomatic 
infections are as likely to be gametocytemic as people who reported no recent malaria 
symptoms. We also hypothesized that the odds of being gametocytemic when infected 
would decrease with age, but that the association would be weaker in sites with lower 
transmission intensity, where less frequent exposures might delay the development of 
immune responses to gametocytes.  
3.3 Methods 
The study was carried out under the auspices of the Malawi International Center 
of Excellence for Malaria Research (ICEMR), and all methods were approved by the 
independent Institutional Review Boards (IRB) of the University of Malawi College of 
Medicine, the University of Maryland, Baltimore, and Michigan State University (MSU). 
The University of Michigan IRB determined this gametocyte study expansion to be non-
regulated based on existing approvals. 
 Study design 
Data were collected in three Districts of southern Malawi during biannual cross-
sectional surveys at the conclusion of each rainy season (April-May) and dry season 
(September-October) from 2012 to 2014. These three Districts represent different 
transmission patterns. Blantyre is a more urbanized District in the highlands with 
expected low transmission, Thyolo a semi-rural District with expected moderate 
transmission, and Chikhwawa a rural District at low elevation with expected high 
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transmission. Compact segments of approximate 30 households were chosen for each of 
10 enumeration areas (EAs) per District; EAs and compact segments were randomly 
selected using two-stage cluster sampling, excluding any EAs on the District border 
between Thyolo and Chikhwawa, and Chikhwawa EAs at >500 m elevation or Thyolo 
EAs at <500 m elevation. Thus, approximately 900 households were selected for study 
and visited during each survey. As the average household size in southern Malawi is 4.2 
persons,28 more than 3,500 individuals were expected to participate each round of 
surveillance. The survey team returned to the same compact segments for each round, 
having communicated closely with local health representatives and EA chiefs to 
encourage high levels of participation. 
At each visit, the field team interviewed household members in the local language 
(Chichewa) to obtain information about household-level variables and individual-level 
variables for all members of the household. A standardized questionnaire sought data on 
household demographics (i.e. age, sex, relationship of all members), house construction, 
use of malaria interventions [including details on insecticide treated net (ITN) quality and 
use, indoor residual spraying (IRS), intermittent preventive therapy in pregnancy (IPTp) 
and other treatment-seeking behaviors], and self-reported recent symptoms of disease.  
 Sample collection and preservation 
Malawian nurses on each field team measured the axillary temperature and took 
peripheral blood samples from all subjects ≥6 months old (mo) who were present and 
consented (or were assented) to participate in the study. During all surveys, the nurses 
collected ~0.5 mL of blood onto slides as thick smears for microscopy, onto filter paper 
for DNA isolation, and into a Hemocue® device (Hb 201+ System, Hemocue, Inc) for 
immediate testing of hemoglobin levels for children 6 mos - 5 yrs old (yo). Initial RNA 
sample collection was undertaken during the dry season 2012 survey for a convenience-
based subset of eight of the 30 EAs: two from Blantyre and three each from Thyolo and 
Chikhwawa. RNA collection was expanded to include all subjects for the subsequent 
surveys. To preserve RNA, whole blood samples of approximately 50 μL were collected 
into 250 μL of RNAprotect® (Qiagen Inc., Valencia, CA).  For qRT-PCR testing for the 
present study, we included all subjects in the eight EAs from whom RNA samples were 
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collected during the dry season 2012, and the same eight EAs during the subsequent rainy 
season 2013 (Figure 3.1).  
The selected EAs differed from the excluded EAs for their respective Districts on 
a number of variables, including age distribution, parasite prevalence, and socioeconomic 
status (SES), and were not considered to be representative of each District as a whole. 
Thus, District was not included as a potential predictor in statistical analyses. Instead, we 
approximated the relative P. falciparum transmission intensity for each specific EA using 
PCR data from the first cross-sectional study survey during the 2012 rainy season. The 30 
study EAs were classified into tertiles of baseline P. falciparum prevalence. The lowest 
tertile included EAs with 0 to <8%, the middle tertile included those with 8 to <15%, and 
the highest tertile included those with ≥15% PCR-based prevalence estimates in the rainy 
season 2012. RNA was sampled from two of the EAs in the lowest tertile: Ngabu EA117 
from Chikhwawa and Chimaliro EA052 from Thyolo; four of the EAs in the middle 
tertile: Makhwira EA051 from Chikhwawa, Nchilamwela EA058 from Thyolo, and 
Misesa EA014 and Soche West Ward EA020 from Blantyre; and two of the EAs from the 
highest tertile: Lundu EA019 from Chikhwawa and Kapichi EA056 from Thyolo. The 
baseline prevalence tertile value was assigned to all individuals residing in households 
within a given EA in the two subsequent surveys included in this qRT-PCR analysis, the 
dry season 2012 and rainy season 2013 surveys. 
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Figure 3.1. Enumeration Areas (EAs) included in each survey of the ICEMR-
Malawi Cross-Sectional Study 
 
 Microscopy procedure 
Thick smears were air dried, methanol fixed, and Giemsa stained upon delivery to 
the lab at the end of each day of sample collection.  Thick smears were read at 100X 
objective magnification by two trained microscopists, who recorded the number of 
parasites seen per 200 white blood cells (WBCs). The two reads were considered 
discrepant if one reader recorded presence of any Plasmodium parasites and the other did 
not, if one reader counted more than 10 times as many as the other when the lowest 
reader was less than 20 parasites seen, or if one reader counted more than twice as many 
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as the other when both reads were 20 parasites or greater. Discrepant slides were sent to a 
third reader. All readers were blinded to the smear results recorded by the other readers. 
The final smear value was calculated as zero if two readers reported no parasites. Using 
an assumed WBC count of 8000/µL, the final smear value per microliter was estimated as 
the geometric mean of the two positive reads multiplied by 40, using the two closest 
reads if all three were positive for parasites. 
Readers were asked to record dichotomously whether or not they observed at least 
one gametocyte while counting parasites per 200 WBCs. Samples were considered to be 
microscopy-positive for gametocytes when any one of the readers reported seeing any 
gametocyte(s). It was therefore possible for a sample to be positive for gametocytes but 
have a final smear value of zero parasites per µL when the various reads were discrepant. 
 Molecular testing 
 To identify gametocytemic individuals, samples were tested in series: all 
individuals for whom blood on a filter paper sample tested positive by PCR for gDNA 
from the P. falciparum lactate dehydrogenase (LDH) gene were classified as parasitemic, 
and their whole blood sample with preserved RNA was tested by qRT-PCR for the 
expression of P. falciparum stage-specific mRNA. The molecular testing methods were 
described in detail in Chapter 2; briefly, for PCR of the filter papers, blood spots were 
fixed by submersion in methanol for 15 minutes, then left to dry for at least two hours. 
Parasite gDNA was then extracted by adding 50 µL of DNase-free water and heating at 
99°C for 30 minutes, vortexing at 15 minutes. These gDNA samples were used in PCR 
reactions targeting the P. falciparum LDH gene, as described by Rantala et al.29 Each 25 
µL reaction consisted of 12.5 µL Taqman® (Life Technologies™, Carlsbad, CA), 0.25 
µL each of forward and reverse primers at 250 nM, 0.30 µL of probe at 300 nM, 10.7 µL 
nuclease-free water, and 1 µL of gDNA sample. All samples were run in duplicate and 
considered dichotomously positive for P. falciparum if LDH had a clear amplification 
curve in at least one of the two wells. 
For individuals with filter papers that were PCR-positive, qRT-PCR was used to 
detect parasite stage-specific mRNA expression based on a novel assay that distinguishes 
ring stage parasites, trophozoites, immature (stage I-III) gametocytes, and mature (stage 
IV-V) gametocytes, as described by Joice et al.30 The preserved RNA samples were kept 
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in a -80°C freezer until thawed for RNA extraction and testing. After thawing, samples 
were spun in a microfuge at room temperature to obtain a pellet. RNA was extracted from 
the selected samples using RNeasy Plus Mini-Kits® (Qiagen Inc., Valencia, CA) and 
treated with RNase-free DNase Sets® (Qiagen Inc., Valencia, CA) to eliminate all traces 
of parasite gDNA. Reverse transcription was performed using Superscript 
complementary DNA (cDNA) Synthesis Kits® (Life Technologies™, Carlsbad, CA) in a 
double reaction compared to the standard protocol, using 50 ng/µL random hexamers as 
the primer. If qRT-PCR could not be performed immediately, the resulting cDNA 
samples were temporarily stored overnight at -20°C. 
The qRT-PCR assay involved the following stage-specific markers: 1) PFE0065w 
for the early asexual stage (ring stage), 2) PF10_0020 for the late asexual stage 
(trophozoite), 3) PF14_0748 for immature gametocytes, 4) PF14_0367 for mature 
gametocytes, and 5) PF11_0209 as a constitutive protein. The assay was performed in 
triplicate for each stage-specific marker using 4 μL of cDNA sample per well. 
Primer/probe mixes were created by combining 18 µL of forward primers and 18 µL of 
reverse primers at a concentration of 900 nM, 5 µL of probe at a concentration of 250 
nM, and 59 µL of nuclease-free water. These mixes were stored at -20°C in a dark box 
with minimal light exposure. Each well of the qRT-PCR reaction consisted of 10 µL of 
ABI TaqMan Gene Expression Master Mix® (Life Technologies™, Carlsbad, CA), 1 µL 
of the primer/probe mix, 5 µL of nuclease-free water, and 4 µL of cDNA sample. The 
results of the qRT-PCR were recorded as positive for a particular marker only if at least 
two of the three wells had a clear amplification curve.  
 Data management and analysis 
All study data were stored in the Research Electronic Data Capture (REDCap) 
system (Vanderbilt University) hosted at the University of Malawi College of Medicine.31 
Some new variable creation and all statistical analyses were performed in Statistical 
Analysis System (SAS) versions 9.3 and 9.4 (SAS Institute, Cary, NC). 
Socioeconomic status (SES) variables were collected at the household level. Ten 
variables pertaining to SES were combined into a single SES indicator variable based on 
the method suggested by Filmer and Pritchett.32 The ten variables were each input into a 
Principal Component Analysis (PCA) based on the following scoring system: Ownership 
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of each of six items (radio, bike, car, house, phone, and television) was indicated by a 
value of 1 if the household owned at least one of the item and 0 if it did not. If the home 
was powered by electricity, it received a score of 1 for that variable, and 0 if it was not. If 
the head of household earned any income, that was indicated with a value of 1. If the 
household reported a shortage of food in the previous month, it received a score of 0; the 
lack of a food shortage in the previous month received a score of 1. Finally, the highest 
level of education achieved by either the head of household or spouse was ranked as a 0 
for ‘No schooling,’ 1 for any years completed of Standard 1-8, or 2 for completing 
anything beyond Standard 8. Higher scores on each component therefore represented 
greater wealth or SES. PCA was performed in SAS using proc factor to obtain weights 
for each item of the ten individual indicators to evaluate their relative importance in 
contributing to the total household score. These weights were obtained from Factor 1, 
which had an eigenvalue of 2.55. The PCA was calculated using 3,599 households in the 
entire dataset from four surveys. These weights were then applied to each of the ten 
components to calculate an overall weighted SES index score for each household during 
each survey. The PCA-weighted SES index score was applied to all individuals within a 
household. The individuals from all 30 EAs from a given survey were grouped into 
quartiles by the SES index scores, including 3,861 participants from dry season 2012, and 
3,754 participants from rainy season 2013. Quartiles of SES were determined for each 
survey independently to minimize the impact of any potential changes in population SES 
over time. The subset of eight EAs where RNA was sampled was extracted from the 
quartiles assigned to the entire dataset for a given survey, leading to uneven sample sizes 
for each quartile within this analysis. 
Household construction was assessed separately from the overall SES index, as it 
may be directly associated with Plasmodium infection if the household materials increase 
exposure to Anopheles vectors. The roof, floor, and walls of the house were each 
classified as natural, rudimentary, or finished. Natural roofs were those made of 
thatch/leaf or sticks/mud or missing entirely; rudimentary roofs were made of rustic 
mat/plastic sheet, reed/bamboo, or wood planks; finished roofs were those made of 
corrugated iron/metal sheets, wood, cement fiber, cement/concrete, or roofing shingles. 
Natural floors were those made of earth/sand or dung; rudimentary floors were those 
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made of wood plants or palm/bamboo; finished floors were those made of 
parquet/polished wood, vinyl or asphalt strips, ceramic tiles, cement, or wall-to-wall 
carpet. Natural walls were those that were made of cane, sticks, bamboo, or reeds, or 
missing entirely; rudimentary walls were those that were made of bamboo/wood with 
mud, carton/plastic sheets/sacks, mud, plywood, or stone with mud; finished walls were 
those made of bricks, cement, cement blocks, covered adobe, plaster, stone with 
lime/cement, or wood planks/shingles. A household overall was categorized as ‘finished’ 
if at least two of the roof, walls, and floor were classified as finished rather than natural 
or rudimentary, and ‘unfinished’ if none or only one of the three was finished. The status 
of the eaves was included as a separate variable, categorized as ‘open’ or ‘closed.’ 
Age groups were defined as young children (6 mos – 5 yrs), school-aged children 
(6 – 15 yrs), or adults (≥16 yrs). We identified whether or not each household owned at 
least one bednet, and which members of the household had slept under the bednet on the 
previous night.   
Symptoms of malaria were defined as reported history of any fever in the 
previous two weeks, any fever, rigors/chills, or headache in the previous 48 hours, or an 
axillary temperature ≥37°C at the time of the survey. Data also were collected on the use 
of any treatments in the previous two weeks for all subjects, including the antimalarials 
lumefantrine-artemether (LA), chloroquine, quinine, and sulfadoxine-pyrimethamine 
(SP)/fansidar. 
Prevalent gametocyte carriers were identified as those that tested positive for any 
P. falciparum gDNA by PCR and subsequently tested positive for the immature 
gametocyte marker, the mature gametocyte marker, or both. Regression analyses focused 
on carriage of mature gametocytes as the outcome, as those individuals represented the 
potentially infectious reservoir at the time of the survey, and there was no certainty that 
subjects with immature gametocytes alone would necessarily develop a mature 
gametocytemic infection. Univariate analyses of the potential predictors of mature 
gametocytemia were performed using chi-squared tests of association when possible, or 
Fisher’s exact tests for the variables with expected values of five or fewer. Classification 
and regression tree (CART) techniques were attempted, but failed to produce a tree with 
nodes due to the low prevalence of gametocytemia in the total population. Logistic 
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regression models were used to evaluate the potential predictors of gametocytemia in the 
total study population, and among the subpopulation that was parasitemic by PCR, in the 
context of multivariable adjustments.  Multilevel models were explored to account for 
clustering at the household and EA levels and prevent overestimation of statistical 
significance, using the proc glimmix command in SAS.  
3.4 Results 
 Samples included in RNA testing and analysis 
RNA samples were tested and analyzed for eight EAs included in the ICEMR-
Malawi Cross-Sectional Study, two from Blantyre and three each from Thyolo and 
Chikhwawa (see Figure 3.1). The schematic of samples collected and included in the 
current molecular analysis of gametocyte prevalence is presented in Figure 3.2. Of 1,077 
individuals from 249 study households in those eight EAs during the dry season 2012 
survey, there were 836 (77.6%) ≥6 months of age who were present and consented to 
give blood samples, though only 825 had samples available for analysis. Samples of 
gDNA on filter paper and mRNA in RNAprotect for molecular testing were only 
collected from a subset of 616 (74.7%) of these subjects from 215 households during this 
initial more limited phase of RNA sampling. Of 1,017 individuals in 248 households 
from the same eight EAs that participated in the rainy season 2013 survey, RNA samples 
were obtained from all 905 (89.0%) individuals ≥6 months of age from 247 households 
who were present and consented to give samples, though only 894 were available for 
analysis. An additional two subjects from rainy season 2013 were excluded as they 
lacked filter paper samples to enable PCR testing for parasite gDNA. Thus, 616 
individuals from 214 households from the dry season 2012 and 892 individuals from 247 
households from the rainy season 2013 formed the study population for molecular 
analysis. Of these, there were 50 samples that tested positive for P. falciparum parasite 
gDNA by PCR from the dry season 2012 and 162 from the rainy season 2013 that were 
subsequently tested by qRT-PCR for stage-specific P. falciparum RNA expression. 
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Figure 3.2. Sample sizes included in the molecular testing of gametocytemia from 
two seasons of the ICEMR-Malawi Cross-Sectional Study 
 
 
Individuals within each of the eight included EAs who provided samples included 
in this molecular testing were compared to the subjects from the same eight EAs that 
were not included. Both gDNA for PCR and RNA for potential qRT-PCR were available 
for only 58.3% of individuals in the dry season 2012, but this expanded to 89.0% of 
individuals in the rainy season 2013, largely due to the intentional addition of RNA 
sampling to the study protocol. During the dry season 2012, RNA sampling proportions 
were low among school-aged children 6 – 15 yrs of age (57.1%) and adults ≥16 yrs 
(57.7%) relative to those among young children 6 mos – 5 yrs of age (70.0%) (Χ2=10.69, 
p=0.005) and among men (48.2%) relative to women (66.8%) (Χ2=38.08, p<0.0001). 
These relationships were generally consistent within each of the eight EAs. The sampling 
proportions were not significantly different for individuals from households made of 
finished vs. unfinished materials (Χ2=1.60, p=0.21) or for different wealth quartiles 
(Χ2=3.13, p=0.37), though the proportion of individuals sampled from the highest wealth 
quartile tended to be slightly lower than the lower wealth quartiles. A greater proportion 
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of individuals who had a temperature ≥37.5°C or reported a fever within the previous two 
weeks were sampled for RNA (64.8%) than people with no measured/reported fever 
(56.6%) (Χ2=4.43, p=0.04). While the RNA sampling coverage was much higher overall 
during the rainy season 2013, the sampling proportions followed similar patterns. 
Children 6 mos – 5 yrs had the highest coverage (99.0%), followed by school-aged 
children 6 – 15 yrs (93.9%), and adults ≥16 yrs (83.2%) (Χ2=48.23, p<0.0001). The 
sampling proportion continued to be higher among women (96.3%) than men (79.5%) 
(Χ2=72.31, p<0.0001) and among individuals with a measured temperature ≥37.5°C or 
reported fever within the previous two weeks (94.2%) compared to those without one 
(87.9%) (Χ2=5.60, p=0.02). There was again no significant difference in the sampling 
proportion for individuals from households with finished materials compared to those 
with unfinished materials (Χ2=1.45, p=0.22). The highest two wealth quartiles had 
slightly lower sampling coverage than the lowest two wealth quartiles, but the difference 
was small and not statistically significant (X2=5.01, p=0.17).  
 Prevalence of parasitemia and gametocytemia 
The results for immature, mature, or any stage gametocyte prevalence for each of 
the sampled EAs differed by season (Table 3.1), as did the prevalence of mature 
gametocytes as a proportion of all PCR-positive parasitemic samples by EA and season 
(Figure 3.3). The prevalence of gametocytemia, like the prevalence of any parasitemia, 
was generally higher during the rainy season 2013 than the dry season 2012 in a given 
EA, though Figure 3.3 seems to indicate that a greater proportion of parasitemic 
infections carried mature gametocytes during the dry season than the rainy season in most 
EAs. Many participants who had mature gametocytes also carried immature gametocytes 
and vice versa, particularly during the rainy season 2013. A majority of the 23 
participants with immature gametocytes also had mature gametocytes during the dry 
season, but a greater proportion of them had immature gametocytes alone (7 of 23) than 
during the rainy season (5 of 70).
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Table 3.1. Prevalence of gametocytemia by EA and season, as determined by qRT-PCR testing of blood samples during two 
surveys in 2012 and 2013 in southern Malawi. 
 Dry Season 2012 Rainy Season 2013 
 
n 
Immature 
gametocytes 
(%) 
Mature 
gametocytes 
(%) 
Any 
gametocytes 
(%) 
n 
Immature 
gametocytes 
(%) 
Mature 
gametocytes 
(%) 
Any 
gametocytes 
(%) 
Total 616 23 (3.7) 21 (3.4) 28 (4.6) 892 70 (7.9) 78 (8.7) 83 (9.3) 
Blantyre         
  Soche West Ward EA020 84 3 (3.6) 4 (4.8) 4 (4.8) 100 6 (6.0) 6 (6.0) 6 (6.0) 
  Misesa EA014 90 2 (2.2) 3 (3.3) 4 (4.4) 95 3 (3.2) 3 (3.2) 3 (3.2) 
Thyolo         
  Kapichi EA056 50 2 (4.0) 2 (4.0) 3 (6.0) 116 11 (9.5) 13 (11.2) 13 (11.2) 
  Nchilamwela EA056 85 4 (4.7) 4 (4.7) 4 (4.7) 119 11 (9.2) 13 (10.9) 13 (10.9) 
  Chimaliro EA052 85 0 (0.0) 0 (0.0) 0 (0.0) 123 2 (1.6) 1 (0.8) 2 (1.6) 
Chikhwawa         
  Ngabu EA117 81 1 (1.2) 1 (1.2) 1 (1.2) 113 8 (7.1) 8 (7.1) 8 (7.1) 
  Lundu EA019 56 8 (14.3) 4 (7.1) 8 (14.3) 113 22 (19.5) 27 (23.9) 30 (26.6) 
  Makhwira EA051 85 3 (3.5) 3 (3.5) 4 (4.7) 113 7 (6.2) 7 (6.2) 8 (7.1) 
EA             Enumeration area 
ICEMR      International Center of Excellence for Malaria Research 
qRT-PCR   Quantitative reverse transcription polymerase chain reaction 
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Figure 3.3. Prevalence of P. falciparum parasitemia by PCR for each EA by season, with gametocyte presence indicated by 
qRT-PCR results among those that were parasitemic 
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In the total study population of 1,508 subjects, 99 (6.56%) tested positive for 
mature gametocytes by qRT-PCR: 21 of 616 (3.41%) from the dry season 2012 and 78 of 
892 (8.74%) from the rainy season 2013. By microscopy, gametocyte prevalences of only 
0.84% during the dry season 2012 (5 of 597 subjects), and 3.36% during the rainy season 
2013 (30 of 892 subjects) were identified. Of the 1,508 subjects, 127 were judged 
positive for any parasitemia by microscopy. More than half of the microscopically 
parasitemic subjects had mature gametocytes by qRT-PCR (66 of 127, 52.0%), but these 
represented only 66.7% of all gametocytemic individuals in the study population as 
detected by the molecular testing strategy, meaning that approximately one-third of the 
gametocytemic reservoir carried submicroscopic P. falciparum infections. 
 Predictors of gametocytemia in the total study population 
The distribution of mature gametocytemia by various characteristics of the study 
population is presented in Table 3.2, with the total prevalence of P. falciparum 
parasitemia by qPCR presented for comparison. Though molecular gametocyte data were 
not available for the first cross-sectional survey from the rainy season (April-May) 2012, 
EAs that had high prevalence of parasitemia in the rainy season 2012 continued to have 
relatively higher prevalence of parasitemia and had higher prevalences of mature 
gametocytemia in the subsequent dry season 2012 and rainy season 2013. The prevalence 
of gametocytemia was 2.5% in the individuals from EAs in the lowest tertile, 5.6% in 
individuals from the middle tertile, and 13.7% prevalence in individuals from the highest 
prevalence tertile at baseline. The prevalence of gametocytemia was higher in the males 
included in the study (7.6% vs. 5.9% in females), but the difference was not statistically 
significant (p=0.21). Household construction (p<0.001) and SES quartile (p=0.01) were 
both associated with differences in gametocyte prevalence. Individuals in households 
constructed with at least two of the three finished materials categories (walls, floors, and 
roof) had a lower gametocyte prevalence (4.2%) than individuals in households with 
fewer finished materials (8.7%). SES quartile was inversely related to gametocyte 
prevalence, with the highest prevalence of gametocytemia in individuals from the lowest 
quartile (8.5%) and the lowest prevalence of gametocytemia in individuals from the 
highest quartile (2.1%). The prevalence of parasitemia and gametocytemia was lower in 
individuals from households that did not own any bednets compared to individuals from 
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households that did own bednets, whether or not the individuals used the bednets on the 
previous night. Among individuals within the households that owned any bednets, the 
prevalence of parasitemia and gametocytemia was higher among the individuals that did 
not sleep under a net on the previous night. Bednet status was significantly associated 
with parasitemia (p<0.01), but there was a slightly higher probability that the observed 
association with gametocytemia may have been attributable to chance (p=0.08). None of 
the considered combinations of symptoms was associated with prevalence of 
gametocytemia, and few subjects had recently been treated with an antimalarial, limiting 
the sample size for further analysis. 
Age category was strongly associated with the prevalence of both parasitemia and 
gametocytemia (p<0.0001 for each). The prevalence of mature gametocytemia in school-
aged children (12.1%) was high compared to that of young children (4.4%) or adults 
(3.4%). There are approximately 2.8 million (21.5% of the national population) children 
≤5 yo, 3.5 million (26.8%) school-aged children 6 – 15 yo, and 6.8 million (51.8%) 
adults ≥16 yo in Malawi, according to the most recent national census from 2008.28 
Applying the age-specific gametocyte prevalences found in this study to the age structure 
of the total population leads to an estimated 777,178 gametocytemic individuals 
nationwide, with 15.9% of these being young children ≤5 yo, 54.5% being school-aged 
children 6 – 15 yo, and 29.6% being adults ≥16 yo. 
Table 3.2. Characteristics of the study population and prevalence of parasitemia  
and gametocytemia by molecular testing, ICEMR-Malawi Cross-Sectional Study 
  P. falciparum parasitemia α Mature gametocytemia 
 n n (%) p-value n (%) p-value 
Total 1508 212 (14.1%)  99 (6.6%)  
Microscopy results      
    Positive for any parasitemia 127 111 (87.4%)  66 (52.0%)  
    Negative for any parasitemia 1362 97 (7.1%) <0.0001 33 (2.4%) <0.0001 
Season      
    Dry 2012 616 50 (8.1%)  21 (3.4%)  
    Rainy 2013 892 162 (18.2%) <0.0001 78 (8.7%) <0.0001 
EA transmission intensity β      
    Low 402 22 (5.5%)  10 (2.5%)  
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  P. falciparum parasitemia α Mature gametocytemia 
 n n (%) p-value n (%) p-value 
    Medium 771 85 (11.0%)  43 (5.6%)  
    High 335 105 (31.3%) <0.0001 46 (13.7%) <0.0001 
Sex      
    Male 580 89 (15.3%)  44 (7.6%)  
    Female 928 123 (13.3%) 0.26 55 (5.9%) 0.21 
Age (mean 17.3 yrs)      
    Young children, 6 mos - 5 yrs 341 32 (9.4%)  15 (4.4%)  
    School-aged children, 6 - 15 yrs 511 114 (22.3%)  62 (12.1%)  
    Adults, ≥16 yrs 656 66 (10.1%) <0.0001 22 (3.4%) <0.0001 
SES Quartile γ      
    Lowest 434 63 (14.5%)  37 (8.5%)  
    2nd 406 70 (17.2%)  28 (6.9%)  
    3rd 425 62 (14.6%)  29 (6.8%)  
    Highest 239 16 (6.7%) <0.01 5 (2.1%) 0.01 
Household characteristics δ      
    Unfinished 809 142 (17.6%)  70 (8.7%)  
    Finished 699 70 (10.0%) <0.0001 29 (4.2%) <0.001 
Eaves      
    Open 387 71 (18.4%)  34 (8.8%)  
    Closed 1121 141 (12.6%) <0.01 65 (5.8%) 0.04 
Bednet use      
    Slept under a net previous night 969 131 (13.5%)  65 (6.7%)  
    Net available but not used 364 66 (18.1%)  29 (8.0%)  
    No nets in household 175 15 (8.6%) <0.01 5 (2.9%) 0.08 
IRS in previous 12 months      
    Yes 334 43 (12.9%)  23 (6.9%)  
    No 1165 166 (14.3%) 0.20 76 (6.5%) 0.71 
Fever in the previous 2 weeks      
    Yes 305 39 (12.8%)  19 (6.2%)  
    No 1202 173 (14.4%) 0.47 80 (6.7%) 0.79 
Fever, rigor, or headache in the 
previous 48 hours 
     
    Yes 193 28 (14.5%)  12 (6.2%)  
    No 1315 184 (14.0%) 0.84 87 (6.6%) 0.83 
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  P. falciparum parasitemia α Mature gametocytemia 
 n n (%) p-value n (%) p-value 
Any treatment sought in the 
previous 2 weeks 
     
    Yes 241 25 (10.4%)  13 (5.4%)  
    No 1267 187 (14.8%) 0.07 86 (6.8%) 0.42 
Antimalarial taken in the previous 
2 weeks 
     
    LA 56 6 (10.7%)  2 (3.6%)  
    Other antimalarial ε 10 3 (30.0%)  1 (10.0%)  
    None 1442 203 (14.1%) 0.23 96 (6.7%) 0.47 
EA              Enumeration area 
ICEMR       International Center of Excellence for Malaria Research 
IRS             Indoor residual spraying 
LA              Lumefantrine artemether 
SES            Socioeconomic status 
Bolded p-values are those <0.05. 
α         Parasitemia as detected by PCR for P. falciparum lactate dehydrogenase (LDH) 
β         Tertiles of parasite prevalence established for all 30 EAs from the first survey (rainy season 2012)  
               data were used as a proxy estimate of transmission intensity in the EA. See Methods for details.  
γ         SES indicator calculated using technique based on Filmer & Pritchett (2001).22 See Methods  
               section for details 
δ         Roof, wall, and floor materials were each classified as finished or unfinished  
               (rudimentary/natural); ‘finished’ households were those with 2 or 3 finished materials,   
               ‘unfinished’ households were those with 0 or 1 
ε        ‘Other’ antimalarials included chloroquine, quinine, or sulfadoxine-pyrimethamine 
As mentioned above, microscopists only identified five gametocytemic subjects 
during the dry season 2012 and 30 during the rainy season 2013. However, results based 
on microscopy still indicated a statistically significant difference in the prevalence of 
gametocytemia by age (X2=6.99, 2 d.f., p=0.03), and a borderline significant association 
between prevalence of gametocytemia and household materials (X2=3.12, 1 d.f., p=0.08). 
Nevertheless, microscopy failed to identify the same patterns of association with EA 
transmission intensity and found no association between gametocyte prevalence and SES 
quartile (data not shown). 
Logistic regression models were used to explore the predictors of gametocytemia 
in the total population (Table 3.3). Season, EA transmission intensity, and age category 
all significantly improved the model fit and were included in adjusted models to test all 
other potential predictors. SES quartile and household characteristics significantly 
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improved the model fit when included independently, but after adjustment for household 
characteristics, the association of SES quartile with gametocytemia was attenuated and 
had a borderline significant p-value. Models were built that tested interaction of the other 
potential predictors with the EA transmission intensity (as approximated by the 
parasitemia prevalence tertile from the preceding rainy season 2012 survey), but small 
sample sizes led to unstable estimates, and the interactions could not be included in the 
final model. The best predictive model included season, EA transmission intensity, age 
category, and household characteristics.  
Adjustment for the predictors in the final model generally led to attenuation of the 
prevalence odd ratios (PORs) compared to the estimates from unadjusted models, but 
most of the key predictors identified from univariate analysis remained statistically 
significant after adjustment. The odds of gametocytemia during the rainy season were 
2.48 times those of the dry season (95% confidence interval (CI): 1.50 – 4.12). The odds 
of gametocytemia for individuals living in EAs that had a moderate intensity of parasite 
prevalence in the baseline survey were 2.58 times those of individuals living in the low 
prevalence EAs (95% CI: 1.27 – 5.26), and the odds of gametocytemia in individuals in 
the high prevalence EAs were 5.05 times those of the low prevalence EAs (95% CI: 2.47 
– 10.35). The odds of gametocytemia among young children 6 mos – 5 yrs were slightly 
elevated compared to the odds in adults ≥16 yrs (POR=1.25, 95% CI: 0.63 – 2.47), 
though the difference was not statistically significant. The odds in school-aged children 6 
– 15 yrs were 4.00 times those of adults ≥16 yrs (95% CI: 2.40 – 6.68). The odds of 
gametocytemia among individuals in households made of unfinished materials were 1.95 
times those of individuals in households made of finished materials (95% CI: 1.20 – 
3.18). The odds of gametocytemia for individuals from households that owned at least 
one net were higher than those of households that did not own any nets, though neither 
difference was statistically significant after adjustment for other key predictors. The odds 
of gametocytemia were slightly higher for the individuals that lived in households that 
owned a net but did not sleep under it the previous night than the individuals that did 
sleep under a net, but the difference in PORs relative to individuals who did not own a 
net was very small after adjustment (2.26 vs. 2.18, respectively). Relative to the highest 
SES quartile, all other quartiles had elevated odds of gametocytemia, but after adjustment 
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for season, age category, EA transmission intensity, and household characteristics, these 
were of only borderline statistical significance. Controlling for these variables changed 
the direction of the association between fever in the previous 2 wks and gametocytemia, 
with an unadjusted POR of 0.93 and an adjusted POR of 1.33; however, the model did 
not preclude the possibility that this observed association was due to chance (95% CI: 
0.77 – 2.30). 
The potential predictors were also tested in a multilevel model that included 
random intercepts at the household- and EA-level in order to more accurately estimate 
associations and conservative standard errors that accounted for potential clustering 
within the data. Unknown EA level factors accounted for a statistically significant portion 
of the unexplained variance in the model that included season, EA transmission intensity, 
age category, and household characteristics (p=0.01). Though the household level 
clustering did not account for a statistically significant part of the remaining variance 
(p=0.12), the random intercept at the household level was retained in the final model to 
achieve conservative estimates of the standard error and avoid overestimation of the 
significance of each predictor. All multilevel models were adjusted for season, EA 
transmission intensity, age category, and household characteristics, despite some loss of 
statistical significance. As expected, accounting for the household and EA level 
clustering led to lower precision for the fixed effect estimates compared to the model 
without random intercepts, though the direction and magnitude of the estimates was fairly 
consistent. The odds of gametocytemia during the rainy season remained significantly 
higher than those during the dry season in the multilevel model (POR=2.41, 95% CI: 1.43 
– 4.09), as did the odds of gametocytemia among school-aged children relative to those 
among adults (POR=4.16, 95% CI: 2.47 – 7.00). The odds of gametocytemia among 
individuals from EAs with medium and high transmission intensity were higher than 
those among individuals from EAs with low transmission intensity, but both fixed effect 
estimates were imprecise in the multilevel model, and only the POR for living in an EA 
with high transmission intensity remained statistically significant (POR=5.52, 95% CI: 
1.00 – 30.42). Living in a household made of unfinished materials was associated with 
higher odds than living in a finished household, but the POR was only of borderline 
statistical significance in the multilevel model (POR=1.71, 95% CI: 0.98 – 2.98). 
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Table 3.3. Logistic regression modeling of the predictors of mature gametocyte 
carriage in the ICEMR-Malawi Cross-Sectional Study from two surveys, n=1508 
 Unadjusted POR 
(95% CI) 
Adjusted POR 
(95% CI)* 
Adjusted POR, 
multilevel model 
(95% CI)* 
Season    
    Dry, 2012 1.00 (ref) 1.00 (ref) 1.00 (ref) 
    Rainy, 2013 2.72 (1.66 - 4.45) 2.48 (1.50 – 4.12) 2.41 (1.43 – 4.09) 
EA transmission intensity α    
    Low 1.00 (ref) 1.00 (ref) 1.00 (ref) 
    Medium 2.32 (1.15 – 4.66) 2.58 (1.27 – 5.26) 2.81 (0.65 – 12.25) 
    High 6.24 (3.10 – 12.57) 5.05 (2.47 – 10.35) 5.52 (1.00 – 30.42) 
Age    
   Young children, 6 mos-5 yrs 1.33 (0.68 – 2.59) 1.25 (0.63 – 2.47) 1.18 (0.59 – 2.34) 
   School-aged children, 6-15 yrs 3.98 (2.41 – 6.57) 4.00 (2.40 – 6.68) 4.16 (2.47 – 7.00) 
   Adults, ≥16 yrs 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Household characteristics β    
    Finished 1.00 (ref) 1.00 (ref) 1.00 (ref) 
    Unfinished 2.19 (1.40 – 3.42) 1.95 (1.20 – 3.18) 1.71 (0.98 – 2.98) 
Bednet use    
    Slept under net previous night 2.44 (0.97 – 6.12) 2.18 (0.84 – 5.63) 2.13 (0.79 – 5.77) 
    Net available but not used 2.94 (1.12 – 7.74) 2.26 (0.83 – 6.11) 2.45 (0.87 – 6.95) 
    No nets in household 1.00 (ref) 1.00 (ref) 1.00 (ref) 
SES Quartile γ    
    Lowest 4.36 (1.69 – 11.25) 2.60 (0.94 – 7.18) 2.65 (0.90 – 7.80) 
    2nd 3.47 (1.32 – 9.10) 2.20 (0.79 – 6.13) 2.11 (0.72 – 6.20) 
    3rd 3.43 (1.31 – 8.98) 2.71 (1.00 – 7.33) 2.81 (1.00 – 7.90) 
    Highest 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Eaves    
    Closed 1.00 (ref) 1.00 (ref) 1.00 (ref) 
    Open 1.57 (1.02 – 2.41) 1.24 (0.76 – 2.02) 1.15 (0.67 – 1.97) 
Fever in previous 2 wks    
    Yes 0.93 (0.56 – 1.56) 1.33 (0.77 – 2.30) 1.29 (0.73 – 2.27) 
    No 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Any antimalarial taken in 
previous 2 wksδ 
   
    Yes 0.67 (0.21 – 2.17) 0.85 (0.25 – 2.84) 0.79 (0.23 – 2.69) 
    No 1.00 (ref) 1.00 (ref) 1.00 (ref) 
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 Unadjusted POR 
(95% CI) 
Adjusted POR 
(95% CI)* 
Adjusted POR, 
multilevel model 
(95% CI)* 
IRS in previous yr    
    Yes 0.96 (0.83 – 1.12) 0.97 (0.86 – 1.10) N/Aε 
    No 1.00 (ref) 1.00 (ref)  
Sex    
    Male 1.30 (0.86 – 1.97) 1.10 (0.71 – 1.69) 1.12 (0.72 – 1.74) 
    Female 1.00 (ref) 1.00 (ref) 1.00 (ref) 
CI             Confidence interval 
EA            Enumeration area 
IRS           Indoor residual spraying 
N/A          Not applicable 
POR         Prevalence odds ratio 
SES          Socioeconomic status 
Bolded values are those where the 95% CI does not contain 1.0. 
*Adjusted for season, EA transmission intensity, age category, and household characteristics (finished  
                   vs. unfinished) 
α        Tertiles of parasite prevalence established for all 30 EAs from the first survey (rainy season 2012)  
               data were used as a proxy estimate of transmission intensity in the EA. See Methods for details.  
β        Roof, wall, and floor materials were each classified as finished or unfinished  
               (rudimentary/natural); ‘finished’ households were those with 2 or 3 finished materials,   
               ‘unfinished’ households were those with 0 or 1 
γ        SES indicator calculated using technique based on Filmer & Pritchett (2001).22 See Methods  
               section for details 
δ        Antimalarials included were lumefantrine artemether, chloroquine, quinine, or sulfadoxine- 
               pyrimethamine 
ε        The model did not converge. 
 
 Predictors of gametocytemia among PCR-positive parasitemic individuals 
Logistic regression models were also used to explore the predictors of 
gametocytemia among only the 212 subjects that were parasitemic by PCR (Table 3.4). 
As there was again a possibility of clustering at the household- and EA-levels, multilevel 
models that included random intercepts for these levels were tested. Neither random 
intercept explained a significant amount of the variance in gametocytemia among the 
parasitemic population. Therefore, there did not appear to be household- or EA-level 
clustering in the data that required the use of multilevel modeling techniques, and the 
final adjusted models did not include random intercepts at these levels.  
The only statistically significant predictor in unadjusted models was age category. 
Similar to the prevalence of gametocytemia in the total population, the odds of 
gametocytemia among school-aged children with parasitemia were 2.38 times the odds of 
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gametocytemia among adults with parasitemia (95% CI: 1.27 – 4.48). The odds of 
gametocytemia among young children with parasitemia were also elevated compared to 
adults with parasitemia, but less so than those of school-aged children, and the difference 
was not statistically significant (POR=1.82, 95% CI: 0.76 – 4.39). Age category was 
therefore included in the adjusted models for all other potential predictors.  
EA transmission intensity did not appear to have a strong association with 
gametocytemia among parasitemic individuals, with the odds among individuals in EAs 
of medium intensity being weakly higher and in EAs of high intensity being weakly 
lower than those of individuals in EAs of low intensity, and neither difference was 
statistically significant. For the other predictors in general, the directions of the 
associations with gametocytemia among parasitemic individuals mirrored the directions 
of the associations with gametocytemia among the population in general, though none of 
the individual predictors other than age category reached the level of statistical 
significance at α<0.05. SES quartile had some of the largest magnitude PORs, despite 
being of borderline statistical significance. Controlling for age category, the odds of 
gametocytemia among parasitemic individuals in the lowest SES quartile were 3.24 times 
higher than the odds among parasitemic individuals in the highest SES quartile (95% CI: 
0.99 – 10.62). The odds of gametocytemia among parasitemic individuals in the second 
and third quartiles were also elevated compared to those in the highest wealth quartile, 
though the associations were weaker and were not statistically significant (Table 3.4). 
Table 3.4. Predictors of gametocytemia among individuals that tested positive for P. 
falciparum parasitemia by PCR, n=212 
 Unadjusted POR 
(95% CI) 
Adjusted POR  
(95% CI)* 
Season   
    Dry, 2012 1.00 (ref) 1.00 (ref) 
    Rainy, 2013 1.28 (0.68 – 2.43) 1.39 (0.72 – 2.69) 
EA transmission intensity α   
    Low 1.00 (ref) 1.00 (ref) 
    Medium 1.23 (0.48 – 3.15) 1.12 (0.43 – 2.97) 
    High 0.94 (0.37 – 2.36) 0.86 (0.33 – 2.23) 
Age   
    Young children, 6 mos - 5 yrs 1.77 (0.75 – 4.18) 1.82 (0.76 – 4.39) 
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 Unadjusted POR 
(95% CI) 
Adjusted POR  
(95% CI)* 
    School-aged children, 6 - 15 yrs 2.38 (1.27 – 4.48) 2.33 (1.22 – 4.43) 
    Adults, ≥16 yrs 1.00 (ref) 1.00 (ref) 
Household characteristics β   
    Finished 1.00 (ref) 1.00 (ref) 
    Unfinished 1.38 (0.77 – 2.45) 1.45 (0.80 – 2.61) 
Bednet use   
    Slept under a net previous night 1.97 (0.64 – 6.08) 1.89 (0.60 – 5.99) 
    Net available but not used 1.57 (0.48 – 5.09) 1.29 (0.39 – 4.34) 
    No nets in household 1.00 (ref) 1.00 (ref) 
SES Quartile γ   
    Lowest 3.13 (0.97 – 10.09) 3.24 (0.99 – 10.62) 
    2nd 1.47 (0.46 – 4.68) 1.56 (0.48 – 5.04) 
    3rd 1.93 (0.60 – 6.22) 2.13 (0.65 – 6.97) 
    Highest 1.00 (ref) 1.00 (ref) 
Eaves   
    Closed 1.00 (ref) 1.00 (ref) 
    Open 1.07 (0.61 – 1.90) 1.24 (0.69 – 2.25) 
Fever in previous 2 wks   
    Yes 1.11 (0.55 – 2.21) 1.07 (0.52 – 2.19) 
    No 1.00 (ref) 1.00 (ref) 
Any antimalarial taken in previous 2 wksδ   
    Yes 0.67 (0.21 – 2.17) 0.48 (0.12 – 2.03) 
    No 1.00 (ref) 1.00 (ref) 
IRS in previous yr   
    Yes 0.96 (0.85 – 1.07) 0.96 (0.86 – 1.07) 
    No 1.00 (ref) 1.00 (ref) 
Sex   
    Male 1.21 (0.70 – 2.09) 1.12 (0.64 – 1.96) 
    Female 1.00 (ref) 1.00 (ref) 
CI             Confidence interval 
IRS           Indoor residual spraying 
PCR         Polymerase chain reaction 
POR         Prevalence odds ratio 
SES          Socioeconomic status 
Bolded values are those where the 95% CI does not contain 1.0. 
*Age category was adjusted for SES quartile. All other values were adjusted for age category. 
α        Tertiles of parasite prevalence established for all 30 EAs from the first survey (rainy season 2012)  
               data were used as a proxy estimate of transmission intensity in the EA. See Methods for details.  
β        Roof, wall, and floor materials were each classified as finished or unfinished  
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 Unadjusted POR 
(95% CI) 
Adjusted POR  
(95% CI)* 
               (rudimentary/natural); ‘finished’ households were those with 2 or 3 finished materials,   
               ‘unfinished’ households were those with 0 or 1 
γ        SES indicator calculated using technique based on Filmer & Pritchett (2001).22 See Methods  
               section for details  
δ        Antimalarials included were lumefantrine-artemether, chloroquine, quinine, or sulfadoxine- 
               pyrimethamine 
3.5 Discussion 
As molecular techniques for the detection of gametocytes have only emerged in 
the last 10-15 years, relatively little epidemiologic data is available to characterize the 
population-level dynamics of gametocytemia with high sensitivity. The current study 
contributes to a growing knowledge base concerning gametocyte infection patterns using 
cross-sectional results from a community-based, all-ages population, and evaluates who 
are potential infectious reservoirs across multiple seasons and settings with different 
transmission intensity. The results confirm that a large proportion of the human 
parasitemic reservoir in these endemic areas carry mature gametocytes and have the 
potential to contribute to ongoing transmission, even in a community-based, nonclinical 
population with many asymptomatic individuals. In fact, recent malaria symptoms were 
not associated with the odds of gametocytemia, either in the total population or among 
those who were parasitemic. This study also identified high odds of gametocytemia 
among P. falciparum-infected school-aged children relative to young children or adults, 
and estimated that more than half of the gametocytemic reservoirs nationwide are school-
aged children (6 – 15 yo). This finding was in contrast to many previous publications, 
which suggested that gametocytemia was most common in P. falciparum infections of 
younger children and decreased monotonically with age. Identification and treatment of 
the asymptomatic gametocytemic reservoir will be a critical step in any efforts aimed at 
malaria elimination and eventual eradication, but our findings suggest that targeting 
interventions at school-aged children may be an efficient strategy for reducing the 
number of human gametocytemic reservoirs. 
Asymptomatic infections were as likely to be gametocytemic as symptomatic 
infections. No combination of malaria-related symptoms (including fever, headache, and 
rigors) was associated with gametocytemia, suggesting that asymptomatic infections can 
potentially contribute to ongoing transmission, and that it would be insufficient to focus 
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treatment on symptomatic people or clinical cases to eliminate infectious human 
reservoirs. More sensitive rapid diagnostic tests are needed for field detection of 
asymptomatic reservoirs of parasitemia in endemic communities. In the absence of new 
detection tools, better understanding of the predictors of gametocytemia can help target 
testing and intervention strategies.   
The most important individual-level predictor of gametocytemia in the study 
population was age. School-aged children (6 – 15 yrs) had notably elevated odds of being 
both gametocytemic and parasitemic in comparison to young children and adults, even 
after adjustment for other key predictors and after accounting for household- and EA-
level clustering in the data. Other individual-level variables collected in the study showed 
low value for prediction of gametocytemia in the total population. Age was also the 
strongest, and only statistically significant, predictor of gametocytemia among 
parasitemic individuals. The odds of gametocytemia for school-aged children 6 – 15 yrs 
with parasitemia were 2.33 times the odds of gametocytemia in adults ≥16 yrs, and the 
difference was statistically significant with a 95% CI of 1.22 – 4.34. The odds of a 
gametocytemia in parasitemic young children (≤5 yrs) were slightly higher than those of 
adults ≥16 yrs (POR=1.82, 95% CI: 0.76 – 4.39), but this difference was not statistically 
significant. While immune reaction to P. falciparum is thought to stimulate the parasite to 
"invest" in gametocytogenesis, the low odds of gametocytemia in P. falciparum 
infections among adults suggest that a lifetime of recurrent infection in an endemic area 
may ultimately lead to effective anti-gametocyte immune responses. However, this would 
lead us to expect the highest odds of gametocytemia in the youngest age groups, which 
was not observed.  
Of the relatively small number of prior studies that reported gametocyte 
epidemiology for community-based samples, most did report a monotonic decrease in 
gametocyte prevalence by age.16–27 The majority of these used microscopy alone for 
gametocyte detection, and all involved samples collected before 2006 across a wide 
variety of nations in both Africa and Asia. Only two of these studies reported an age-
distribution similar to that found in the current study. In a study from holoendemic rural 
villages in Burkina Faso testing 410 individuals for gametocytemia using QT-NASBA 
for Pfs25 mRNA, Ouédraogo et al. reported the highest odds of gametocyte prevalence 
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among children 5 – 9 yrs, followed by those 10 – 14 yrs.33 The odds of gametocyte 
prevalence were also elevated among children <5 yrs compared to adults, but were 
slightly lower than those of the school-aged children. However, no statistical tests were 
reported comparing gametocyte prevalence across the different age groups of children; 
age was assessed as a linear predictor. In a study in Thailand, Coleman et al. reported 
microscopy-based gametocytes per 500 WBCs in 6,494 subjects from a low prevalence 
area with mixed species infections.34 The prevalence of P. falciparum gametocytemia 
peaked in the 10 – 15 yo age group, but the authors did not report any statistical testing 
related to age. No previous studies have reported on the epidemiology of gametocytemia 
in Malawi. Differences between our results and previous findings may be attributable to 
the improved sensitivity of the molecular assays, geographic variations in parasite 
epidemiology, or possibly a true shift in the age-distribution of gametocytemia compared 
to the populations in earlier studies. Many recent interventions have focused on the 
populations that suffer the greatest burden of malaria disease, namely pregnant women 
and children <5 yo. It is possible that increasing coverage of bednets and other 
interventions in the past decade has minimized the frequency of infection in children <5 
yo, resulting in a delay in the development of transmission-blocking immunity (TBI) to 
gametocytes, and correspondingly higher likelihood of gametocytemia in P. falciparum-
infected school-aged children. Additional research with longitudinal sample collection in 
one geographic region, with consistent methodology and data on antibody responses, is 
necessary to disentangle the causal relationships; regardless, the results have implications 
for malaria elimination efforts, with school-aged children currently representing the 
majority of the gametocytemic reservoir in Malawi, suggesting a need for interventions to 
reduce the infection prevalence in these older children in order to interrupt transmission.. 
Populations with lower SES in our study tended to harbor a higher prevalence of 
gametocytes than populations with higher SES. Aspects of household construction that 
could increase exposure to mosquito vectors explained part of this association, as the 
magnitude of the estimated association between SES quartile and gametocytemia was 
attenuated after controlling for household construction characteristics. Although 
household characteristics did not account for the entirety of the association between SES 
quartile and prevalence of gametocytemia, the remaining association was not statistically 
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significant and did not demonstrate a clear monotonic trend as SES quartile decreased. 
Although the association had borderline statistical significance after using a multilevel 
model to account for household- and EA-level clustering, individuals in households that 
were made of all unfinished or only one finished material (of walls, floor, and roof) had 
higher odds of gametocytemia than individuals in households made of at least two 
finished materials. While general economic improvements would likely contribute to a 
reduction in the burden of Plasmodium infections and malaria disease, areas with 
relatively low SES and high proportions of rudimentary/unfinished households may 
represent another effective target for Plasmodium screening and intervention activities.  
EAs that had higher P. falciparum prevalence during the baseline survey in rainy 
season 2012 tended to have higher prevalence of gametocytemia in the two subsequent 
surveys included here. After accounting for clustering at the EA and household levels, the 
estimated association between the variables representing EA transmission intensity and 
gametocytemia remained high, despite loss of precision. This provides some evidence in 
favor of consistently elevated prevalences at some sites over time, though further data 
collection would be required to explain the specific EA-level variables responsible for 
these consistently elevated prevalences (i.e. proximity to standing water sources, 
elevation, ITN coverage, etc). Identification of infectious ‘hot-spots’ through parasite 
surveillance could therefore guide future interventions to efficiently reduce the human 
infectious reservoir. For instance, sites identified as harboring a large prevalence of 
gametocytemic/parasitemic individuals can theoretically be targeted for interventions to 
reduce the prevalence of gametocytemia during the dry season, in order to interrupt the 
transmission cycle before mosquito populations increase with the arrival of the seasonal 
rains. To be effective, good surveillance data would be needed to identify the target, high 
prevalence areas where transmission intensities are high. 
Our results suggest a high degree of across- and within-District heterogeneity in 
both the prevalence of P. falciparum parasitemia overall, and gametocytemia specifically. 
Molecular testing for gametocytes was performed in a limited selection of only eight EAs 
of ~30 households each across a large geographic area (see Figure 3.1). The 10 EAs per 
District that were included in the ICEMR-Malawi Cross-Sectional Study were randomly 
selected, and more likely to be representative of their respective Districts. The eight EAs 
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chosen for qRT-PCR testing were chosen based on logistical considerations, not random 
selection, and individuals in the qRT-PCR tested EAs differed from those in other study 
EAs on a number of key variables. This suggests that any simple descriptive 
epidemiology results from this study cannot be extrapolated to estimate the local 
prevalence of gametocytemia in each District, and that Plasmodium surveillance 
activities will need to have a high degree of granularity in order to identify all potential 
‘hot spots’ of transmission. While the high degree of heterogeneity may limit our ability 
to assign relevant average prevalences across the larger geographic areas sampled in the 
study, nonetheless, analyses about the associations of various predictors with 
gametocytemia within this study should still be internally valid, and may be generalizable 
to other populations, particularly to those with similar degrees of P. falciparum 
endemicity.  
There is some potential for selection bias within each sampled EA, as not all 
individuals were present and some were not included in the gametocyte RNA sampling. 
Subjects that had recently been ill with a reported fever were more likely to participate 
than those who were not. Young children <5 yrs were also more likely to be sampled than 
individuals in older age categories, and women were more likely to be sampled than men. 
This could have led to selection bias in estimating the associations of age and sex with 
the odds of gametocytemia if the older children/adults and men who were present at 
home during the day tended to be those who were sick, and had higher prevalences of 
infection than their unsampled counterparts. This would lead to overestimation of the 
odds of gametocytemia in men and school-aged children/adults relative to women and 
young children. However, in this community-based sample, recent symptom status had 
no association with the odds of either gametocytemia or any P. falciparum parasitemia, 
so there is little evidence to support a relationship between the sampling proportions by 
age or sex and the measured study outcome of gametocytemia. Thus, selection bias is 
unlikely to significantly impact the analysis of the predictors of gametocytemia. 
 The cross-sectional nature of the data introduced a number of limitations. By 
identifying only prevalent infections and not incident infections, the associations reported 
above may be related to differences in risk for developing a gametocytemic P. falciparum 
infection, differences in the duration of gametocyte carriage, or both. This distinction 
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may not matter in terms of identifying which infectious reservoir groups to target for 
interventions, but could influence the types of interventions required to effectively reduce 
the size of that reservoir population. If the predictor is related more to the risk of 
developing a new gametocytemic infection, it will be more successful to emphasize 
interventions targeted at preventing exposure to mosquitoes, through the use of ITNs, 
IRS, or elimination of vector breeding sites. If the increase prevalence associated with a 
predictor is related more to longer durations of gametocytemia, the priority should be to 
target high risk groups with screening and treatment interventions to shorten these 
durations. In reality, the prevalence differences are likely due to combinations of duration 
and risk, requiring a multipronged intervention approach, but greater emphasis on certain 
strategies in different high prevalence groups could improve the efficiency for 
transmission reduction. 
These cross-sectional measurements also limit assessment of trends in 
infectiousness over time, in particular the extent to which there is active P. falciparum 
transmission during the dry season vs. whether gametocytes simply persist in certain 
people until transmission resumes with the next rainy season. Previous research has 
indicated that certain individuals might harbor long-term gametocytemic infections in 
areas of highly seasonal transmission.11,12 Longitudinal data would also enable clonal 
identification that could help determine whether specific individuals or groups of 
individuals contribute disproportionately to seasonal transmission cycles. If this does 
occur, the ability to identify these chronically gametocytemic infections might further 
improve targeted treatment to more efficiently reduce transmission. 
Assessment of the impacts of anti-malaria interventions was also limited by the 
cross-section nature of the data and the nonrandom distribution of interventions in the 
study population. IRS was performed in 2012 by the government only in Chikhwawa 
District, creating issues of collinearity with EA-level variables and likely contributing to 
the failure of convergence of the multilevel model that included IRS as a coefficient. The 
prevalence of gametocytemia was higher in individuals from households that owned at 
least one bednet than for households that did not, suggesting not that bednets increased 
the risk of gametocytemia, but likely via a reverse causal relationship, where households 
with high malaria risks were more likely to obtain and/or receive bednets. This perhaps 
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indicates successful logistics for distribution of bednets in the area, but the temporal 
ambiguity of the cross-sectional data limits the opportunity to evaluate the potential 
protective impact that bednet distribution could have for reduction of the gametocytemic 
reservoir in other study populations. In households that owned nets, the odds of 
gametocytemia were higher for those people who did not sleep under a bednet the 
previous night than for those who did (POR, multilevel model=1.15, 95% CI: 0.70 – 
1.91), but the difference was small and not statistically significant (p=0.58). Bednet 
coverage was high in this population, with 88.4% of study participants living in a 
household that owned at least one net, suggesting that net distribution alone is insufficient 
to eliminate the infectious reservoir.  
Beyond the lack of longitudinal data, one limitation of the current study was the 
sample size. At 1,508, the overall study population was large, but only 99 individuals 
were classified as having mature gametocytes. Despite interest in potential interaction of 
the predictors of gametocytemia with transmission intensity, the sample size was too 
small to enable adequate testing of interaction terms in multiple regression, leading to 
very unstable estimates. As settings with low transmission intensity will inherently have 
small sample sizes, this limitation may be difficult to overcome without attempts to 
oversample areas with low transmission. 
Another important limitation of the present study was that the identification of 
individuals with mature gametocytes in their peripheral blood only confirms potential 
infectiousness. Density of gametocytes in the peripheral blood is known to be associated 
with infectiousness to mosquito vectors,8,10 so submicroscopically infected gametocyte 
carriers may not necessarily contribute to the infectious reservoir to the same degree as 
their microscopically parasitemic counterparts, and their role in the population 
transmission dynamics remains uncertain.7 The current study did not directly demonstrate 
the infectiousness of gametocyte-positive samples through the use of membrane feeding 
assays, though other research has indicated that submicroscopic infections with 
gametocyte densities of <1 gametocyte/µL are capable of transmitting P. falciparum to 
naïve vectors.8,10,35 The relationship between gametocyte density and proportion of 
mosquitoes infected is nonlinear, with surprisingly frequent transmission of these very 
low density infections.8 Future research using dynamic mathematical models could 
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perform sensitivity analyses to estimate the number of new infections caused by low 
density asymptomatic infections using a combination of findings from our population 
epidemiologic study with membrane-feeding data from laboratory settings.  
In addition to the density of gametocytemia, the contribution of a gametocytemic 
individual to the infectious reservoir will also be driven by the duration of gametocyte 
carriage and the frequency of biting encounters with uninfected Anopheles mosquitoes, 
among other possible factors. Even if a low density, asymptomatic infection infects a 
smaller percentage of the mosquitoes that take a blood meal than a higher density 
symptomatic infection, the absolute number of infected mosquitoes could be higher for 
the asymptomatic infection if a greater number of mosquitoes take a blood meal from that 
person over the full course of their infection. If mosquito vectors tend to bite 
gametocytemic individuals at a higher rate than uninfected or infected but not 
gametocytemic individuals, it would increase the relative importance of these individuals 
to ongoing transmission, even when their gametocyte density is low. Ongoing research 
with the ICEMR-Malawi Cross-Sectional Study involves expanded vector collection 
within study households to assess potential variations in the household-level distributions 
of vectors, and blood meal testing to assess potential variations in biting patterns in 
relation to the gametocyte status of individuals within the households and surroundings. 
Months of persistent gametocyte carriage could also increase the total number of 
mosquitoes exposed to the asymptomatic infection. Further research with longitudinal 
data is needed to better characterize the duration of gametocytemia in infections of all 
parasite densities, but, again, future studies with dynamic models can investigate the 
relative amount of new mosquito infections stemming from asymptomatic vs. 
symptomatic human infections under different realistic assumptions and conditions. 
Because an individual must be parasitemic in order to be gametocytemic, the 
predictors of gametocytemia in the population as a whole are influenced by the predictors 
of any P. falciparum infection. As mentioned above, we also evaluated the predictors of 
gametocytemia among parasitemic individuals to determine which individuals are more 
likely to carry gametocytes when infected, and found that only age category was a 
statistically significant predictor. Previous research has led to the hypothesis that certain 
external ‘stressors,’ such as co-infection with multiple clones (multiplicity of infection, 
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[MOI]), antibody response to the parasite, and the use of non-curative treatment, may 
increase the parasite’s investment in gametocytes.8 Results of the current study offer 
mixed interpretations regarding the factors that may stimulate the parasite to develop 
gametocytes. EA-level variables did not necessarily support the hypothesis that MOI was 
associated with increased odds of gametocytemia. Neither the rainy season nor increased 
EA transmission intensity, both of which would likely increase clonal competition within 
individuals, were associated with the odds of gametocytemia among parasitemic subjects. 
Household- and EA-level variation did not contribute to the overall variance in 
gametocyte status when random intercepts were included in multilevel models. While 
these cross-sectional data are limited in developing causal inference regarding the 
stimulation and timing of gametocytogenesis within individuals, our study provides no 
evidence that such relationships play a significant role in the population-level dynamics 
of the gametocytemic reservoir. 
On the other hand, interpretation of the individual- and household-level predictors 
of gametocytemia is more consistent with the ‘stress’ hypothesis for gametocytogenesis. 
Individual- and household-level variables that increased the odds of being parasitemic 
also tended to increase the odds of being gametocytemic when infected, though the 
magnitudes of the associations were weak and none were individually statistically 
significant. These results are consistent with the hypothesis in so far as increased risk of 
infection may indicate greater MOI and higher frequency of previous infections, thereby 
stimulating an immune response to P. falciparum infection. However, in a small subset of 
30 gametocytemic and 30 non-gametocytemic samples that were PCR-positive for P. 
falciparum and matched on age, season, microscopically evaluated parasite density, and 
anemia status (for children <5), MOI was not associated with increased odds of 
gametocytemia.36 While the current study results may be consistent with the ‘stressor’ 
hypothesis for gametocytogenesis, they cannot be interpreted as such with confidence due 
to the lack of statistical significance and temporal ambiguity regarding frequency of 
infection in specific individuals. 
Despite the limitations, this analysis contributed to the small body of literature 
that used sensitive molecular detection methods to characterize the epidemiology of 
gametocytemia in an all-age, community-based study population. Further research is 
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needed to confirm whether the observed relationships are consistent in different 
geographic areas, but these results can complement the growing attempts to define the 
role of the asymptomatic reservoirs in perpetuating Plasmodium transmission, and 
ultimately aid in the design of efficient interventions to eliminate malaria disease. 
Even in an area of Malawi with high coverage of bednets, our results show that 
interventions targeting primarily children <5 yrs will have limited success at interrupting 
transmission, since school-aged children in our populations had both higher odds of being 
parasitemic and higher odds of being gametocytemic given parasitemia. Longitudinal 
research is also needed to evaluate whether the higher prevalence of gametocytemia 
among school-aged children reflects higher risk (incidence) of developing gametocytemia 
or longer duration of gametocytemia. Chapter 4 of this dissertation will explore 
treatment-seeking behaviors to estimate potential differences in duration of infection, but 
this strategy is limited compared to longitudinal study designs for understanding duration 
of asymptomatic infections. The identification of older children as a key infectious 
reservoir lends itself to an opportunity for expanding school-based distribution of 
intervention materials or increased education on avoiding/treating infection. Whether a 
school-based intervention would reach the most at-risk students requires study, but such 
an option may be promising in areas with relatively high rates of school attendance 
through the later teenage years.  
The confirmation that asymptomatic infections are frequently gametocytemic 
highlights them as a key challenge for efforts aimed at malaria elimination. There is an 
urgent need for new tools to help rapidly and sensitively detect all Plasmodium infections 
in endemic communities, and for new antimalarial drugs with strong gametocytocidal 
effects to enable large scale treatment without encouraging resistance against the first line 
clinical treatments. Without such new tools, malaria elimination may be impossible to 
achieve in most endemic regions. Intervention efforts should expand to cover older 
children and young adults, who are important reservoirs of infection, despite 
experiencing relatively lower incidence of clinical disease. Even using existing 
intervention strategies, such targeting could potentially help reduce the persistence of 
Plasmodium transmission and help achieve malaria control. 
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CHAPTER 4 Treatment-seeking behavior and use of antimalarials in three Districts 
of southern Malawi: Relevance for potential Plasmodium transmission 
4.1 Abstract 
Untreated Plasmodium infections can persist for months, with potentially long 
infectious periods. Antimalarial treatment is key for clearance of infections, thus limiting 
the duration of their contribution to transmission. Treatment-seeking behaviors play an 
important role in determining prompt and proper antimalarial interventions. Thus, we 
studied treatment-seeking in three eco-geographically diverse Districts of southern 
Malawi to assess potential intervention needs that would reduce the human infectious 
reservoir and make progress toward malaria elimination. 
Methods: Approximately 3,000 individuals from 900 households in three Districts 
of southern Malawi were included in each of four cross-sectional surveys. Participants 
were questioned about fever and treatment-seeking in the two weeks prior to each survey. 
Multilevel logistic regression models were used to analyze the predictors that a febrile 
person would seek any treatment, that a person seeking treatment would attend a 
government or private clinic as opposed to another source, and that a person seeking 
treatment would receive an antimalarial. Cox regression was used to assess differences in 
the time from fever onset until treatment was sought. 
Results: Most people who reported a recent fever had sought treatment (>85%), 
but few afebrile people had (5.5%). Among those who did seek treatment, few afebrile 
people (<5%) and few febrile people who went to shops or other local treatment sources 
(<8%) received any antimalarial drug. Antimalarial use was most common among febrile 
people who had visited a government or private clinic (>40%). Among febrile people, 
greater distance to health facilities was associated with less frequent treatment seeking in 
the urban Blantyre District and semi-rural Thyolo District, but not in the rural 
Chikhwawa District. Overall, greater distances to health facilities were associated with 
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lower odds of seeking treatment at a government or private clinic instead of a shop or 
other local source. The proportion of febrile people who sought treatment decreased and 
the time from fever onset to treatment-seeking increased with age category in all three 
Districts, but school-aged children (6 – 15 years old (yo)) and adults (≥16 yo) were more 
likely to attend a shop or other local source than young children (≤5 yo), who were 
significantly more likely to be taken to a government or private facility. Of individuals 
who sought treatment but did not receive an antimalarial, 6.9% that had gone to a 
government or private facility, and 16.8% that had gone to a shop or other local source, 
tested positive for P. falciparum by PCR when surveyed. Diagnostic blood testing was 
not performed on >45% of individuals at a government or private facility and >90% of 
individuals at a shop or other local source. All children ≤15 yo were more likely to 
receive an antimalarial than adults at either source of treatment and whether or not they 
were diagnostically tested. Only a quarter of participants that tested positive for P. 
falciparum by PCR at the time of survey reported seeking any treatment in the previous 
two weeks. 
Conclusions: Afebrile people in Malawi rarely seek treatment, so asymptomatic 
reservoirs of Plasmodium infection are likely to have long durations of infection. Among 
those that do seek treatment, diagnostic testing and antimalarial treatment are not always 
provided, particularly among those who seek treatment only at shops and other local 
sources rather than government or private clinics. Diagnostic testing capacity and 
antimalarial drug availability should be increased at local sources of care to reach a 
greater proportion of the infectious reservoir, but it is unlikely that malaria elimination 
can be achieved in such highly endemic areas until more sensitive diagnostic techniques 
and safer gametocytocidal drugs are readily available. 
4.2 Introduction 
As international efforts have begun to shift towards a goal of malaria elimination 
and eradication, attention has increasingly focused on interrupting Plasmodium 
transmission by eliminating reservoirs of infection in addition to treating cases.1–5 Mass 
screening and treatment (MSAT) interventions (also known as Intermittent Screening and 
Treatment [IST]) have been attempted in some settings with limited success, possibly due 
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to the presence of undetected, low-density infections that perpetuate transmission, and the 
use of antimalarials with limited gametocytocidal properties.6–9 Mass drug administration 
(MDA) has also been recommended as a strategy to overcome limitations in the 
sensitivity of parasite detection methods.10 These strategies prompt concerns about 
promotion of drug resistance and the potential for adverse reactions, particularly among 
people who are glucose-6-phophate dehydrogenase (G6PD) deficient for whom the 
primary gametocytocidal drug, primaquine, is counterindicated.11 There is a need for 
improved methods of both screening and treatment in order to approach elimination. 
Meanwhile, a better understanding of transmission dynamics based on which human 
groups are important reservoirs of infection could help target future interventions for 
more effective interruption of transmission. 
Broadly, the contributions of infected humans to ongoing transmission depends 
on whether or not they carry infectious gametocytes, how many  Anopheline mosquitoes 
bite these gametocytemic people, how likely those mosquitoes are to develop infectious 
sporozoites given that they took a blood meal, and how likely these now infectious 
mosquitoes are to subsequently bite a new human. Each of these broad components is 
influenced by a number of additional factors that contribute to a person’s relative 
importance in maintaining transmission.  
Recent results from the Malawi International Center of Excellence for Malaria 
Research (ICEMR) cross-sectional study have shown that both submicroscopic 
parasitemia and asymptomatic parasitemia are common in communities of southern 
Malawi.12 Furthermore, Chapter 3 of this dissertation demonstrated that gametocyte 
carriage, especially submicroscopic gametocytemia, is common among these prevalent 
infections. The importance of these potentially infectious reservoirs to ongoing 
transmission, however, is difficult to assess. Other researchers have found that 
individuals with very low-density gametocytemia can transmit the infection to Anopheles 
vectors, but that the probability of infecting a given mosquito increases with greater 
gametocyte density in the human peripheral blood.11,13 However, low density gametocyte 
infections may still be important if these people are bitten by a large number of 
mosquitoes, whether due to disproportionate exposure to mosquito bites in a given time 
frame, or a long duration of gametocyte carriage. 
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Duration of infectiousness is key to understanding human contributions to 
infection transmission, but this remains poorly characterized for Plasmodium, particularly 
in natural settings. Clinical trials are the best recent sources of data on infection 
durations, and show that mature and immature gametocytes are resistant to sulfadoxine-
pyrimethamine (SP), chloroquine, amodiaquine, and quinine, allowing gametocytemia to 
persist for up to a month after treatment, even when clearance of asexual stage parasites 
prevents additional gametocytogenesis.11,14 Artemisinin combination therapies (ACTs) 
appear to be more effective against immature gametocytes, leading to lower prevalence 
of gametocytemia in the weeks post-treatment than for non-ACT regimens, but still have 
limited effect on mature gametocytes and may also allow gametocyte persistence for 
several weeks.11,14 It is difficult to obtain data on the duration of gametocytemia in 
untreated infections, as even an asymptomatic infection should be treated when detected, 
to prevent both potential development into a symptomatic case and potential transmission 
to other vulnerable individuals. Data from the 1950s indicated that untreated or 
inadequately treated P. falciparum parasitemia persisted for an average of 222 days, and 
could last for more than a year.15 More recent evidence from population-level molecular 
testing for gametocytemia in an area with highly seasonal transmission found that 
submicroscopic gametocyte carriage could persist for months through the long dry season 
in untreated infections.16,17 Thus, treatment with an effective antimalarial is critical for 
limiting the duration of infectiousness and thereby reducing an individual’s potential 
contribution to ongoing transmission. 
In Malawi, Ministry of Health (MoH)-provided health services are largely free, 
and the recommended first-line treatment for Plasmodium infections is a course of 
lumefantrine-artemether (LA), an ACT.18,19 The MoH recommends that diagnosis be 
made by microscopy wherever possible, with rapid diagnostic testing (RDT) as a 
potential alternative, in patients with fever or recent history of fever or any illness that 
can be a complication of malaria (coma, convulsions, anemia, jaundice, etc). Presumptive 
treatment is not recommended for adults unless both microscopy and RDTs are 
unavailable. Presumptive treatment is considered acceptable for children under 5 years 
old (yo), though laboratory confirmation is still suggested. In addition to MoH sources, 
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antimalarial drugs may also be available through non-governmental, private sources, 
including health care facilities and local shops. 
A repeated sample cross-sectional study in the communities of three Districts of 
southern Malawi collected data on the actual treatment-seeking practices of individuals in 
the two weeks prior to the surveys at the end of each rainy and dry season in 2012 and 
2013. The current analysis aims to: (1) assess the general predictors for seeking any form 
of treatment across the four surveys, (2) analyze the predictors of seeking treatment at a 
government or private facility, as opposed to a traditional healer, community health 
worker, or shop, (3) determine which individuals are likely to receive antimalarials given 
that they sought care. Although longitudinal blood samples from participants were not 
available, treatment-seeking behaviors and use of antimalarials have implications for the 
potential duration of infectiousness in the community-based human reservoirs for 
Plasmodium infection. The results will help identify gaps in the treatment of human 
reservoirs that are unchecked by current standard practices in southern Malawi, and 
suggest directions for future interventions to interrupt transmission. 
Previous analyses of this study population found that school-aged children were an 
important reservoir of parasitemia overall,12 as well as gametocytemia specifically 
(Chapter 3). We hypothesized that these elevated prevalences compared to younger 
children may be related to lower odds of receiving prompt and adequate antimalarial 
treatment, leading to longer duration of disease in school-aged children than younger 
children. We also hypothesized that recently afebrile individuals, including those with P. 
falciparum infections, were unlikely to seek any type of treatments, or to receive 
antimalarial treatments when they did seek care. 
4.3 Methods 
The study was carried out under the auspices of the Malawi ICEMR, and all 
methods were approved by the independent Institutional Review Boards (IRB) of the 
University of Malawi College of Medicine, the University of Maryland, Baltimore, and 
Michigan State University (MSU). 
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 Study design 
Data were collected in three Districts of southern Malawi during biannual cross-
sectional surveys at the conclusion of each rainy season (April-May) and dry season 
(September-October) in 2012 and 2013. These three Districts represent different 
transmission patterns. Blantyre is a more urbanized District in the highlands with 
expected low transmission, Thyolo a semi-rural District with expected moderate 
transmission, and Chikhwawa a rural District at low elevation with expected high 
transmission. Compact segments of approximately 30 households were chosen within 
each of 10 enumeration areas (EAs) per District; EAs and compact segments were 
randomly selected using two-stage cluster sampling, excluding any EAs on the District 
border between Thyolo and Chikhwawa, Chikhwawa EAs at >500 m elevation, or Thyolo 
EAs at <500 m elevation. Thus, approximately 900 households were selected for study 
and visited during each survey. As the average household size in southern Malawi is 4.2 
persons,20 more than 3,500 individuals were expected to participate in each round of 
surveillance. The survey team returned to the same compact segments and roughly the 
same households for each round, having communicated closely with local health 
representatives and EA chiefs to encourage high levels of participation. 
At each visit, the field team interviewed household members in the local language 
(Chichewa) to obtain information about household-level variables and individual-level 
variables for all members of the household, both present and absent. A standardized 
questionnaire sought data on household demographics (i.e. age, sex, relationship of all 
members), house construction, use of malaria interventions [including details on 
insecticide treated net (ITN) quality and use, indoor residual spraying (IRS), intermittent 
preventive therapy in pregnancy (IPTp) and other treatment-seeking behaviors], and self-
reported recent symptoms of disease. Participants were asked about whether any member 
of the household had experienced a fever in the previous two weeks, whether they had 
sought treatment or medical advice related to any illness or health concern in the previous 
two weeks, where such treatment was obtained, whether a finger or heel stick was 
performed there to diagnostically test for Plasmodium infection, and to identify any 
medications that were taken in the previous two weeks. 
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 Sample collection and testing 
Malawian nurses who were members of each field team measured the axillary 
temperature and took finger-pricked peripheral blood samples from all subjects ≥6 
months old (mo) who were present and consented (or were assented) to participate in the 
study. During all surveys, the nurses collected ~0.5 mL of blood onto slides as thick 
smears for microscopy, onto filter paper for DNA isolation, and into a Hemocue® device 
(Hb 201+ System, Hemocue, Inc) for immediate testing of hemoglobin levels for children 
6 mo – 5 yo. RNA-protected sample collection was undertaken during the dry season 
2012 survey for a convenience-based subset of eight of the 30 EAs. This "RNA 
collection" was expanded to include all subjects for the subsequent surveys. To preserve 
parasite RNA, whole blood samples of approximately 50 μL were collected into 250 μL 
of RNAprotect® (Qiagen Inc., Valencia, CA). 
Thick smears were air dried, methanol fixed, and Giemsa stained upon delivery to 
the lab at the end of each day of sample collection.  Thick smears were read at 100X 
objective magnification by two trained microscopists, who recorded the number of 
parasites seen per 200 white blood cells (WBC). The two reads were considered 
discrepant if one reader recorded presence of any Plasmodium parasites and the other did 
not, if one reader counted more than 10 times as many as the other when the lowest 
reader counted less than 20 parasites, or if one reader counted more than twice as many 
as the other when both reads counted 20 parasites or greater. Discrepant slides were sent 
to a third reader. All readers were blinded to the smear results recorded by the other 
readers and any information about the subject. The final smear value was calculated as 
zero if two readers reported no parasites. Using an assumed WBC count of 8000/µL, the 
final smear value per microliter was estimated as the geometric mean of the two positive 
reads multiplied by 40, using the two closest reads if all three were positive for parasites. 
Molecular tests for the presence of P. falciparum genomic DNA (gDNA) were 
performed using polymerase chain reaction (PCR). The methods were described in detail 
in Chapter 2; briefly, for PCR of the filter papers, blood spots were fixed by submersion 
in methanol for 15 minutes, then left to dry for at least 2 hours. Parasite gDNA was then 
extracted by adding 50 µL of DNase-free water and heating at 99°C for 30 minutes, 
vortexing at 15 minutes. These gDNA samples were used in PCR reactions targeting the 
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P. falciparum lactate dehydrogenase (LDH) gene, as described by Rantala et al.21 Each 
25 µL reaction consisted of 12.5 µL Taqman® (Life Technologies™, Carlsbad, CA), 
0.25 µL each of forward and reverse primers at 250 nM, 0.30 µL of probe at 300 nM, 
10.7 µL nuclease-free water, and 1 µL of gDNA sample. All samples were run in 
duplicate and considered dichotomously positive for P. falciparum if LDH had a clear 
amplification curve in at least one of the two wells. 
 Data management and analysis 
All study data were stored and managed in the Research Electronic Data Capture 
(REDCap) system (Vanderbilt University) hosted at the University of Malawi College of 
Medicine.22 Questionnaire responses during the first survey from the rainy season 2012 
were collected on paper in the field and later entered into REDCap at the ICEMR-Malawi 
offices by two independent study personnel. REDCap functions were used to compare the 
double-entered data, and the original paper records were used to resolve any 
discrepancies in data entry. All data for the subsequent three surveys were collected 
electronically in the field on android-based tablets using OpenDataKit 
(http://opendatakit.org) and uploaded to REDCap at the end of each day of field data 
collection. Geographic locations of study households were captured using the global 
positioning system (GPS) embedded in the tablets during the fourth survey in the dry 
season of 2013. Roughly the same households had been included in all prior surveys, 
though it is possible that there was some variation in specific household participation 
during the preceding surveys. Geographic data were managed and all maps created using 
ArcMap version 10.2.1 (Esri, Redlands, CA). 
Several variables were created for evaluation as potential predictors of treatment-
seeking outcomes. Distance to health care facilities was calculated to estimate access to 
health care. The ‘mean center’ method in ArcMap was used to estimate the centroid of 
the compact segment of ~30 households sampled for each EA. Locations of health care 
facilities were collected by the Japanese International Cooperation Agency (JICA), and 
the types of facilities were separated into two categories. Dispensaries, maternity wards, 
or dispensary/maternity wards were grouped into one category; ‘other’ health facilities 
included central hospitals, district hospitals, hospitals, primary health centers, urban 
health centers, and district health offices. Other key characteristics of these facilities, 
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such as antimalarial drug availability and quality of care were unknown, but the locations 
nonetheless allow a rough estimation of access to health care. The proximity analysis tool 
in ArcMap was used to calculate the Euclidean distance in kilometers (km) from the 
centroid of the study households in each EA to the nearest dispensary/maternity facility 
and ‘other’ facility.  
Plasmodium transmission intensity was estimated for each EA using prevalence 
from the first survey as a proxy estimate. PCR data from the original cross-sectional 
study survey during the 2012 rainy season were used to classify the 30 study EAs into 
tertiles of baseline P. falciparum prevalence. The lowest tertile included EAs with 0% to 
<8%, the middle tertile included those with 8% to <15%, and the highest tertile included 
those with ≥15% PCR-based prevalence estimates in the rainy season 2012. The baseline 
prevalence tertile value was assigned to all individuals residing in households within a 
given EA. 
Socioeconomic status (SES) variables were collected at the household level. Ten 
variables pertaining to SES were combined into a single indicator variable based on the 
method suggested by Filmer and Pritchett.23 The ten variables were each input into a 
Principal Component Analysis (PCA) based on the following scoring system: Ownership 
of each of six items (radio, bike, car, house, phone, and television) was indicated by a 
value of 1 if the household owned at least one of the item and 0 if it did not. If the home 
was powered by electricity, it received a score of 1 for that variable, and 0 if it was not. If 
the head of household earned any income, that was indicated with a value of 1. If the 
household reported a shortage of food in the previous month, it received a score of 0; the 
lack of a food shortage in the previous month received a score of 1. Finally, the highest 
level of education achieved by either the head of household or spouse was ranked as a 0 
for ‘No schooling,’ 1 for any years completed of Standard 1-8, or 2 for completing 
anything beyond Standard 8. Higher scores on each component therefore represented 
greater wealth or SES. PCA was performed in SAS using proc factor to obtain weights 
for each of the ten individual indicators to indicate their relative importance in 
contributing to the total household SES index score. These weights were obtained from 
Factor 1, which had an eigenvalue of 2.55. The PCA was calculated using 3,599 
households in the entire dataset from four surveys. These weights were then applied to 
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each of the ten components to calculate an overall weighted SES index score for each 
household. The PCA-weighted SES index score was applied to all individuals within a 
household. The individuals were then grouped into quartiles of SES index scores for each 
survey separately, to minimize the impact of any potential changes in overall SES over 
time. All analyses were based on the individual’s SES quartile within the study 
population of each survey. 
Household construction was assessed separately from the overall SES index, as it 
may be directly associated with Plasmodium infection if the household materials increase 
exposure to Anopheles vectors. The roof, floor, and walls of the house were each 
classified as natural, rudimentary, or finished. Natural roofs were those made of 
thatch/leaf or sticks/mud or missing entirely; rudimentary roofs were made of rustic 
mat/plastic sheet, reed/bamboo, or wood planks; finished roofs were those made of 
corrugated iron/metal sheets, wood, cement fiber, cement/concrete, or roofing shingles. 
Natural floors were those made of earth/sand or dung; rudimentary floors were those 
made of wood plants or palm/bamboo; finished floors were those made of 
parquet/polished wood, vinyl or asphalt strips, ceramic tiles, cement, or wall-to-wall 
carpet. Natural walls were those that were made of cane, sticks, bamboo, or reeds, or 
missing entirely; rudimentary walls were those that were made of bamboo/wood with 
mud, carton/plastic sheets/sacks, mud, plywood, or stone with mud; finished walls were 
those made of bricks, cement, cement blocks, covered adobe, plaster, stone with 
lime/cement, or wood planks/shingles. A household overall was categorized as ‘finished’ 
if at least two of the roof, walls, and floor were classified as finished rather than natural 
or rudimentary, and ‘unfinished’ if none or only one of the three was finished. 
We also created a number of individual-level variables. Not all subjects could be 
given an exact age in months or years, but most subjects in this analysis could be 
categorized as either: young children (≤5 yo), school-aged children (6 – 15 yo), or adults 
(≥16 yo). The ownership of bednets was assessed at the household level; in households 
that owned at least one bednet, we identified which individuals had slept under a net on 
the previous night. 
This analysis considered several outcomes related to treatment-seeking. 
Interviewers asked whether each subject had sought treatment or medical advice for any 
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type of illness or condition in the two weeks previous to the survey, and, if so, what 
source(s) of treatment. Participants who had visited a government hospital, government 
health center, government health post, government mobile clinic, private hospital/clinic, 
private pharmacy, private doctor, or private mobile clinic were classified as having 
visited any government or private facility for this analysis. Participants who had not 
visited a government or private facility but who had gone to a community health worker, 
shop, traditional practitioner, or ‘other’ (primarily described as taking medications that 
they already owned or taking them from neighbors and family) were classified as having 
visited ‘other’ sources of care. Participants were also asked to report any medications 
taken in the previous two weeks, including the antimalarials LA, chloroquine, quinine, 
and SP/Fansidar. Subjects were classified as having sought treatment in the previous two 
weeks if they had visited any type of facility, reported taking any medication, or 
reportedly sought treatment or took medication even though the interviewee did not know 
the source of treatment or type of medication taken. Interviewees were asked to report 
any fever in the previous two weeks or any fever, rigors/chills, headache, diarrhea, 
nausea/vomiting, cough, abdominal pain, rash, or other symptoms in the previous 48 
hours. The field nurses measured the temperature of any subjects who were present at the 
time of survey and consented to sample collection. Subjects were classified as febrile for 
this analysis only if they reportedly had a fever in the previous two weeks, as this was the 
relevant time period for the data on treatment-seeking. Subjects that reported seeking 
treatment for fever were also asked about the number of days that had passed since the 
onset of fever before they sought care. 
All data analysis was performed using Statistical Analysis Systems (SAS) version 9.3 and 
9.4 (SAS Institute, Cary, NC). Analyzed outcomes were either binomial (sought 
treatment or not, sought treatment at a government or private facility versus other source, 
and received an antimalarial or not) or time to event (time from onset of fever to seeking 
treatment). All predictors were categorical except the distances to health facilities, which 
were estimated continuously in kilometers, and non-normally distributed. For univariate 
analyses of binomial outcomes, Wilcoxon-Mann-Whitney and Chi-squared tests of 
association were used for the continuous predictors and categorical predictors, 
respectively. Fisher’s exact test was used to obtain p-values when any cells had expected 
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values of less than five. Logistic regression was used to analyze the predictors that a 
person sought treatment given that they reported a fever in the previous two weeks. 
Multilevel logistic regression models with random intercepts were used to account for 
clustering of treatment-seeking behaviors at the household and EA levels. Among those 
who reported being febrile and seeking treatment in the previous two weeks, multilevel 
logistic regression was also used to assess the predictors of seeking treatment at a 
government or private clinic as opposed to with a community health worker, shop, 
traditional practitioner, or other source, again including random intercepts for the 
household and EA levels. For those individuals who reported having a fever in the 
previous two weeks, the Kaplan-Meier method was used to plot the time in days from the 
onset of fever to seeking treatment, stratified by various potential predictors. The Log-
Rank test was used to test for homogeneity of the stratified survival curves, and Cox 
proportional hazards regression was used to calculate unadjusted and adjusted hazard 
ratios (HRs) for the key predictors. The results of the Cox proportional hazards analysis 
were very similar to those of the multilevel logistic regression analysis of the overall odds 
of seeking treatment, and therefore were not included here. We also analyzed the 
predictors that an individual would receive an antimalarial among the subpopulation that 
had sought treatment in the previous two weeks, using multilevel logistic regression with 
random intercepts at the EA- and household-levels. Interactions of interest, particularly 
the interaction of District with other key predictors, were explored in each regression, and 
retained in the final adjusted models when statistically significant or important for 
interpretation. 
4.4 Results 
 Description of study population 
The current analysis includes data collected during four surveys. Questionnaires 
were completed for 3,459 individuals from 879 households from rainy season 2012, 
3,861 individuals from 909 households from dry season 2012, 3,754 individuals from 921 
households from rainy season 2013, and 3,670 individuals from 924 households from dry 
season 2013. Consent documentation was lost or not obtained for 794 individuals from 
rainy season 2012, 383 from dry season 2012, 433 from rainy season 2013, and 482 from 
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dry season 2013; after these subjects were excluded, 2,665 individuals from 820 
households, 3,478 individuals from 908 households, 3,321 individuals from 917 
households, and 3,188 individuals from 922 households, respectively, were included in 
the final analysis. Basic characteristics of the study population from each survey are 
presented in Table 4.1. As household respondents were asked to provide details about all 
members, including those not present at the time of survey, some aspects of treatment-
seeking were unknown for a large proportion of the study population, and PCR and 
microscopy results were not available for absent subjects. There was a notable increase in 
bed net ownership between the first and second surveys, reflecting a MoH bed net 
distribution campaign that occurred between the ends of the rainy and dry seasons of 
2012. 
Table 4.1. Characteristics of the study population from four surveys of the ICEMR-
Malawi Cross-Sectional Study, 2012 - 2013 
 Rainy season 
2012 
Dry season 
2012 
Rainy season 
2013 
Dry season 
2013 
 n (%) n (%) n (%) n (%) 
Total 2,665 3,478 3,321 3,188 
District     
    Blantyre 838 (31.4%) 1,110 (31.9%) 1,050 (31.6%) 999 (31.3%) 
    Thyolo 879 (33.0%) 1,135 (32.6%) 1,103 (33.2%) 1,035 (32.5%) 
    Chikhwawa 948 (35.6%) 1,233 (35.5%) 1,168 (35.2%) 1,154 (36.2%) 
Sex     
    Male 1,053 (39.5%) 1,539 (44.3%) 1,356 (40.8%) 1,285 (40.3%) 
    Female 1,611 (60.5%) 1,939 (55.8%) 1,965 (59.2%) 1,903 (59.7%) 
Age     
    Infants, <6 mos 39 (1.5%) 60 (1.7%) 37 (1.1%) 47 (1.5%) 
    Young children, 6 mos - 5 yrs 613 (23.0%) 704 (20.3%) 736 (22.2%) 677 (21.2%) 
    School-aged children, 6 - 15 yrs 795 (29.8%) 1,083 (31.2%) 1,086 (32.7%) 1,065 (33.4%) 
    Adults, ≥16 yrs 1,155 (43.3%) 1,610 (46.3%) 1,460 (44.0%) 1,399 (43.9%) 
PCR results      
    Positive for P. falciparum α 363 (17.5%) 342 (12.4%) 605 (20.1%) 306 (10.5%) 
    Negative for P. falciparum 1,715 (82.5%) 2,418 (87.6%) 2,412 (80.0%) 2,622 (89.6%) 
    Not available 587 718 304 260 
Microscopy results     
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 Rainy season 
2012 
Dry season 
2012 
Rainy season 
2013 
Dry season 
2013 
 n (%) n (%) n (%) n (%) 
    Positive for any parasitemia 229 (11.4%) 158 (5.8%) 405 (13.3%) 182 (6.2%) 
    Negative for any parasitemia 1,789 (88.7%) 2,552 (94.2%) 2,637 (86.7%) 2,735 (93.8%) 
    Not available 647 768 279 271 
EA transmission intensity β     
    Low 885 (33.2%) 1,143 (32.9%) 1,055 (31.8%) 1,026 (32.2%) 
    Medium 839 (31.5%) 1,158 (33.3%) 1,094 (32.9%) 1,066 (33.4%) 
    High 941 (35.3%) 1,177 (33.8%) 1,172 (35.3%) 1,096 (34.4%) 
SES Quartile γ     
    Lowest 724 (27.4%) 912 (26.2%) 875 (26.5%) 865 (27.8%) 
    2nd 671 (25.4%) 875 (25.2%) 774 (23.5%) 766 (24.7%) 
    3rd 642 (24.3%) 874 (25.2%) 845 (25.6%) 749 (24.7%) 
    Highest 608 (23.0%) 814 (23.4%) 804 (24.4%) 727 (23.4%) 
Household characteristics δ     
    Unfinished 1,299 (48.9%) 1,667 (48.0%) 1,538 (46.3%) 1,438 (45.1%) 
    Finished 1,355 (51.1%) 1,805 (52.0%) 1,783 (53.7%) 1,750 (54.9%) 
Eaves     
    Open 423 (15.9%) 870 (25.1%) 762 (22.9%) 810 (25.4%) 
    Closed 2,232 (84.1%) 2,600 (74.9%) 2,559 (77.1%) 2,378 (74.6%) 
Bednet use     
    Slept under a net previous night 913 (35.4%) 2,014 (58.0%) 2,270 (68.4%) 1,783 (55.9%) 
    Net available but not used 513 (19.9%) 960 (27.6%) 658 (19.8%) 910 (28.5%) 
    No nets in household 1,153 (44.7%) 501 (14.4%) 393 (11.8%) 495 (15.5%) 
IRS in previous 12 months     
    Yes 470 (17.7%) 376 (10.9%) 867 (26.2%) 698 (22.4%) 
    No 2,185 (82.3%) 3,081 (89.1%) 2,444 (73.8%) 2,424 (77.6%) 
Fever in the previous 2 weeks     
    Yes 1,008 (46.1%) 749 (21.6%) 666 (20.1%) 548 (17.5%) 
    No 1,181 (54.0%) 2,721 (78.4%) 2,654 (79.9%) 2,575 (82.5%) 
Any treatment or advice for illness 
sought in the previous 2 weeks 
    
    Yes 923 (34.6%) 799 (23.0%) 753 (22.7%) 615 (19.3%) 
    No 1,051 (39.4%) 2,672 (76.8%) 2,567 (77.3%) 2,510 (78.7%) 
    Unknown 691 (25.9%) 7 (0.2%) 1 (0.0%) 63 (2.0%) 
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 Rainy season 
2012 
Dry season 
2012 
Rainy season 
2013 
Dry season 
2013 
 n (%) n (%) n (%) n (%) 
Days of fever until treatment 
sought, mean (SD) 
2.15 (2.29) 1.85 (1.62) 2.09 (1.92) 1.75 (1.77) 
Source of treatment sought     
    Government or private facility 387 (41.9%) 365 (45.7%) 347 (46.1%) 317 (51.5%) 
    Shop, traditional healer, 
community health worker, other 
499 (54.1%) 311 (38.9%) 256 (34.0%) 244 (39.7%) 
    Source unknown 37 (4.0%) 123 (15.4%) 150 (19.9%) 54 (8.8%) 
Antimalarial taken in the previous 
2 weeks 
    
    LA 165 (6.2%) 113 (3.3%) 194 (5.8%) 113 (3.5%) 
    Other antimalarial ε 36 (1.4%) 21 (0.6%) 26 (0.8%) 11 (0.4%) 
    None 2,464 (92.5%) 3,344 (96.2%) 3,101 (93.4%) 3,064 (96.1%) 
EA              Enumeration area 
ICEMR       International Center of Excellence for Malaria Research 
IRS             Indoor residual spraying 
LA              Lumefantrine artemether 
LDH           Lactate dehydrogenase 
PCR           Polymerase chain reaction 
SD              Standard deviation 
SES            Socioeconomic status 
α         Parasitemia as detected by PCR for P. falciparum LDH gene 
β         Tertiles of parasite prevalence established for all 30 EAs from the first survey (rainy season 2012)  
                 data were used as a proxy estimate of transmission intensity in the EA. See Methods for details. 
γ         SES indicator calculated using technique based on Filmer & Pritchett (2001).23 See Methods  
                 section for details 
δ         Roof, wall, and floor materials were each classified as finished or unfinished  
                 (rudimentary/natural); ‘finished’ households were those with 2 or 3 finished materials,   
                 ‘unfinished’ households were those with 0 or 1 
ε        ‘Other’ antimalarials included chloroquine, quinine, or sulfadoxine-pyrimethamine 
 
Additional details about the relationships between different treatment-seeking 
variables are presented in Figure 4.1. Subjects that did not report a fever in the previous 
two weeks were less likely to seek treatment than those that were febrile. While some 
individuals who were reportedly afebrile had received an antimalarial in the previous two 
weeks, most subjects that had received an antimalarial had been febrile. In the study 
population, there were only 25 (<0.2%) subjects who took an antimalarial drug without 
experiencing fever in the previous two weeks. Among febrile individuals whose 
 96 
 
treatment source was known, just over half sought care at a government or private facility 
as opposed to at a shop, community health worker, traditional healer, or ‘other’ source. 
Individuals who were febrile and sought treatment at either a government or a private 
health care facility were most frequently given an antimalarial. LA was the most 
commonly dispensed antimalarial for individuals from all treatment sources. At 
government or private health care facilities, LA was given to 38.0% of febrile individuals 
while only other antimalarials were given to 4.5%. At other treatment sources, only 5.8% 
of febrile individuals received LA, and 2.1% received another antimalarial. Of 585 
subjects who reported taking LA, 11 had also taken another antimalarial. Three had taken 
SP/fansidar in addition to LA: one who had gone to a government or private facility, one 
who had gone to another source, and one whose source of treatment was unknown. The 
other eight had taken quinine with LA, all of whom had gone to a government or private 
facility. Of 94 individuals who only took antimalarials other than LA, 59 (62.8%) took 
SP/fansidar alone, 33 (35.1%) took quinine alone, and one (1.1%) took both SP/fansidar 
and quinine. Only one individual in the study population reported taking chloroquine, the 
use of which has been rare following concerns about chloroquine resistance in the early 
1990s, though recent evidence indicates a return of chloroquine-sensitivity.24 
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Figure 4.1. Relationship of treatment-seeking variables in the ICEMR Cross-
Sectional Study population across four surveys from rainy and dry seasons in 2012 
and 2013 
 
 Treatment-seeking in study EAs 
Each survey included a compact segment of approximately 30 households from 
10 EAs in each of the three Districts (Blantyre, Thyolo, Chikhwawa). Among individuals 
with reported fever in the previous two weeks in a given EA, the proportion that sought 
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treatment tended to be high across the three Districts, though there was some variation 
among specific EAs within each District. A higher proportion of individuals sought 
treatment from the EAs in Blantyre than in Thyolo or Chikhwawa on average, and there 
was a slight increase in the average proportion seeking treatment over time since the 
surveys began, though the increase was not consistent for all EAs (Figure 4.2). There did 
not appear to be a clearly distinguishable pattern in the proportion of febrile individuals 
seeking treatment during dry seasons compared to rainy seasons. 
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Figure 4.2. Proportion of febrile individuals that sought treatment in the previous 
two weeks in each enumeration area (EA) across four surveys 
 
TA Traditional authority 
STA Sub-traditional authority 
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EAs were divided into quartiles by the proportion of febrile individuals who 
reportedly sought treatment in the previous two weeks averaged across all four surveys 
and mapped with the location of health facilities (Figure 4.3). There were a large number 
of health facilities in both Blantyre and Thyolo Districts, with fewer in Chikhwawa. Most 
health facilities were classified as either dispensaries or maternities. In Blantyre, the 
distance from each compact segment to the nearest maternity care facility or dispensary 
ranged from 0.37 km to 2.46 km, with an average of 1.53 km (standard deviation (SD): 
0.76) and a median of 1.37 km. The distance to the nearest health facility of another type 
(local and District health offices and hospitals) ranged from 0.72 km to 4.46 km, with an 
average of 2.83 km (SD: 1.45) and a median of 2.33 km. The average distances to either 
type of health facility were longer for both Thyolo and Chikhwawa than Blantyre. In 
Thyolo, the distance from each compact segment to the nearest maternity or dispensary 
ranged from 0.72 km to 5.30 km, with an average of 2.78 km (SD: 1.22) and a median of 
2.38 km. The distance to the nearest health facility of another type ranged from 4.40 km 
to 16.81 km, with an average of 12.01 km (SD: 3.88) and a median of 13.73 km. In 
Chikhwawa, the distance from each compact segment to the nearest maternity or 
dispensary ranged from 0.55 km to 9.30 km, with an average of 6.24 km (SD: 2.69) and a 
median of 6.87 km. The distance to the nearest health facility of another type ranged from 
2.35 km to 23.67 km, with an average of 12.32 km (SD: 5.51) and a median of 11.91 km. 
None of the 10 EAs in Blantyre was within the lowest quartile for proportion of febrile 
individuals who sought treatment. Most of the EAs from the lowest quartile were in the 
Thyolo District, and a few were in Chikhwawa; however, Thyolo and Chikhwawa both 
contained EAs from the highest quartile as well. Despite some spatial heterogeneity, the 
range of proportions was fairly small, with more than 80% of febrile individuals seeking 
treatment in all EAs except one in Thyolo. In that EA, only 68.9% of febrile individuals 
had sought treatment in the two weeks prior to survey. 
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Figure 4.3. Map of the proportion of febrile individuals who sought treatment in the 
previous two weeks in each EA, averaged over four surveys, 2012 - 2013 
 
 Predictors of treatment-seeking among individuals 
We also analyzed predictors of treatment-seeking following reported fever in the 
previous two weeks using multilevel logistic regression models with random intercepts to 
account for potential household- and EA-level clustering (Table 4.2). These random 
intercepts were statistically significant in all models, suggesting further unexplained 
variation at both levels. As previously stated, febrile individuals had the highest odds of 
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seeking treatment in Blantyre District, and Thyolo District had the lowest (crude odds 
ratio (OR) using Blantyre as reference = 0.61, 95% confidence interval (CI): 0.41 – 0.93). 
The odds of seeking treatment when febrile in the previous two weeks were also lower in 
Chikhwawa District than Blantyre (crude OR = 0.82, 95% CI: 0.54 – 1.24), but the 
difference was not statistically significant. Preliminary analyses indicated that the 
associations between other potential predictors and treatment-seeking varied by District, 
so the final, adjusted logistic regression models were built separately for each District, 
although the same predictors were retained in all final models for comparisons. 
Febrile subjects had lower odds of seeking treatment during the rainy season than 
the dry season (crude OR = 0.77, 95% CI: 0.61 – 0.97), but this may have been 
attributable to a general increase in the odds of treatment over time, and the low 
proportion of febrile subjects that sought treatment during the first survey (82.3%), which 
was during the rainy season, compared to the later three surveys (all 87-92%). 
Collinearity limited the ability to control for both season and survey in an adjusted 
model; survey was retained as it better fit the data. Febrile individuals from each survey 
had higher odds of seeking treatment than those from the preceding survey in the final 
adjusted models, though the ratios were only statistically significant in Blantyre and 
Chikhwawa. The odds ratios by survey in Thyolo did not consistently increase over time. 
Distance from compact segment of residence to health facilities was not 
associated with the odds of seeking treatment when febrile in crude analysis, but there 
was strong evidence for interaction with District on the multiplicative scale (Table 4.2). 
A one km increase in distance from the compact segment of households to the nearest 
dispensary/maternity ward was associated with statistically significantly lower odds of 
seeking treatment when febrile in Blantyre (OR = 0.63, 95% CI: 0.45 – 0.88) and Thyolo 
(OR = 0.74, 95% CI: 0.63 – 0.86). In Chikhwawa, however, where the distances to health 
facilities tended to be farther (ranging from 0.55 km to 9.30 km), there was no association 
between a one km change in distance to a dispensary/maternity ward and the odds of 
seeking treatment when febrile (OR = 1.00, 95% CI: 0.91 – 1.09). After adjusting for the 
distance to a dispensary/maternity ward, the distance to other types of health care 
facilities was not associated with the odds of seeking treatment in any of the three 
Districts. 
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Sex was associated with the odds of seeking treatment in a crude model, but not 
after controlling for other relevant predictors. Age category, however, was a statistically 
significant predictor after adjustments for other key predictors in all three Districts (Table 
4.2). Young children (≤5 yrs) had the highest odds of seeking treatment when febrile in 
all Districts, with nearly two times the odds of adults (≥16 yrs) in both Thyolo and 
Chikhwawa and nearly four times the odds of adults in Blantyre, though the Blantyre 
estimate was less precise than those of Thyolo and Chikhwawa. The odds for school-aged 
children (6 - 15 yrs) were also higher than those for adults in all Districts, but the 
magnitudes of the associations were smaller than for young children, and were not 
statistically different from those of adults in any of the Districts. 
There was a positive crude association between the odds of seeking treatment and 
both SES quartile and household construction, but only household construction was 
significantly associated in the adjusted models, with an association that varied by District 
(Table 4.2). Having a finished household was associated with increased odds of seeking 
treatment when febrile only in Blantyre and Thyolo, though the estimate was imprecise 
and not statistically significant in Blantyre. In the most rural District of Chikhwawa, 
having a finished household was associated with lower odds of seeking treatment relative 
to individuals who lived in unfinished houses, though the ratio was not statistically 
significant. 
Previous analyses in this study population found that bednet ownership was highest 
among people with the highest prevalence of Plasmodium infections. The current analysis 
also found that individuals living in households that owned at least one bednet had higher 
odds of seeking treatment when febrile than individuals in households with no bednets. 
After controlling for other key predictors, the association was significant only in 
Chikhwawa. In Thyolo, the directions of association were the same as Chikhwawa, but 
did not reach statistical significance. In Blantyre, subjects who lived in a household that 
owned bednets but did not report sleeping under one the previous night actually had 
lower odds of seeking treatment than individuals in households that did not own any nets, 
but neither this association, nor the increased odds of seeking treatment among those that 
did report using a net compared to non-owners was statistically significant.
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Table 4.2. Predictors of treatment-seeking among individuals with reported fever in the previous two weeks by District using 
multilevel models with random intercepts for household and EA, ICEMR-Malawi Cross-Sectional Study 2012 - 2013 
 
n 
Sought 
treatment in 
past two wks 
n (%) 
Unadjusted OR, all 
Districts  
(95% CI) 
Adjusted* OR, 
Blantyre 
(95% CI) 
Adjusted* OR, 
Thyolo 
(95% CI) 
Adjusted* OR, 
Chikhwawa 
(95% CI) 
District       
   Blantyre 805 722 (89.7%) 1.00 (ref)    
   Thyolo 949 797 (84.0%) 0.61 (0.41 – 0.93)    
   Chikhwawa 1215 1068 (87.9%) 0.82 (0.54 – 1.24)    
Season       
   Dry 1297 1152 (88.8%) 1.00 (ref)    
   Rainy 1672 1435 (85.8%) 0.77 (0.61 – 0.97)    
Survey       
   Rainy season 2012 1006 828 (82.3%) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 
   Dry season 2012 749 652 (87.1%) 1.45 (1.09 – 1.94) 1.27 (0.69 – 2.33) 0.92 (0.54 – 1.59) 1.45 (0.86 – 2.45) 
   Rainy season 2013 666 607 (91.1%) 2.27 (1.62 – 3.17) 1.51 (0.77 – 2.99) 1.46 (0.79 – 2.69) 2.43 (1.33 – 4.46) 
   Dry season 2013 548 500 (91.2%) 2.25 (1.57 – 3.22) 2.59 (1.15 – 5.84) 1.18 (0.63 – 2.18) 2.50 (1.32 – 4.73) 
EA transmission intensity α       
   Low 940 821 (87.3%) 1.00 (ref)    
   Medium 954 821 (86.1%) 0.93 (0.60 – 1.44)    
   High 1075 945 (87.9%) 1.07 (0.69 – 1.66)    
Distance to nearest health 
facilities (km) 
      
   Dispensary/maternity   0.97 (0.91 – 1.03) 0.63 (0.45 – 0.88) 0.74 (0.63 – 0.86) 1.00 (0.91 – 1.09) 
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n 
Sought 
treatment in 
past two wks 
n (%) 
Unadjusted OR, all 
Districts  
(95% CI) 
Adjusted* OR, 
Blantyre 
(95% CI) 
Adjusted* OR, 
Thyolo 
(95% CI) 
Adjusted* OR, 
Chikhwawa 
(95% CI) 
   Other facilities   1.00 (0.97 – 1.03)    
Age       
   Young children, ≤5 yrs 862 790 (91.6%) 2.10 (1.58 – 2.80) 3.68 (1.82 – 7.44) 1.86 (1.16 – 3.00) 1.99 (1.25 – 3.17) 
   School-aged children, 6-15 yrs 649 573 (88.3%) 1.43 (1.07 – 1.91) 1.20 (0.68 -2.11) 1.64 (0.97 – 2.79) 1.56 (0.95 – 2.56) 
   Adults, ≥16 yrs 1428 1200 (84.0%) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Sex       
   Male 1094 975 (89.1%) 1.33 (1.05 – 1.70)    
   Female 1875 1612 (86.0%) 1.00 (ref)    
Household characteristics β       
   Finished 1433 1273 (88.8%) 1.34 (1.03 – 1.74) 2.10 (0.87 – 5.08) 1.59 (1.05 – 2.40) 0.85 (0.52 – 1.38) 
   Unfinished 1529 1309 (85.6%) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 
Bednet use       
   Slept under net previous night 1631 1472 (90.3%) 2.09 (1.60 – 2.73) 1.31 (0.71 – 2.39) 1.63 (0.99 – 2.69) 1.95 (1.20 – 3.16) 
   Net available but not used 569 495 (87.0%) 1.54 (1.11 – 2.14) 0.61 (0.31 – 1.20) 1.14 (0.633 – 2.03) 2.30 (1.21 – 4.37) 
   No nets in household 736 601 (81.7%) 1.00 (ref) 1.00 (ref) 1.00 (ref) 1.00 (ref) 
SES Quartile γ       
   Lowest 893 756 (84.7%) 1.00 (ref)    
   2nd 702 613 (87.3%) 1.25 (0.91 – 1.71)    
   3rd 754 667 (88.5%) 1.39 (1.01 – 1.91)    
   Highest 597 531 (88.9%) 1.38 (0.95 – 1.98)    
CI             Confidence interval 
EA            Enumeration area 
OR           Odds ratio 
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n 
Sought 
treatment in 
past two wks 
n (%) 
Unadjusted OR, all 
Districts  
(95% CI) 
Adjusted* OR, 
Blantyre 
(95% CI) 
Adjusted* OR, 
Thyolo 
(95% CI) 
Adjusted* OR, 
Chikhwawa 
(95% CI) 
SES          Socioeconomic status 
Bolded values are those where the 95% CI does not contain 1.0. 
*Each OR adjusted for the other variables listed in the column. 
α        Tertiles of parasite prevalence established for all 30 EAs from the first survey (rainy season 2012) data were used as a proxy estimate of                             
                   transmission intensity in the EA. See Methods for details. 
β        Roof, wall, and floor materials were each classified as finished or unfinished (rudimentary/natural); ‘finished’ households were those with 2 or 3  
                   finished materials, ‘unfinished’ households were those with 0 or 1 
γ        SES indicator calculated using technique based on Filmer & Pritchett (2001).23 See Methods section for details 
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 Sources of treatment 
Multilevel level logistic regression was used to assess predictors of seeking 
treatment at a government or private facility compared to other sources among the febrile 
individuals who sought treatment (Table 4.3). Random intercepts were again included to 
account for potential clustering at the household- and EA-levels. Interactions by District 
were explored, but none proved to be significant for retention in the final adjusted model. 
The OR for Thyolo relative to Blantyre was statistically significant in the final adjusted 
model when only fixed effects were included; incorporation of random intercepts for 
multilevel modeling led to loss of precision for the estimate such that p=0.08, but District 
was retained as a predictor in the final model. 
Just as a relatively small proportion of febrile individuals sought treatment during 
the two weeks prior to the first survey in the rainy season 2012 compared to later surveys, 
a relatively low percentage of those who did seek treatment chose to do so at a 
government or private facility over a shop, traditional healer, community health worker, 
or ‘other’ source during the first survey (44.1%) compared to the later three surveys (54.3 
– 59.5%). 
When young children (≤5 yo) sought treatment for fever, they had significantly 
higher odds of doing so at a government or private facility than did either school-aged 
children (6 – 15 yo) or adults (≥16 yo), for whom the odds were nearly equal. The OR for 
febrile young children seeking treatment compared to adults was 1.70 (95% CI: 1.37 – 
2.10), whereas for school-aged children compared to adults the OR was 1.02 (95% CI: 
0.80 – 1.30). 
Few of the evaluated predictors were significant after adjustment for survey and 
age. Increased distance of EA households from the nearest health facilities 
(dispensary/maternity) was associated with lower odds of using a government or private 
facility among those that sought any treatment for fever in the two weeks prior to survey 
in both crude and adjusted models. A one km increase in distance was associated with 
0.88 times the odds of seeking care at a government or private facility instead of a shop, 
traditional healer, community health worker, or other source.
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Table 4.3. Predictors of seeking treatment at a government or private health facility instead of at a shop, traditional healer, 
community health worker, or 'other' source among febrile individuals who sought treatment at a known source 
 
n 
Treated at govt/pvt facility Unadjusted OR 
(95% CI) 
Adjusted OR,* multilevel 
(95% CI) n (%) p-value 
Season      
    Dry 1041 577 (55.4%)  1.00 (ref)  
    Rainy 1323 662 (50.0%) 0.01 0.81 (0.68 – 0.95)   
Survey      
    Rainy season 2012 814 359 (44.1%)  1.00 (ref) 1.00 (ref) 
    Dry season 2012 576 313 (54.3%)  1.51 (1.22 – 1.87) 1.54 (1.19 – 1.99) 
    Rainy season 2013 509 303 (59.5%)  1.86 (1.49 – 2.33) 2.03 (1.55 – 2.67) 
    Dry season 2013 465 264 (56.8%) <0.001 1.67 (1.32 – 2.10) 1.67 (1.27 – 2.20) 
District      
    Blantyre 661 411 (62.2%)  1.00 (ref) 1.00 (ref) 
    Thyolo 732 337 (46.0%)  0.52 (0.42 – 0.64) 0.63 (0.37 – 1.06) 
    Chikhwawa 971 491 (50.6%) <0.001 0.62 (0.51 – 0.76) 1.12 (0.53 – 2.35) 
EA transmission intensity α      
    Low 762 420 (55.1%)  1.00 (ref)  
    Medium 733 385 (52.5%)  0.90 (0.74 – 1.10)  
    High 869 434 (49.9%) 0.11 0.81 (0.67 – 0.99)  
Age      
   Young children, ≤5 yrs 733 441 (60.2%)  1.59 (1.32 – 1.92) 1.70 (1.37 – 2.10) 
   School-aged children, 6-15 yrs 520 256 (49.2%)  1.02 (0.83 – 1.26) 1.02 (0.80 -1.30) 
   Adults, ≥16 yrs 1087 530 (48.8%) <0.001 1.00 (ref) 1.00 (ref) 
Sex      
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n 
Treated at govt/pvt facility Unadjusted OR 
(95% CI) 
Adjusted OR,* multilevel 
(95% CI) n (%) p-value 
    Male 885 460 (52.0%)  0.97 (0.82 – 1.15)  
    Female 1479 779 (52.7%) 0.74 1.00 (ref)  
Distance to nearest health 
facilities (km) 
     
   Dispensary/maternity n/a Median (govt/pvt): 2.46 
Median (other): 2.49 <0.001 0.92 (0.90 – 0.95) 0.88 (0.79 – 0.99) 
   Other facilities n/a Median (govt/pvt): 9.56 
Median (other): 11.37 <0.001 0.98 (0.97 – 0.99) 
 
Household characteristics β      
    Finished 1173 680 (58.0%)  1.00 (ref)  
    Unfinished 1186 559 (47.1%) <0.001 0.65 (0.55 – 0.76)  
Bednet use      
    Slept under net previous night 1335 715 (53.6%)  1.26 (1.04 – 1.54)  
    Net available but not used 437 243 (55.6%)  1.37 (1.07 – 1.76)  
    No nets in household 574 274 (47.7%) 0.02 1.00 (ref)  
SES Quartile γ      
    Lowest 688 335 (48.7%)  1.00 (ref)  
    2nd 560 274 (48.9%)  1.01 (0.81 – 1.26)  
    3rd 614 322 (52.4%)  1.16 (0.94 – 1.45)  
    Highest 486 298 (61.3%) <0.001 1.67 (1.32 – 2.12)  
CI             Confidence interval 
EA            Enumeration area 
km            Kilometers 
OR           Odds ratio 
SES          Socioeconomic status 
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n 
Treated at govt/pvt facility Unadjusted OR 
(95% CI) 
Adjusted OR,* multilevel 
(95% CI) n (%) p-value 
 
Bolded values are those where the 95% CI does not contain 1.0 and p<0.05. 
*All ORs adjusted for the full set of variables listed in the column. Final model included random intercepts at the EA- and household-levels. 
α        Tertiles of parasite prevalence established for all 30 EAs from the first survey (rainy season 2012) data were used as a proxy estimate  
                    of transmission intensity in the EA. See Methods for details. 
β        Roof, wall, and floor materials were each classified as finished or unfinished (rudimentary/natural); ‘finished’ households were those  
                   with 2 or 3 finished materials, ‘unfinished’ households were those with 0 or 1 
γ         SES indicator calculated using technique based on Filmer & Pritchett (2001).23 See Methods section for details 
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 Predictors of antimalarial use among treatment-seeking individuals 
The proportion of treatment-seeking individuals who received an antimalarial 
varied by EA, ranging from 11.0% to 43.1% on average across all four surveys. The EAs 
were divided into quartiles by the proportion of treatment-seeking individuals who 
received antimalarial treatment and mapped with the locations of health facilities in 
Figure 4.4. Nearly all of the EAs from the highest quartile were in Chikhwawa, while the 
other quartiles were more distributed among Thyolo and Blantyre EAs. In the four cross-
sectional surveys, 1,416 (45.8%) individuals went to a government or private health care 
facility, 1,310 (42.4%) went to a shop, community health worker, traditional healer, or 
other source only, and 364 (11.8%) went to an unknown source. Of these, 544 (38.4%), 
91 (7.0%), and 44 (12.1%), respectively, reported taking an antimalarial. The frequencies 
of antimalarial use by other study variables for the two categories of known treatment 
sources are presented in Table 4.4. 
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Figure 4.4. Proportion of individuals in each study EA that received an antimalarial, 
given that they sought treatment in the two weeks prior to any of four cross-
sectional surveys, 2012 - 2013 
 
There were many statistically significant predictors of taking an antimalarial 
given that treatment was sought in univariate analysis (Table 4.4). Febrile individuals 
were more likely to receive an antimalarial than afebrile individuals from both treatment 
sources, though a small proportion of reportedly afebrile individuals did receive an 
antimalarial. Subjects from whom a finger- or heel-stick blood sample was taken to test 
for parasite presence were more likely to be given an antimalarial at both treatment 
 113 
 
sources than untested individuals, though few of those who sought treatment at sources 
other than government and private facilities were known to have been tested. Even 
though the pretreatment PCR and microscopy status were not available, subjects who had 
been treated with an antimalarial were still more likely to be parasitemic by either 
detection method at the time of survey. The amount of time since initiating treatment was 
not recorded. A higher proportion of subjects received antimalarials during the rainy 
season than the dry season from either category of treatment source, and the proportion 
was also higher for EAs with greater estimated transmission intensity than lesser 
estimated intensities. The proportion of people who received antimalarials in each 
District varied by the source of treatment. The association with sex also varied by 
treatment source, with males being more likely than females to receive an antimalarial at 
a government or private facility, but a greater proportion of females than males receiving 
antimalarials from other sources of treatment. A higher proportion of young and school-
aged children than adults received an antimalarial by either treatment source, though the 
relationship had only borderline significance in ‘other’ sources of treatment (p=0.06). 
Individuals with lower SES quartile and unfinished houses were more likely to receive 
antimalarials when treated at a government or private facility, but these variables were 
not statistically significantly associated with antimalarial treatment among those that 
frequented ‘other’ sources of treatment. Finally, there was not strong evidence for an 
association beyond chance between net use and availability and antimalarial use from 
government or private facilities, though the proportion of individuals who received an 
antimalarial was weakly higher for non-owners of nets when obtained from other 
treatment sources (p=0.08).  
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Table 4.4. Frequencies of antimalarial use among individuals that sought any 
treatment in the previous two weeks from four surveys by source of treatment,α 
2012 - 2013 
 Government or private 
facility 
Shop, traditional healer, 
community health worker, 
other 
  Antimalarial used  Antimalarial used 
 n n (%) p-value n n (%) p-value 
Total 1416 544 (38.4%)  1310 91 (7.0%)  
Fever in the previous two wks       
    Yes 1239 527 (42.5%)  1125 89 (7.9%)  
    No 177 17 (9.6%) <0.001 185 2 (1.1%) <0.001 
Finger or heel stick performed?       
    Tested 580 334 (57.6%)  30 4 (13.3%)  
    Untested 640 189 (29.5%)  1034 83 (8.0%)  
    Unknown 196 21 (10.7%) <0.001 246 4 (1.6%) <0.001 
Microscopy results at time of 
survey 
      
    Positive for any parasitemia 91 54 (59.3%)  141 16 (11.4%)  
    Negative for any parasitemia 1186 449 (37.9%) <0.001 1061 68 (6.4%) 0.03 
PCR results at time of survey       
    Positive for P. falciparum 146 92 (63.0%)  212 21 (9.9%)  
    Negative for P. falciparum 1148 417 (36.3%) <0.001 1010 65 (6.4%) 0.07 
Season       
    Dry 682 219 (32.1%)  555 27 (4.9%)  
    Rainy 734 325 (44.3%) <0.001 755 64 (8.5%) 0.01 
Survey       
    Rainy season 2012 387 159 (41.1%)  499 35 (7.0%)  
    Dry season 2012 365 113 (31.0%)  311 14 (4.5%)  
    Rainy season 2013 347 166 (47.8%)  256 29 (11.3%)  
    Dry season 2013 317 106 (33.4%) <0.001 244 13 (5.3%) 0.009 
District       
    Blantyre 464 126 (27.2%)  308 10 (3.3%)  
    Thyolo 406 131 (32.3%)  456 49 (10.8%)  
    Chikhwawa 546 287 (52.6%) <0.001 546 32 (5.9%) <0.001 
EA transmission intensity β       
    Low 481 146 (30.4%)  417 12 (2.9%)  
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 Government or private 
facility 
Shop, traditional healer, 
community health worker, 
other 
  Antimalarial used  Antimalarial used 
 n n (%) p-value n n (%) p-value 
    Medium 447 144 (32.2%)  397 21 (5.3%)  
    High 488 254 (52.1%) <0.001 496 58 (11.7%) <0.001 
Sex       
    Male 518 217 (41.9%)  499 31 (6.2%)  
    Female 898 327 (36.4%) 0.04 811 60 (7.4%) 0.41 
Age       
    Young children, ≤5 yrs 472 206 (43.6%)  328 26 (7.9%)  
    School-aged children, 6 -15 yrs 286 136 (47.6%)  300 27 (9.0%)  
    Adults, ≥16 yrs 646 195 (30.2%) <0.001 670 35 (5.2%) 0.06 
SES Quartile γ       
    Lowest 376 170 (45.2%)  397 26 (6.6%)  
    2nd 327 139 (42.5%)  337 24 (7.1%)  
    3rd 363 131 (36.1%)  326 24 (7.4%)  
    Highest 339 101 (29.8%) <0.001 244 15 (6.2%) 0.94 
Household characteristics δ       
    Unfinished 629 302 (48.0%)  696 50 (7.2%)  
    Finished 787 242 (30.8%) <0.001 608 41 (6.7%) 0.76 
Bednet use       
    Slept under a net previous night 811 312 (38.5%)  710 47 (6.6%)  
    Net available but not used 286 106 (37.1%)  248 11 (4.4%)  
    No nets in household 309 121 (39.2%) 0.86 339 31 (9.1%) 0.08 
EA              Enumeration area 
PCR           Polymerase chain reaction 
SES            Socioeconomic status 
 
Bolded p-values are those <0.05. 
α         Antimalarials included lumefantrine artemether, chloroquine, quinine, or sulfadoxine- 
                   pyrimethamine. Individuals whose treatment source was unknown (n=364) were excluded. 
β         Tertiles of parasite prevalence established for all 30 EAs from the first survey (rainy season 2012)  
                   data were used as a proxy estimate of transmission intensity in the EA. See Methods for  
                   details. 
γ         SES indicator calculated using technique based on Filmer & Pritchett (2001).23 See Methods  
                   section for details 
δ         Roof, wall, and floor materials were each classified as finished or unfinished  
                   (rudimentary/natural); ‘finished’ households were those with 2 or 3 finished materials,   
                   ‘unfinished’ households were those with 0 or 1 
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There were 872 individuals who sought treatment at a government or private 
health facility in the previous two weeks that did not report taking any antimalarial. Of 
these, 311 (35.7%) had received an antibiotic (amoxicillin, penicillin, or Bactrim/ 
cotrimoxazole), an additional 13 (1.5%) received oral rehydration salts, and 338 (38.8%) 
received only an analgesic (acetaminophen/paracetamol, aspirin, ibuprofen, or 
Indocin/indomethacin). The treatment was unknown or uncategorized for the remaining 
210 individuals (24.1%). Of these 872 individuals, 785 provided a blood sample for PCR 
testing during one of the cross-sectional surveys, and 54 (6.9%) tested positive for P. 
falciparum parasitemia. Nine (9) of the PCR-positive subjects were known to have been 
tested by a finger or heel stick at the health facilities, despite not receiving an 
antimalarial: five (5) of these were sub-microscopically parasitemic, but four (4) had 
microscopically detectable parasitemia, with the parasitemia of one of the subjects 
estimated to be 12,164 parasites/µL, one estimated at 715 parasites/µL, and the other two 
estimated at <100 parasites/µL. 
There were 1,219 individuals who did not report taking an antimalarial after 
visiting only a shop, traditional healer, community health worker, or other source of 
treatment. Of these, 184 (15.1%) received an antibiotic, an additional 7 (0.6%) received 
oral rehydration salts, and 882 (72.4%) received only an analgesic. The treatment was 
unknown or uncategorized for the remaining 146 individuals (12.0%). Of these 1,219 
individuals, 1,136 provided a blood sample for PCR testing during one of the cross-
sectional surveys, and 191 (16.8%) tested positive for P. falciparum parasitemia. Nine (9) 
of the PCR-positive subjects were known to have been tested by a finger- or heel-stick 
blood sample at the health care source: only three (3) of these were sub-microscopically 
parasitemic. The estimated parasitemia for the remaining six (6) individuals ranged from 
154 – 60,999 parasites/µL. 
Multilevel logistic regression modeling was used to explore the predictors of 
antimalarial use among febrile individuals who sought treatment, with random intercepts 
to adjust for clustering at the household and EA levels (Table 4.5). Both random 
intercepts accounted for a significant component of the unexplained variance, and thus 
were retained in the final adjusted models. Few afebrile people sought treatment, and of 
these a very small proportion received an antimalarial. As the causal pathways leading to 
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antimalarial use were thought to potentially differ between afebrile and febrile 
individuals, and because the small sample size precluded effective adjustment or 
assessment of interaction in regression modeling, afebrile individuals were excluded from 
the regression analysis. Because microscopy and PCR results were collected after 
treatment-seeking, and parasite infection status at the time of treatment-seeking could not 
be properly classified for all individuals, neither was considered as a potential ‘predictor’ 
of antimalarial use in regression modeling. 
According to Malawi MoH recommendations, a finger- or heel-stick should be 
used to obtain blood samples to diagnostically test for Plasmodium infection by 
microscopy or RDT in any febrile, treatment-seeking person before they should be 
prescribed an antimalarial.18 Many febrile individuals in this study population who sought 
care were not reportedly tested, even among those who sought care at government or 
private health care facilities, yet antimalarials were more likely to be used by the 
individuals who were tested for infection. Subjects who had a blood sample tested were 
more likely to have been treated according to their actual infection status than subjects 
who were untested, in whom the infection status would be unknown and therefore the 
antimalarial use presumptive. For this reason, ‘testing’ a finger- or heel-stick blood 
sample was explored as an interaction term in the adjusted regression models. As the 
preliminary analyses also indicated differences in the frequencies of antimalarial use 
among different categories of subjects by source of treatment, separate models were built 
for individuals who sought treatment at a government or private facility versus those who 
sought treatment at other sources. Subjects whose source of treatment was unknown were 
excluded from these adjusted models. Few subjects that had sought treatment at a non-
government or private facility were tested, so models using blood testing as an interaction 
term failed to converge for the ‘other’ treatment source model and were ultimately 
excluded. 
In the final model for government or private facilities, febrile individuals had 
higher odds of receiving an antimalarial during the rainy season than the dry season, and 
in Thyolo or Chikhwawa than Blantyre, although the ratio between Thyolo and Blantyre 
was not statistically significant (Table 4.5). Young children (≤5 yo) and school-aged 
children (6 – 15 yo) had higher odds of receiving antimalarials than adults. There was an 
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association between SES quartile and odds of antimalarial treatment, but the direction of 
association varied by whether or not the individual had a blood test. Household 
characteristics were not significantly associated with the odds of antimalarial treatment 
after adjustment for SES quartile, and were not included in the final model. 
There were several important interactions between the reported associations and 
blood testing status at the government or private health care facility. Season and District 
had the same direction of association with antimalarial use among those that were blood 
tested as those that were untested and treated presumptively, though the magnitude of the 
associations was larger among the untested subjects (Table 4.5). This was not the case for 
school-aged children or for SES quartile. For school-aged children the magnitude of the 
association with antimalarial use (relative to adults) was lower among those that were 
untested for parasitemia than among those that were tested. Individuals who had a higher 
SES quartile, even after controlling for District, had significantly lower odds of receiving 
antimalarial treatment if they had been tested by a finger or heel stick than individuals in 
a lower SES quartile, but had slightly higher odds of receiving presumptive treatment 
when untested for parasitemia (though the difference was not statistically significant). 
Only 91 of the 1,310 individuals who sought treatment at a shop, community health 
worker, traditional healer, or other source received an antimalarial (Table 4.4), and none 
of the considered variables proved to be a statistically significant predictor of antimalarial 
use in this group. The significance of the random intercepts at the EA (p<0.0001) and 
household (p=0.02) levels suggest unexplained variation at both levels. Various results 
are presented for comparison to the association at government or private facilities; the 
directions of the associations are generally similar, though not significant (Table 4.5). 
The odds of antimalarial treatment from ‘other’ sources are very low compared to the 
odds at government or private facilities (crude OR for antimalarial treatment at 
government/private facility vs. ‘other’ sources = 8.62, 95% CI: 6.75 – 11.00). 
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Table 4.5. Predictors of the use of any antimalarialα in the previous two weeks among febrile individuals who had sought 
treatment, 2012-2013 
 Unadjusted OR 
(95% CI) 
Government or private facility, 
Adjusted* OR 
(95% CI) 
‘Other’ health care source,  
Adjusted* OR 
(95% CI) 
Treatment source    
    Government or private facility 8.62 (6.75 – 11.00)   
    Shop, traditional healer, 
community health worker, other 
1.00 (ref)   
    Unknown 2.39 (1.59 – 3.61)   
Finger or heel stick performed    
    Tested 6.57 (5.38 – 8.03) NR  
    Untested 1.00 (ref)   
Season    
    Dry 1.00 (ref) 1.00 (ref) 1.00 (ref) 
    Rainy 1.41 (1.18 – 1.70) Tested: 1.20 (0.82 -1.75) 
Untested: 1.77 (1.19 – 2.64) 
1.36 (0.78 – 2.36) 
District    
    Blantyre 1.00 (ref) 1.00 (ref) 1.00 (ref) 
    Thyolo 1.19 (0.93 – 1.53) Tested: 1.55 (0.86 – 2.80) 
Untested: 1.59 (0.74 – 3.40) 
1.57 (0.42 – 5.95) 
    Chikhwawa 1.74 (1.39 – 2.18) Tested: 2.31 (1.34 – 4.00) 
Untested: 3.69 (1.74 – 7.83) 
1.17 (0.28 – 4.88) 
EA transmission intensity β    
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 Unadjusted OR 
(95% CI) 
Government or private facility, 
Adjusted* OR 
(95% CI) 
‘Other’ health care source,  
Adjusted* OR 
(95% CI) 
    Low 1.00 (ref)  1.00 (ref) 
    Medium 1.06 (0.84 – 1.35)  1.58 (0.45 – 5.62) 
    High 2.07 (1.66 – 2.57)  2.21 (0.57 – 8.54) 
Sex    
    Male 1.05 (0.87 – 1.30)   
    Female 1.00 (ref)   
Age    
    Young children, ≤5 yrs 1.76 (1.43 – 2.17) Tested: 1.37 (0.91 – 2.08) 
Untested: 1.56 (1.01 – 2.43) 
1.68 (0.92 – 3.06) 
    School-aged children, 6 - 15 yrs 1.72 (1.37 – 2.17) Tested: 2.22 (1.35 – 3.64) 
Untested: 1.67 (0.99 – 2.82) 
1.72 (0.94 – 3.17) 
    Adults, ≥16 yrs 1.00 (ref) 1.00 (ref) 1.00 (ref) 
SES Quartile γ    
    Lowest 1.00 (ref) 1.00 (ref) 1.00 (ref) 
    2nd 1.05 (0.82 – 1.33) Tested: 1.02 (0.58 – 1.80) 
Untested: 1.06 (0.61 – 1.85) 
1.09 (0.55 – 2.18) 
    3rd 0.86 (0.68 – 1.09) Tested: 0.54 (0.32 – 0.91) 
Untested: 1.07 (0.61 – 1.86) 
0.90 (0.44 – 1.82) 
    Highest 0.76 (0.59 – 0.99) Tested: 0.54 (0.28 – 1.02) 
Untested: 1.28 (0.65 – 2.53) 
1.23 (0.51 – 2.97) 
Household characteristics δ    
    Unfinished 1.26 (1.06 – 1.51)   
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 Unadjusted OR 
(95% CI) 
Government or private facility, 
Adjusted* OR 
(95% CI) 
‘Other’ health care source,  
Adjusted* OR 
(95% CI) 
    Finished 1.00 (ref)   
Bednet use    
    Slept under a net previous night 0.97 (0.78 – 1.20)   
    Net available but not used 0.94 (0.72 – 1.24)   
    No nets in household 1.00 (ref)   
CI               Confidence interval 
EA              Enumeration area 
NR             Not reported 
OR             Odds ratio 
SES            Socioeconomic status 
Bolded values are those for which p<0.05. 
*Adjusted models included all variables listed in their respective column and random intercepts for EA- and household-level.  
            The model for government/private facilities was also adjusted for whether or not a finger/heel stick test was performed, 
            though the independent effect of testing was not recorded in consideration of the large number of interacting variables.  
α         Antimalarials included lumefantrine artemether, chloroquine, quinine, or sulfadoxine-pyrimethamine. Individuals for whom 
                   treatment source was unknown (n=364) were excluded from the two final, adjusted models by treatment source. 
β         Tertiles of parasite prevalence established for all 30 EAs from the first survey (rainy season 2012) data were used as a proxy  
                   estimate of transmission intensity in the EA. See Methods for details. 
γ         SES indicator calculated using technique based on Filmer & Pritchett (2001).23 See Methods section for details 
δ         Roof, wall, and floor materials were each classified as finished or unfinished (rudimentary/natural); ‘finished’ households were  
                   those with 2 or 3 finished materials, ‘unfinished’ households were those with 0 or 1 
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 Parasitemia and fever among subjects that did not seek treatment 
Of the 8,800 individuals from the study population over all four surveys that did 
not seek treatment in the two weeks prior to the survey, 7,686 provided samples for PCR 
testing and answered the question about experiencing fever in the previous two weeks. 
There were 1,188 individuals who tested positive for P. falciparum by PCR (15.5%); 
only 56 of these (4.7%) reported experiencing a fever in the previous two weeks. As 395 
subjects who had recently sought treatment were PCR-positive for P. falciparum, this 
meant that 75.0% of all prevalent P. falciparum infections at the times of the cross-
sectional surveys had not recently pursued antimalarial treatment. 
4.5 Discussion 
Plasmodium infection is endemic in southern Malawi, despite high coverage 
(>80%) with bednets.12 Chapter 3 of this dissertation showed that gametocyte carriage is 
common among prevalent infections in both urban and rural areas in southern Malawi, 
suggesting potential contributions to ongoing transmission of the parasite. Other studies 
have indicated that untreated or inadequately treated Plasmodium infections can persist 
chronically for months, and effective antimalarial treatment of chronic infections may be 
necessary to effectively interrupt transmission.15–17 To explore the implications of 
inadequate treatment on transmission, the present study assessed treatment-seeking 
behaviors and antimalarial use in three Districts of southern Malawi, and identified 
several key ways in which the current practices are inadequate for clearing chronic 
Plasmodium infections. Our results may have implications for future policy changes and 
intervention efforts to reduce the burden of malaria. 
A high proportion (~87%) of people who reported having a fever in the previous 
two weeks reported seeking some kind of treatment outside the home. Subjects who did 
not report experiencing a fever in the two weeks prior to survey were unlikely to seek 
treatment, and unlikely to receive any antimalarial if they did seek treatment. Prevalent 
Plasmodium infections are frequently afebrile in endemic populations, though symptom 
status is not associated with gametocytemia/potential infectiousness (Chapter 3). In this 
community-based sample, 75% of prevalent infections had not recently sought any 
treatment, and less than 5% of these individuals reported a fever in the previous two 
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weeks. Since these afebrile infections can be gametocytemic, interruption of transmission 
will require special efforts to detect and treat them with effective gametocytocidal drugs. 
Although the proportion of febrile individuals who sought treatment was high 
overall, there were important differences in treatment-seeking patterns of different groups 
of people. A major finding of both the gametocyte analysis in Chapter 3 and general 
parasitemia analysis in Walldorf et al.12 was the high prevalence of any parasite infection 
and gametocytemic infection in school-aged children, 6 – 15 yo. As most of the mortality 
due to malaria is concentrated in children under 5 yo, a majority of intervention efforts 
have focused on preventing and treating infections in these young children. Most people 
in this malaria-endemic region of Malawi seem to be aware of the elevated risk to young 
children, as the odds of seeking treatment for a febrile child under 5 yo were roughly 
twice those for febrile adults (≥16 yo). The odds of treatment-seeking for school-aged 
children fell between that of young children and adults, though they were not statistically 
significantly different from either category in the final adjusted models by District. The 
same pattern by age category existed in the analysis of time to treatment-seeking after 
fever onset. 
Interestingly, school-aged children were more similar to adults in terms of the 
source of treatment sought, with young children having significantly greater odds of 
being taken to a government or private facility than the two older age categories. Just 
over half of febrile school-children and adults sought treatment at a shop or other source, 
with no evidence of a difference between the two groups. Since people who frequented a 
shop or other source had a much lower probability of being treated with an antimalarial 
than people who attended a government or private clinic, these treatment-seeking 
behaviors may contribute to the observed high prevalence of infection in school-aged 
children. These older children are still viewed as having enough risk to prompt more 
frequent treatment than adults when febrile, but the type of treatment sought may be 
inadequate since they are perceived as being at lower risk than younger children. Thus, 
infections in school-aged children may be of longer duration than those of younger 
children, since they are less likely to receive prompt and adequate antimalarial treatment. 
Adults, who were treated less frequently and typically at inadequate sources, do not have 
the highest prevalences of infection, so it is likely that many years of previous infection 
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eventually offers some degree of protective natural immunity from the risks of 
developing new Plasmodium infections, and/or some immune protection that can limit 
the natural duration of their infections relative to young and school-aged children.  
Treatment-seeking behaviors had a complex relationship with urbanicity. People 
from the mostly urban Blantyre District were more likely to seek treatment than their 
more rural counterparts in Thyolo and Chikhwawa. On the other hand, the odds of 
seeking treatment in Chikhwawa, the most rural District with the fewest health-care 
facilities, were actually higher than in Thyolo, a semi-rural District with a higher density 
of health facilities, though this difference was not statistically significant. Given that 
significant variation remained unexplained at the EA-level in the final multilevel model, 
further research is needed to determine the etiology of the observed between-District 
relationships and treatment-seeking beyond basic categorizations of urban vs. rural. 
One potential EA-level explanatory variable that was considered in this analysis, 
the distance from the households to the nearest health care facilities, had a complex 
interaction with the District. The accuracy of this distance variable is unknown, as the 
health care facilities were mapped by a separate JICA research project, and the specific 
locations of health facilities where study participants sought treatment were unknown. 
The health facility data from JICA is also unlikely to have captured locations for all the 
types of treatment sources reported by participants of this study, such as local shops, 
traditional healers, or community health workers. Nonetheless, the JICA spatial data were 
compared to the locations of study households to give a rough approximation of the 
general accessibility of healthcare as a potential barrier to seeking treatment. 
Curiously, in the more rural Chikhwawa District, where the health facilities were 
sparser and the distances greater, proximity to the nearest health facility was not 
associated with the odds of seeking treatment when febrile. Conversely, in both Blantyre 
and Thyolo Districts, which are less rural and have a greater density of health facilities, 
greater distance from the nearest health facility was associated with significantly lower 
likelihood that febrile people sought treatment. This may have been because individuals 
in remote Chikhwawa EAs were more likely to visit unmapped local shops when ill, but 
the subsequent analysis of treatment seeking at a government or private facility versus 
other more local sources, did not provide unequivocal support for this interpretation. 
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After adjustment for other predictors, residents of Chikhwawa did not have lower odds of 
seeking treatment at government or private facilities than residents of the other two 
Districts. Though the absolute percent of individuals who used such a facility instead of 
another type of source was lower in Chikhwawa than in Blantyre, it was actually higher 
than in Thyolo. Another potential explanation for the observed associations could involve 
the relative magnitudes of distances. In Blantyre, all study EAs were less than 2.5 km 
from the nearest dispensary or maternity ward. In Chikhwawa, however, people lived, on 
average, more than 6.2 km from the nearest dispensary or maternity ward. A distance of 
one km may have a stronger impact on perceived access to care when the difference is 
between one and two km, than when it is between six and seven km, and a long journey is 
already required. Future studies of treatment-seeking may need to consider differences in 
how people perceived access to health care in addition to the actual distances from health 
care facilities. 
As malaria disease and Plasmodium infection are seasonal in the region, 
treatment-seeking behaviors were also compared between dry and rainy season surveys. 
Interpretation of these findings was limited by differences in data from the first survey, 
which occurred during the rainy season of 2012. During that survey, the proportion of 
participants that sought treatment when febrile and the proportion of those that went to 
government or private facilities instead of another type of source were both much lower 
than for all subsequent surveys. Without additional data points from before 2012, it is 
difficult to determine whether these findings represent a true change in treatment-seeking 
behaviors after May 2012, whether the comparatively low rates were random, or whether 
they were artefacts of the differences in data collection methods, participation, and survey 
completion in the initial run of the survey. Since the low proportions of the first survey 
(rainy season 2012) represented one of the two rainy season samples, rainy season was 
crudely associated with lower odds of seeking treatment when febrile, lower odds of 
seeking treatment at a government or private facility, and longer times to seeking 
treatment after fever onset; however, it is unclear whether this reflects a true seasonal 
difference in individual treatment-seeking behaviors. Additional data from subsequent 
surveys during the rainy and dry seasons of 2014 may offer insight into this 
interpretation. 
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There was a very slight tendency for people with lower SES or who lived in 
houses made of more ‘unfinished’ materials to seek treatment less often and less quickly 
when febrile, and to go to government or private facilities less often than those in higher 
SES quartiles or those living in finished houses. These associations tended to be weak, 
and were rarely statistically significant after adjusting for other key predictors. The lack 
of a large treatment gap by SES may be attributable to the free provision of most health 
services by the MoH in Malawi. Differences in perception of risk and access to health 
care facilities by SES may explain the observed crude associations. There was, however, 
an interesting interaction between District and house materials in the model for the odds 
of seeking any treatment when febrile. Consistent with the other SES-treatment 
relationships, people who lived in finished houses were more likely to seek treatment 
than those who lived in unfinished houses in both Blantyre and Thyolo; however, 
individuals in finished houses in Chikhwawa were less likely to seek treatment than those 
in unfinished houses. The difference in Chikhwawa may have been due to chance, as the 
confidence interval included the null value, but it bears considering that high-risk 
individuals in this District with high transmission intensity may potentially be more 
aware of their risks and respond accordingly. 
This interpretation seems to be consistent with the association of bednet use and 
treatment-seeking in Chikhwawa. Earlier research in this study population found that 
individuals with high prevalence of Plasmodium infection were more likely to live in 
households that owned at least one bednet than households without one, even if they 
themselves did not use the bednet the night before the survey.12 Individuals from the 
households in Chikhwawa who owned any nets, both those that had slept under them on 
the previous night and those who had not, were significantly more likely to seek 
treatment when febrile, and to do so more quickly after the onset of fever, than 
individuals who did not own nets. Treatment-seeking and bednet ownership likely share a 
common underlying cause. People who own bednets may have more risk averse 
personalities, causing them to seek out both bednets and treatments, or they may be aware 
of their own greater risk and exposure to mosquito bites. There is somewhat more support 
for the latter explanation, as those people who owned but did not use bednets had 
similarly high odds of seeking treatment in Chikhwawa as individuals that used the 
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bednet on the previous night, despite seemingly lower concern for risk aversion. 
Furthermore, the relationships were strongest in Chikhwawa, the district with the highest 
transmission intensity. After adjusting for other key predictors, net ownership and use 
were not associated with the source of treatment sought. 
Although treatment-seeking is largely driven by the perceptions of illness among 
people in the communities, the odds of receiving an antimalarial given that treatment is 
sought are largely determined by the health care providers. Analyses of antimalarial 
treatment patterns are limited by the lack of data from said providers regarding each of 
the reported treatment-seeking visits. Patient self-reporting of medication use may be 
open to misclassification, and when antimalarials were not provided it is unknown 
whether this was due to the provider’s choice or medication shortages. A further 
limitation is the lack of longitudinal blood samples from the time pre-treatment to 
accompany the samples taken at the time of survey. Subjects whose samples were 
positive by either PCR or microscopy could potentially have been infected subsequent to 
seeking treatment, and uninfected individuals could have cleared a previous infection 
since seeking treatment, whether naturally or through the use of antimalarials. One useful 
indicator to address this limitation involves whether or not sick people were tested for 
Plasmodium infection when they sought treatment, as per the Malawian MoH 
recommendations.18 Antimalarial use in individuals that had been tested for Plasmodium 
offers insight into actual infection status at the time of treatment-seeking, despite 
potential misclassification of low-density/submicroscopic infections enabled by the 
absence of more sensitive detection methods. Antimalarial use among untested 
individuals, on the other hand, reflects presumptive treatment by the health care 
professionals. Although this is not a measure of the true infection status of study 
participants, it is informative as to the beliefs and practices of health care workers. A 
much larger proportion of patients (~41%) who attended a government or private facility 
were known to have been tested than of those who went to a shop or other source (~2%), 
so essentially all treatment at ‘other’ sources was presumptive.  
Among individuals who were tested for malaria at a government or private 
facility, antimalarial treatment conformed to the patterns of risk factors for Plasmodium 
infection that were detected in earlier analyses (Chapter 3 and Walldorf et al.12). 
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Individuals had slightly higher odds of receiving an antimalarial during the rainy season 
than the dry season, if they lived in Thyolo or Chikhwawa Districts than in Blantyre 
District, if they were young or school-aged children than adults, and if they were from 
lower SES quartiles than higher SES quartiles. Febrile people who were blood tested 
were more likely to receive an antimalarial than those who were not, but inferences from 
this finding were limited by lack of knowledge about the presence and severity of other 
relevant symptoms at the time of seeking treatment that may have prompted testing and 
treatment, the lack of information about whether Plasmodium testing was available when 
treatment was sought, and the lack of knowledge about the actual results of the blood 
testing to determine whether antimalarial treatments were dispensed appropriately. The 
results do appear suggestive of general compliance with the MoH recommendations, but 
we can also conclude that the process is not infallible for the detection and treatment of 
Plasmodium infection. 
Previous research on malaria treatment-seeking behaviors in sub-Saharan Africa 
has typically taken a more clinical perspective of treatment-seeking in terms of its impact 
on malaria survival for symptomatic cases, as opposed to the potential role of treatment 
in reducing transmission from the human infectious reservoirs. This is reflected in a 
frequent focus on vulnerable subpopulations, such as children25–31 and pregnant 
women.32–35 A critical review also pointed out that previous studies using Knowledge, 
Attitudes, and Practices (KAP) surveys have provided insight as to perceptions of risk 
and barriers to treatment, but that such knowledge and attitude did not necessarily 
correspond with actual behaviors.36 This review also noted heterogeneity across different 
settings, and even over time within the same settings, with differences in study 
methodology limiting the ability for comparisons.36 The current study encompassed 
reports of actual recent treatment-seeking behaviors among an all-ages study population 
across several different time points and a variety of eco-epidemiologic settings with 
various transmission intensities. This breadth enabled direct assessment of the 
heterogeneity of studied associations in different transmission contexts. As previously 
analyzed parasitological data from each survey were also available, we were able to 
consider the treatment-seeking results in terms of their relevance to ongoing transmission. 
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While the assessment of heterogeneity was a strength of the study, there were 
limitations in the measurement and estimation of some of the study parameters. Symptom 
status is an important factor in treatment-seeking, but the classification of symptomatic 
individuals was based on only one dichotomous variable in this analysis. The only 
symptom measured in the time frame of relevance for the data on treatment seeking was 
fever. Classification of fever in the previous two weeks was based on self-report, and 
milder episodes of fever may have been underrecognized and underreported, while more 
severe febrile episodes were disproportionately likely to have been captured. However, 
since it is each individual’s own perceptions of disease that influence their decisions to 
seek treatment, self-report is perhaps more relevant to the outcome of the analysis than a 
clinical threshold temperature measurement. Access to treatment was approximated only 
by Euclidean distance to health facilities, and did not consider any land features that 
might introduce additional challenges to accessing care, such as poor road conditions 
during the rainy season in remote areas. We also lacked information about the quality of 
health facilities and general availability of diagnostic testing and antimalarial treatment at 
the GPS-located facilities, which may have impacted individuals’ perceptions of their 
access to care at the nearest facilities. Finally, as with many previous studies,36 data on 
antimalarial use was only available dichotomously, and information on prescribed dose 
and actual use were unavailable for any analysis of ‘appropriate’ treatment. 
There were a number of individuals who tested positive for P. falciparum 
infection at the time of survey, but had not been given an antimalarial when they sought 
treatments in the previous two weeks. We cannot rule out the possibility that some of 
these infections developed after the treatment visit, however that number is likely to be 
small. There were 54 PCR-positive P. falciparum infections among people who had 
recently visited a government or private facility and not received an antimalarial (6.9%) 
and 191 (16.8%) who had visited any other source and not received an antimalarial. It is 
unlikely that all of these were new infections since the time of seeking treatment, and not 
all were submicroscopic at the time of survey. Better detection at health care facilities 
could have potentially identified and treated these individuals to more quickly remove 
them from the population of infectious reservoirs. 
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As mentioned above, the single strongest predictor of receiving an antimalarial 
when seeking treatment was the source of the treatment. Individuals who sought 
treatment at a government or private facility had 8.6 times the odds of receiving an 
antimalarial as individuals who sought treatment at a shop or other source. Since only 30 
individuals who sought treatment at these other sources were tested for fever, most 
antimalarial dispensation is likely presumptive treatment. There were no statistically 
significant predictors of antimalarial treatment at these sources, likely because the 
precision of the estimates was limited by the relatively small number of subjects who 
received an antimalarial (91 of 1,310, 7.0%). 
Even among individuals who were untested for fever, the proportions that 
received an antimalarial as presumptive treatment were higher at government or private 
facilities (29.5%) than among all subjects that went to other treatment sources (7.0%). 
Health care providers seemed to be generally aware of the risk factors for Plasmodium 
infection, being more likely to provide presumptive treatment to the groups of individuals 
that were also more likely to be treated when infection status was determined by blood 
testing; however, the providers may overestimate the impact of some risk factors in 
determining whether they should provide antimalarials. For instance, after blood testing, 
there was only a weak association (OR=1.20) between rainy season and the odds of 
receiving an antimalarial, but antimalarials were significantly more likely to be dispensed 
presumptively to untested individuals during the rainy season than the dry season 
(OR=1.77). The magnitude of the association between receiving an antimalarial and 
residence in Chikhwawa relative to Blantyre was also greater for individuals who were 
presumptively treated than for individuals who had a blood test before receiving 
treatment. The same was true of the association between the odds of young children 
receiving an antimalarial relative to adults, which had a slightly larger magnitude among 
untested individuals treated presumptively than among individuals that had had a blood 
test. On the other hand, health care providers in the area may underestimate the 
prevalence of infection in school-aged children, for whom the magnitude of the 
association was lower among untested individuals than among those who had had a blood 
test. Health care professionals also had similar or even higher odds of providing 
antimalarials presumptively to individuals of higher SES quartiles than lower SES 
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quartiles, though the lower odds of treatment for higher SES individuals after diagnostic 
testing suggest that their actual risk of infection is lower than for individuals from lower 
SES quartiles. Additional studies of knowledge, attitudes, and practices about 
presumptive treatment among health care workers could help identify the underlying 
causes of such associations, but the results suggest potential undertreatment of infections 
in school-aged children, individuals of lower SES, and dry season infections when 
diagnostic testing is not performed. 
Ultimately, while this study faces several limitations in developing causal 
inferences regarding treatment-seeking behaviors and antimalarial use, the findings about 
current practices highlight several needs for intervention to interrupt Plasmodium 
transmission. There is an urgent need to develop safe antimalarials with gametocytocidal 
properties to quickly limit potential infectiousness. These drugs should have low risks of 
side effects for use in the general population, and should be distinct from first-line 
antimalarials reserved for the clinical treatment of symptomatic cases in order to 
minimize the promotion of resistance to first-line drugs. Specific interventions and 
outreach will be necessary to treat asymptomatic, gametocytemic infections, as afebrile 
individuals in these populations are currently unlikely to seek any treatment that could 
lead to diagnosis and clearing of infection. Furthermore, in endemic areas, it may be 
useful to perform a blood test for Plasmodium infection in all individuals who come into 
contact with the health care system, even if they are asymptomatic and accompanying a 
sick individual or if they are symptomatic with symptoms that are not suggestive of 
malaria disease. This could help to detect some of the ‘silent’ reservoirs of infection in 
the population, but demands more sensitive diagnostic techniques and higher facility 
testing capacity than are currently available in order to maximize effectiveness. 
When they did seek treatment, many individuals in this study population did not 
choose to visit government or private facilities, opting instead for other, local sources 
such as shops, community health workers, or traditional healers, despite the fact that most 
government-provided services are free. Government facilities may need to be more 
accessible to encourage use in rural areas with high prevalence of Plasmodium infection, 
but it may also be helpful to expand access to diagnostic testing, at least in the form of 
RDTs, and antimalarial treatments through shops in endemic areas, particularly those that 
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are far from government facilities. This may especially help reduce the contribution of 
school-aged children to ongoing transmission. The prevalence of gametocytemia was 
high in this age group, compared to both young children and adults, but they were less 
likely than young children to get treatment, and more likely to be taken to a shop or other 
source. These behaviors would contribute to relatively longer duration of infection and 
higher prevalence in school-aged children than young children, even if the incidence rates 
are similar between the two groups. Increased education and awareness of the high 
prevalence of infection in this age group, both among health care providers and the 
general population, and increased diagnostic and treatment capacity in local shops, could 
help increase treatment and reduce the prevalence of infection in these school-aged 
individuals with high odds of gametocyte carriage. Additional research in underway 
through ICEMR-Malawi to evaluate the potential of other school-based interventions in 
order to target this age-group directly in the hopes of efficiently reducing the number of 
infectious human reservoirs of Plasmodium.  
In conclusion, current treatment practices in southern Malawi seem to be 
insufficient to reduce the ongoing Plasmodium transmission. New efforts should focus on 
treating infections in all afebrile people, who are frequently gametocytemic, but rarely 
seek antimalarial treatment that could help limit the duration of the potentially infectious 
period. Though treatment-seeking is common among febrile individuals, many do not 
receive adequate antimalarial treatment to clear infection, particularly individuals who do 
not attend government or private facilities. Low perceptions of the risks during the dry 
season, in individuals from low SES, and in school-aged children may demand 
informative outreach. The effectiveness of all such strategies is limited until cheap and 
sensitive diagnostic techniques are widely available to detect chronic, low-density 
infections in the community, and until safe gametocytocidal drugs can be incorporated 
with antimalarials that clear asexual stage parasites to quickly clear gametocytemia and 
end the infectious period. 
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CHAPTER 5 Conclusions 
 
5.1 Review of major findings 
This dissertation used data from a repeated-sample, cross-sectional study to better 
characterize the human infectious reservoir for malaria in southern Malawi. The first 
analysis validated the use of a two-stage molecular testing process, using polymerase 
chain reaction (PCR) to select Plasmodium parasite-infected samples for testing with a 
novel quantitative reverse transcription polymerase chain reaction (qRT-PCR) assay that 
assessed parasite stage composition, particularly presence of gametocytes (Chapter 2). 
This assay was used to analyze the epidemiology of gametocytemia in a community-
based study population, by identifying the human reservoirs with the potential to 
contribute to ongoing transmission, and determining the predictors of gametocyte 
carriage at the population-level (Chapter 3). Finally, treatment-seeking behaviors in the 
study population were evaluated to better understand who receives appropriate 
antimalarial treatment, which can limit the duration of infectiousness, and identify gaps 
where additional outreach and intervention will be needed to reduce the infectious 
reservoir in the population (Chapter 4). Overall, these studies demonstrated that people 
with asymptomatic Plasmodium infections, even when the blood density of parasites is 
submicroscopic, are as likely to carry gametocytes as people reporting recent symptoms, 
and therefore do have the potential to contribute significantly to ongoing transmission, 
particularly as afebrile people are very unlikely to seek or receive any antimalarial 
treatment in this region. Since untreated asymptomatic infections may persist chronically 
for months, and have been shown to be often gametocytemic, any plans for malaria 
elimination will need to address the asymptomatic reservoir to achieve significant 
reductions in transmission. 
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 qRT-PCR Validation (Chapter 2) 
The qRT-PCR assay used for analysis of P. falciparum stage-composition was 
recently developed by collaborators at Harvard University, and initially tested in samples 
from clinical cases.1 It had not been used to test samples from the general community, in 
whom the frequency and densities of infection are generally lower than that observed 
among clinically ill populations. Molecular testing can detect densities of ~1 
gametocyte/µL, which captures the majority of gametocyte densities of potential 
relevance to transmission. However, the per sample cost of the qRT-PCR assay and the 
long testing process (two to three days to process a group of 10 samples) made it 
inefficient to test all samples from the cross-sectional study, in which the majority of 
people were expected to be aparasitemic. This demanded an alternative testing strategy, 
using PCR results to first screen the population for prevalent P. falciparum infections. 
This limited the threshold of detection of the testing to that of PCR for lactate 
dehydrogenase (LDH), which is ~2.7 parasites/µL at the Malawi ICEMR laboratory. 
Using qRT-PCR to test all samples would likely have detected a few additional people 
with very low parasitemia, but the cost of detecting each additional positive sample 
would have been prohibitively high. Regardless, this method significantly improved upon 
the sensitivity of microscopy. True validation of the test was complicated by the lack of a 
gold standard for comparison, but the evidence seems to suggest that the qRT-PCR 
results corresponded well with the PCR results, and that the findings of the combined 
testing strategy were consistent with significant improvement over microscopy in the 
sensitivity for the detection of gametocytes. 
There were two particular benefits to using this qRT-PCR assay as opposed to 
testing for Pfs25 or Pfg377, the previously used mRNA markers of mature gametocyte 
presence.2,3 First, the primers were designed to span exon-exon junctions, such that the 
parasite genomic DNA would not contain the specific sequences. All positive test results 
should therefore reflect only mRNA expression by the specific stages of the parasite 
present, and reduce the chance for false positives (improved specificity).1 Secondly, the 
assay allows the simultaneous detection and distinction of both immature and mature 
stage gametocytes relative to asexual stages. Immature gametocytes are particularly 
challenging to distinguish from asexual ring stages by morphology under microscopic 
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examination,4 and the previously identified marker of immature gametocyte stages, 
pfs16,5 has rarely been used, and not for population-based prevalence studies. Thus, this 
assay and testing strategy could be applied to a variety of questions about stage-specific 
dynamics of P. falciparum infection. 
Ultimately, the use of this assay will allow for the quantification of each stage of 
the parasite relative to the others, but the model calculations are in development and did 
not correlate well with the qualitative detection of each stage of the parasite in this 
community-based sample. This may be attributable to the fact that the mathematical 
model for inferring relative quantities of each stage was developed based on stage-
specific counts in clinical cases and in vitro parasites only, and may not extrapolate well 
to the parasite patterns of less severe and asymptomatic infections. For this reason, only 
the qualitative assessment of stage-specific presence was included in the present analysis. 
 Predictors of gametocytemia (Chapter 3) 
The analysis of the predictors of gametocytemia in the total population generally 
corresponded to the predictors of any parasitemia in the total population. Among 
individuals who were parasitemic, the directions of the associations tended to be the same 
as for the predictors of any parasitemia in the population, suggesting that being at higher 
risk and/or more frequently exposed to mosquitoes and P. falciparum infection increases 
the likelihood of being gametocytemic when infected. The predictors of 
gametocytogenesis are very poorly understood, but it is thought that some ‘stressors’ to 
the parasite may stimulate investment in gametocytogenesis as a way to encourage 
transmission before elimination by the potential threat.5 These ‘stressors’ could include 
immune responses to the parasite; however, when P. falciparum infected, adults had the 
lowest odds of carrying gametocytes compared to younger children and school-aged 
children, which suggests that the development of immunity can ultimately prevent 
gametocyte carriage. Previous research has documented the presence of transmission-
blocking immunity (TBI) in sera from people in endemic areas, mediated through 
immune responses to sexual stage antigens Pfs48/45 and Pfs230, among other unknown 
factors.5 It is purely speculative, given that no such conclusions can be drawn from these 
cross-sectional data, but possible that development of a specific immune response to 
gametocytes takes many years, while the development of immune responses to asexual 
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stages of the parasite is more immediate, and the immune system’s attacks on asexual 
stages of the parasite prompt them to invest in gametocytogenesis, therefore leading to 
elevated rates of gametocyte carriage in people with frequent exposures in the short term. 
This dynamic would correspond well to previous hypotheses that the parasite invests in a 
relatively large proportion of asexual stages in order to overwhelm the immune system 
and allow gametocytes to evade immune detection and clearance,5 which could delay 
development of TBI. The interpretation would also correspond to the tendency toward 
higher odds of gametocytemia when infected among individuals that also had higher odds 
of any parasitemia, but none of these individual associations was statistically significant. 
It is also possible that these people with more frequent exposures are also more likely to 
be asymptomatic after developing a non-sterilizing immune response, and may simply 
seem to have higher odds of gametocytemia because the duration of the infection has 
been longer than in lower risk individuals, who are more likely to show symptoms. 
However, little is known about the dynamics of gametocytemia over the course of an 
individual infection, so an older infection would not necessarily be more likely to be 
gametocytemic than a newer infection. This is especially difficult to study in high 
transmission areas where the Entomological Inoculation Rate (EIR) may be so high that a 
new infectious bite occurs almost daily. Alternatively, all of the observed associations 
may have simply been due to chance, given the imprecise estimates and weak 
associations observed, so it is difficult to draw any firm conclusions based on the data 
available. The most significant finding was that school-aged children have high odds of 
being gametocytemic when infected compared to adults and younger children, 
emphasizing their potential importance in propagating P. falciparum transmission. 
Overall, the lack of strong predictors, other than age, of gametocytemia among 
parasitemic individuals suggests that future studies and interventions may not need to 
specifically detect gametocyte carriage, and that simply identifying any-stage infections 
will be a sufficient approximation of gametocyte presence.  
This study did confirm that people who are infected but asymptomatic are often 
gametocytemic, and therefore may potentially contribute to transmission. While they may 
exhibit a transmission blocking immune response that limits the success of transmission 
to the vector, or may have lower-density infections that have decreased likelihood of 
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infecting a mosquito in a single blood meal, gametocyte carriage is a prerequisite for 
transmission potential. If none of the individuals who were asymptomatically infected 
were carrying gametocytes, it would have suggested that these cases are irrelevant to 
population transmission dynamics. The evidence that they are frequently gametocytemic 
suggests the need for further research into the specific transmission potential of these 
‘silent’ infections compared to symptomatic cases. 
 Treatment-seeking (Chapter 4) 
The results of Chapter 4 are useful for understanding the implications of the 
findings of Chapter 3. First, differences in treatment-seeking by age help to explain the 
observed odds of parasitemia and gametocytemia in school-aged children, which were 
higher than those of younger children. When they are febrile, younger children are more 
likely to be taken to government or private health facilities, locations where patients are 
far more likely to receive an antimalarial than at the small shops and other treatment 
sources, which more often serve school-aged children. Additionally, school-aged children 
who were P. falciparum-infected by PCR were less likely to report a fever in the previous 
two weeks (~18%) than young children who were P. falciparum infected (~42%), and 
afebrile people were unlikely to seek or receive any treatment in this study. Both 
situations would allow for Plasmodium infections in school-aged children to go untreated 
more often than those in younger children. The prevalence of gametocytemia was nearly 
three times as high in school-aged children as in younger children. As a rough 
approximation, if the incidence rates were assumed to be approximately equal, this would 
suggest that the duration of gametocytemia in school-aged children is more than three 
times as long as that of younger children. Implementing interventions to encourage 
antimalarial treatment-seeking among school-aged children may be an efficient way to 
reduce the infectious reservoir, when these children do experience symptomatic disease.  
Despite the availability of free services at government health facilities, a large 
proportion of the study population reported seeking treatment solely at a shop or other 
local source, even though it was rare to receive antimalarial treatment there. More than 
15% of the people who had gone to these shops and did not receive an antimalarial were 
P. falciparum-infected by PCR when surveyed. Since these people sought treatment, they 
could potentially have been removed from the infectious reservoir population if they had 
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been properly treated. Efforts should be undertaken to either remove the additional 
barriers to seeking treatment at government or private facilities (greater number, larger 
capacity, less distance), or to expand malaria diagnostic testing and treatment capacity 
through local shops. The latter option might be more directly helpful in the short term, 
although the former is necessary to improve the long-term health conditions of the 
country. 
Afebrile individuals rarely sought or received treatment. Given that asymptomatic 
Plasmodium infections can still be gametocytemic, and potentially infectious to vector 
mosquitoes, existing interventions and treatment patterns will be insufficient to clear 
these ‘silent’ infections and interrupt transmission in highly endemic areas. Active 
intervention efforts will be needed to reach all infected populations and test for current 
infection. Mass antimalarial drug administration has been suggested as a possible 
alternative to individual screening and treatment in order to surmount the challenge of 
detection with the limited and insensitive field tools that are currently available.6 Both 
mass treatments and diagnostic screening follow by treatments would increase selective 
pressure and could promote the development and spread of antimalarial resistance in 
endemic populations, so the choice of treatments used will have to balance effectiveness 
in parasite clearance against the risks of developing resistance to those compounds. 
5.2 Future research 
One limitation of the present research is that the mere presence of mature 
gametocytes in people does not guarantee infectiousness to mosquitoes, only potential 
infectiousness. While these studies have proven that asymptomatic infections can be 
gametocytemic, it does not necessarily confirm that they are infectious. Questions have 
been raised about whether the low density infections and existence of TBI could limit the 
role of people with asymptomatic infections in population transmission dynamics.7 
Research on the likelihood of infecting mosquitoes from gametocytemic infections of 
different densities has shown that there is certainly an increase in the probability of 
infection with increasing gametocyte density, but that even very low densities of 
gametocytes are surprisingly infectious.5,8 However, people can also develop 
transmission-blocking immune factors that are taken up with gametocytes in a mosquito 
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blood meal and hinder parasite development within the mosquito.5,9–11 The immune 
response that protects from malaria symptoms in asymptomatic infections might be 
correlated with TBI, such that asymptomatically infected people would not necessarily be 
infectious when gametocytemic. The extent of TBI in asymptomatically infected people 
could be testing using membrane-feeding assays to feed mosquitoes on blood taken from 
asymptomatic and symptomatic human infections, matched on gametocyte density. We 
could then compare the proportion of mosquitoes that developed infectious sporozoites in 
the weeks following membrane feeding for those fed on blood from asymptomatically 
infected vs. symptomatically infected humans. Furthermore, the blood samples from 
asymptomatically and symptomatically infected people could be tested for the presence 
of sexual stage antigens Pfs48/45 and Pfs230, which contribute to TBI.11 These 
experiments would provide further information about the potential infectiousness of 
asymptomatic human infections. It does not seem likely that all asymptomatic infections 
would have immune responses that completely block transmission, but it is possible that 
asymptomatically infected people are less infectious per mosquito blood meal than 
symptomatically infected people, and further research could clarify the relative degree of 
infectiousness. 
Even with a reduced degree of infectiousness, people with asymptomatic 
infections may contribute significantly to population transmission dynamics if they have 
longer periods of untreated infectiousness. It would be both ethically and logistically 
challenging to obtain quality data on the duration of gametocytemia in symptomatically 
and asymptomatically infected individuals without providing antimalarial treatments. 
However, mathematical models could be used to explore the contributions of each group 
under a variety of different realistic assumptions and conditions, and this could be a guide 
for determining intervention priorities. 
The results of this dissertation research suggested several potential community-
level intervention trials. Given the high prevalence of infection and gametocytemia in 
school-aged children, school-based interventions may be a cost-effective way to prevent 
Plasmodium transmission. Expansion of the Malawi ICEMR cross-sectional study is now 
beginning to consider this question, by investigating whether school attendance is linked 
to infection risk, such that school-based interventions would not reach the most 
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vulnerable or highest prevalence groups of children. If schools could be used for 
interventions applied over a period of days or weeks, the limitation introduced by daily 
differences in attendance could be mitigated. Such interventions might include using 
schools as bases for distribution of long-lasting insecticide treated nets (LLINs), 
educational campaigns about the need for people of all ages to sleep under bed nets, or 
for periodic distribution of antimalarial treatments at key times during the year. Since the 
interventions would hopefully have both direct and indirect transmission-reducing effects 
on the incidence and prevalence of malaria, intervention trials should include many 
school catchment areas, and randomly assign the intervention to schools, with both 
passive and active detection of infections in the surrounding populations of intervention 
and non-intervention catchment areas. It would be helpful to select sites where 
surveillance data has already been collected to control for baseline prevalence variations. 
To increase the rates of adequate antimalarial treatment among Plasmodium-infected 
populations, interventions would either need to expand people’s treatment-seeking at 
government or private facilities, or increase the availability of appropriate treatments 
through shops and community health workers. In either case, qualitative research would 
be a necessary first step. People who report using shops for recent treatment should be 
interviewed to obtain more information about the perceived barriers to seeking treatment 
at government facilities. Shop workers could also be interviewed to determine the reasons 
why antimalarials are rarely provided to customers. These qualitative results would help 
to identify specific actions that could be taken to change population perceptions of the 
barriers to care, or to increase access to antimalarial treatments among customers of 
shops. 
5.3 Implications for malaria interventions 
The findings that emerged from investigations in this dissertation strongly suggest 
that new tools, strategies, and research capacities are needed before malaria elimination 
can even be considered possible in areas of high endemicity like most of Malawi. 
Because they are often gametocyte carriers, asymptomatic infected people must be 
detected and treated with effective anti-gametocytocidal drugs in order to prevent 
ongoing transmission. However, asymptomatic infections are often submicroscopic, so 
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traditional detection methods are insufficient. There is an urgent need for both increased 
access to molecular testing in malaria endemic settings, and for the development of more 
sensitive detection methods that are affordable and easy to use in both laboratory and 
field settings. Until such tools are widely accessible, mass screen and treat (MSAT) 
interventions are unlikely to identify enough of the infectious reservoir to effectively 
interrupt local transmission. This supposition has been borne out by the failures of recent 
MSAT trials.12–15  
Furthermore, the antimalarial treatments like sulfadoxine pyrimethamine (SP) and 
artemisinin combination therapies (ACTs) that clear asexual parasite stages often have 
limited effects on gametocytes, whether mature or immature, and allow gametocytemia to 
persist for several weeks after clinical symptoms disappear. The safety concerns related 
to the gametocytocidal drug primaquine have prevented its widespread adoption, despite 
World Health Organization (WHO) recommendations to include a low dose (0.25 mg/kg) 
with the use of first-line ACTs for treatment of clinical malaria cases.16,17 If there is to be 
any hope for malaria elimination in endemic areas with high EIRs, gametocyte clearance 
must become a priority in antimalarial treatment strategies. New gametocytocidal drug 
development is critical, whether for mass distribution, or to be taken in combination with 
first-line antimalarials in the treatment of clinical cases. An ideal drug would have rapid 
impacts on both immature and mature gametocytes, would not compete with the 
mechanism of action of the first-line treatment (thus minimizing selection for resistance), 
and would have limited side effects. In the absence of a new gametocytocidal drug, field 
testing methods to detect people with glucose-6-phosphate dehydrogenase (G6PD) 
deficiency could help to screen out those for whom the use of primaquine is 
contraindicated to enable safe mass drug administration with primaquine.  
Until new treatments and sensitive detection methods are available to effectively 
address the challenge of asymptomatic human reservoirs, the best hope for interrupting 
transmission is to prevent human exposure to anopheline mosquito bites. Insecticide-
treated bed net coverage in Malawi is already quite high among people with high 
prevalence of Plasmodium infection. However, school-aged children should be 
encouraged to sleep under bed nets more frequently to reduce ongoing transmission from 
this high prevalence group, even though distribution of bed nets alone will not eliminate 
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the ‘silent’ reservoir or completely interrupt transmission in these areas. Vector control 
strategies could be expanded and emphasized in zones of Malawi with high transmission. 
Indoor residual spraying attempts have been limited in the country thus far, and have had 
a restricted geographical scope.18 Given the potentially long duration of untreated human 
infections, vector control efforts would need to occur at regular intervals and be 
combined with other efforts to treat the human infectious reservoir in order to achieve 
maximum effects on transmission levels. 
The evidence provided in this dissertation suggests that achieving malaria 
elimination in the region will require a comprehensive plan to treat the ‘silent’ reservoirs 
of Plasmodium infection. While there may be some hope of targeting interventions at the 
school-aged children who comprise a large proportion of the gametocytemic reservoir in 
southern Malawi, limited capacity to detect and treat all asymptomatic infections means 
that elimination will remain unattainable. International efforts that go beyond malaria 
control and are aimed at the ultimate goal of eradication should support research into 
gametocytocidal drugs, transmission blocking vaccines, and sensitive field diagnostic 
techniques that can be used safely on a wide scale, in order to eliminate this debilitating 
and deadly disease.
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